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Abstract 
 
Near-Infrared spectroscopy (NIRS) is applied in pharmaceutical industry for monitoring drug content 
during tablet manufacturing process. NIRS method, once developed and validated, is used over years 
and it is of critical importance to insure method robustness towards formulation, process, 
instrumental, acquisition and environmental factors. Design of Experiments (DoE) methodology was 
proposed in this work for systematic study of the effect of compression pressure, pre-compression 
pressure and tableting speed on Average Euclidean Distance (AED) which reflects NIR spectral 
features of the studied caffeine tablets, and Root Mean Squared Error of Prediction (RMSEP) as a key 
performance indicator of the developed NIRS calibration model for caffeine content prediction. Study 
was performed in diffuse reflectance (DR) and diffuse transmittance (DT) measurement mode. 
Tableting factors shown to have significant influence on the studied responses have been considered 
in the development of the robust calibration models in DR and DT mode, using Global Calibration 
Model (GCM) approach. Three studied factors have shown to be significant in DR mode whereas, 
compression pressure and tableting speed have shown significant effect on the studied responses in 
DT mode. Developed robust method in DT mode have shown superior performances compared to DR 
mode, exhibiting total error (RMSEP) of 1.21 % calculated on the independent test set. DoE setup, 
with the selection of factors and responses adopted in this study was not reported elsewhere. 
 
Simultaneous NIRS quantification of two APIs in powders and tablets requires several challenges to 
be overcome. Overlapping absorption peaks of formulation components result in method specificity 
problem. Strategy for selecting the samples used for developing the prediction models is needed. 
Robustness of the method towards formulation factors needs to be assessed due to complex 
formulation.  Fast and simple method for simultaneous quantification of Hydrochlorothiazide (HTZ) 
and Metoprolol Tartrate (MTP) in powders and tablets was proposed in work. Simulation of industrial 
scale tablet machine using tablet press replicator - Presster® was proposed as fast and cost-effective 
alternative for design and manufacture of tablet sets needed for NIRS calibration model development. 
Balance Reference Method (BRM) was proposed as an alternative to HPLC and UV-spectroscopy 
which are traditionally used as reference methods in NIRS model development. The proposed 
experimental setup was suggested for the feasibility study stage of the method development. The two 
model drugs were simultaneously quantified using NIRS exhibiting RMSEP of 1.69 and 1.31 mg in 
HTZ powder and tablet samples respectively, while MTP powder and tablet samples were predicted 
with RMSEP of 3.15 and 3.00 mg respectively. NIRS analysis of Metoprolol Tartrate and 
Hydrochlorothiazide in powders and tablets was not yet reported in the literature. 
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The compressibility and compatibility of a powder formulation is conventionally determined by 
compaction followed by destructive tensile strength and relative density measurement of the final 
compact. In this study, a non-destructive near-infrared spectroscopic (NIRS) was evaluated for the 
determination of powder compressibility and compactibility. Twelve different formulations were 
investigated with 2 batches produced per formulation. Relative density and tensile strength were 
measured using a traditional, destructive method on one tablet batch and subsequently by a developed 
non-destructive chemometric NIRS method on the second batch of the particular formulation. The 
outcomes of the two approaches were compared to validate the developed method. All data sets were 
fitted to the three established mathematical equations to calculate equation factors, which represent a 
formulation compressibility and compactibility. The study focus was set on the equation factor 
comparison between the traditional and the newly designed method. The results have shown a high 
degree similarity between the outcomes of the two methods. A discrepancy between the two methods 
was observed for the outcomes of the equation factors after fitting to Leuenberger equation. The 
approach using NIRS is suggested as a promising tool for monitoring tablet manufacturing process. 
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1. Introduction 
 
Near-infrared spectroscopy (NIRS) is a technique becoming increasingly popular both in industry and 
academia. The reason is that it is very fast compared to the other analytical techniques. Very often it 
takes only several seconds to do a measurement. NIR is nondestructive analytical technique, which 
requires little or no sample preparation. It is very versatile. If sample contains molecular bonds such 
as C-H, N-H, O-H or S-H and if the concentration of the analyte exceeds about 0.1% of the total 
composition, then it is very likely that the analysis with NIRS would be feasible. Measurement 
procedure is quite simple and requires as little as few hours of training. There are, however, 
disadvantages that should be considered. The preliminary work, typical of any chemometric method, 
requires expertise and time. The system should be “taught” of what is in the sample relevant for the 
analyzed parameter. This task may be time-consuming. Currently available chemometric software 
packages offer user-friendly interfaces and big choice of data pre-treatments, wavelength selection 
algorithms, various regression methods such as multiple liner regression (MLR), partial least squares 
(PLS), principal components regression (PCR), neural networks (NN), support vector machines 
(SVM) among others. After several hours or days invested for calibration development, the multiple 
advantages of NIRS analysis would certainly outweigh the time required for method development. 
 
With current advances in computer technology and user friendly chemometric software packages it is 
not necessary for the developer or the operator that is using the technique, to have a firm theoretical 
understanding of near-infrared spectroscopy (NIRS). It is, however, needed for the meaningful 
development of NIRS method and interpretation of the results, that the basics of the technology and 
chemometrics are understood. NIRS methodology contains some theoretical considerations that are 
not relevant in more common spectroscopic applications. Hydrogen bonding shifts dominate the 
spectrum. Spectral interactions and nonlinearities deviate from Lambert - Beer’s law. The 
development of applications is significantly different from the UV-Vis and mid-IR applications. NIRS 
method development depends, to high extent, on statistics and chemometrics. 
 
Near-infrared spectroscopy (NIRS) is the study of interaction of electro-magnetic radiation that 
spans the range from 700 to 2.500 nm (14.285 – 4.000 cm-1), and the matter. Absorption in 
NIR spectral range is represented by overtones and combinations of the fundamental molecular 
vibrations from the mid-infrared (MIR) region. Overtones and combinations a r e  mainly 
associated with C-H, N-H, O-H and S-H functional groups. NIRS requires the use of chemometrics to 
analyze the functional groups present in a sample matrix. As a quality and process control technique, 
NIRS is applied to analyses of raw materials, intermediate and finished products. It has been 
widely used in food and agricultural industries since several decades. Pharmaceutical industry is 
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quite slow in accepting NIRS as a common analytical technique, which could be due to the fact that 
there is absence of primary absorption bands that could be assigned to the analyte. In recent years, 
an increasing amount of research has been carried out on NIRS and its application in pharmaceutical 
industry. The advances in hardware and software tehchnologies have enabled the necessary 
growth in use of NIRS in pharmaceutical industry. The regulatory authorities promoting the innovative 
concepts of pharmaceutical manufacturing, stimulate the use of NIR spectroscopy which is considered 
as a useful process analytical technology tool.  
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1.1 Historical Development of NIR Spectroscopy 
 
William Herschel’s discovery of near-infrared radiation has the greatest importance for the 
development of NIR spectroscopy (Davies T., 1998). He was considered one of the greatest 
astronomers of the time. In the year of 1800, he published two papers on the heating effect in the 
spectrum of solar radiation. He has used a glass prism as a dispersive element to transfer the sunlight 
onto three thermometers with carbon-blackened bulbs. Beyond the red end of the visible 
electromagnetic spectrum, he observed the heating effect. Herschel defined this phenomenon as 
“radiant heat” considering it as a form of energy different from light. Thirty five years later, Ampere 
found that NIR was not a different form of energy but a light energy that spans beyond the visible 
spectral range. At the beginning of the 20th century, the nature of the electromagnetic spectrum was 
studied and explained by many scientists. James Clerk Maxwell have formulated four equations 
defining the propagation of light (Maxwell J. C., 2011). The work of Kirchoff, Stefan and Wien was 
rounded up in 1900 by the law of radiation discovered by Max Plank (Planck M., 1901). 
 
In the first half of the 20th century, the spectral features of many organic compounds were explained 
and assigned to functional groups. Infrared spectroscopy was not so widely excepted and was reserved 
mostly for the scientists and spectroscopists. Suitable spectrometers did not exist at that time and the 
few existing ones were available only in governmental institutions. The first quantitative NIR 
application was the determination of atmospheric moisture at the Mount Wilson observatory by F.E. 
Fowle in 1912. In 1938, Ellis and Bath determined water content in gelatin. In the early 1940s, 
Barchewitz analyzed fossile fuels and Barr and Harp published the spectra of some vegetable oils. 
Until 1970, only about 50 scientific papers, related to NIR, had been published. In the 1930s, lead 
sulphide has been studied as a materials suitable for the detection of infrared light. The upcoming 
Second World War stimulated the development of heat sensors based on lead sulphide. After the 
Second World War, lead sulphide detectors, covering the wavelength region of 1000-2500 nm, 
became commercially available (Pasquini C., 2003). 
 
Research in the field of NIRS was developing slowely after the Second World War. Many scientists 
considered the technique too complex as it was characterized by weak and overlapping absorption 
bands based on overtones and combination bands of fundamental MIR absorptions. The degree of 
absorption of NIR radiation by a matter was two to three orders of magnitude weaker compared to 
MIR. The baseline dependency on many instrumental, acquisition and sample properties was creating 
additional confusion among the scientists. The lack of chemometric software packages made the peak 
assignment and spectra interpretation difficult. On the other hand, very sensitive PbS detectors were 
commercially available together with powerful tungsten lamps as a good source of NIR radiation, and 
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that enabled diffuse reflection measurements of solid samples. The components of the first NIR 
spectrometers were relatively inexpensive which stimulated the manufacturing of the first NIR 
instruments. 
 
Near-infrared spectrometers rely to a great extent on the computer technologies. Computers control 
NIR instruments, data acquisition and enable calibration process and data analysis that require 
thousands of calculations which would be inconsivable without the aid of computer. Work on diffuse 
light scattering in transmission and reflection by Kubelka and Munk in 1931, set a foundation for the 
NIR measurements of solid samples. The discovery of principal components analysis (PCA) and 
Mahalanobis`s mathematical approach for representing data clustering and separation in 
multidimensional score space, helped in further development and use of NIR spectroscopy. The first 
commercially available computer was launched on the market in 1950s. Several years later, 
programming language Fortran, was developed by the company IBM. In the beginning of 1980s, 
personal computers has been widely spread and became the driving force for the development of NIR 
instrumentation (Wahr J. A., 1996). 
 
In the mid of 20th century there was a growing demand for fast, quantitative determinations of 
moisture, protein, fat and other common parameters in different agricultural products. Scientist named 
Karl Norris, who was working for US Department of Agriculture at that time, was assigned to solve 
the problem of the need for fast analysis of wheat grains. He has managed to solve the problem and 
provide a solution based on NIR technology. The equipment that he has used was fairly simple but 
able to provide sufficient performances to satisfy the needs of the market. In 1968, Ben-Gera and 
Norris published the work on applying multiple linear regression (MLR) to the problem of calibration 
related to agricultural products (Ben-Gera I. et al., 1968). In the early 1970s the first NIR laboratory 
instruments were launched on the market by the companies Dickey-John, Technicon and Neotec. The 
first process instruments were developed in Germany and UK.  
 
In the 1980s, the microprocessors have started being integral part of the design of NIR instruments. 
Data acquisition was controlled by the microprocessor technology and the data manipulation was 
much faster. Data analysis and interpretation was enhanced by including MLR, PLS and PCA 
algorithms in the software packages. Companies developing chemometric software have emerged 
offering a various possibilities of data treatments. NIR technology has developed rapidly since 1970s. 
In many fields, NIR spectroscopy is now the measurement technique of choice (Saeed M., 2011). 
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1.2 Theory of Near Infrared Spectroscopy 
 
1.2.1 Molecular Vibrations 
 
Energy status of the molecules change after the NIR radiation energy is absorbed. Rotational and 
vibrational quantum numbers represent the changes in energy status of molecules. Vibrational energy 
has higher magnitude compared to a rotational energy. Molecules are in a ground energetic state, i.e. 
at the lowest energy level, unless excited. When the substance is irradiated with the light from NIR 
source, some of the molecules will absorb the photon energy and reach the higher energetic level. 
Most of the molecules reach the first energy level next to the ground state and very few second or 
higher energy level. Such a changes in rotational and vibrational energy represent the first or higher 
overtone absorption bands in NIR spectra. Probability of such transitions is very low, and for that 
reason the intensity of overtone bands is ten to hundred times weaker compared to the absorption 
bands from fundamental vibrations (Wilson E. B., 1955; Quack M., 1990). 
 
Vibration of covalent bonds in a molecule does not obey Hooke`s law of harmonic motion. The 
quantum vibrational energy levels are not equidistant within a potential energy well. This 
phenomenon is called anharmonicity. Anharmonicity is reflected in the fact that the frequency of the 
overtones is slightly less than the integer multiples of the fundamental vibrational frequencies. This 
results in the overtones being found at slightly longer wavelengths than expected (Sokolnikoff, I. S. 
and Dickerson S. R., 1956; Rychlewski, J., 1984). 
 
 
 
Figure 1: Schematic representation of the harmonic (A) and anharmonic (B) models for the potential energy of a 
diatomic molecule. 
 
de = equilibrium distance (U = minimum) (Pasquini 2003) 
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1.2.2 Origin of absorption bands in NIR 
 
When the energy of NIR light that irradiates the molecules equals the difference between two 
vibrational energy levels, molecules will interact with the frequencies of the light. Some frequencies 
of the incident radiation will be absorbed and the other partially absorbed or not absorbed at all. The 
dependence of the intensity of the absorbed radiation on the frequency of the incident light source 
constitutes the absorption spectra of a analyte. In the interaction of the matter with the light wave it is 
crucial that the electrical field of the electromagnetic wave can interact with the electric field of the 
molecules. Such an interaction results in absorption of the light by the matter. Absorption can occur 
only if the vibrational movement of the atoms that form the molecular bond or the atoms forming a 
local group of vibrating atoms, creates a change in the diplole moment. 
 
Transitions to excited states that involve two vibrational modes at the same time are also allowed. 
Those are called combination bands and occur in polyatomic molecules. In NIR spectroscopy, the 
importance of combination bands is quite significant. Overtone absorption bands originate from the 
functional groups that contain C-H, N-H, O-H or S-H atomic bonds. Overtone vibrations that 
originate from the above mentioned covalent bonds are combined with lower-frequency fundamental 
bands such as C=O and C-C to generate overtone-combination bands. Combination bands are very 
useful in NIR spectroscopy. Unlike MIR, in NIR spectroscopy, for combination bands to occur, it is 
necessary that only one of the combining vibrations is active,  causing a  dipole change. The other 
may be inactive. This feature is unique and makes some vibrations visible in NIR spectral range while 
not observable in MIR range. 
 
Intensity of absorption bands is dependent on the degree of the dipole change during thvibration of the 
covalent bonds. Covalent bonds show fundamental vibrational transitions in the region of 3000 - 
4000 nm. Intensities of the combination absorption bands are around ten times weaker compared 
to fundamental vibrations whereas, up to thousand times weaker for the overtone vibrations. The 
spectral features in NIR region are dominated by overtones and combination absorption bands. 
(Workman J. J., 1992). 
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1.2.3 Sample Presentation and Measurement Modes in NIR Spectroscopy 
 
Sample presentation to an NIR instrument is one of the critical factors affecting NIR measurements. 
Figure 2 illustrates sample presentation modes, i.e. diffuse reflection, diffuse transmission, specular 
reflection, transmission and transflection. In the case of diffuse reflection, incident light irradiates the 
surface of the sample, is diffusely reflected from the surface layer of the sample, and finally detected. 
In order to apply this measurement mode, the sample should be opaque and not transparent, e.g. 
powder or tablet. Diffuse transmission measurement mode is characterized by an incident light that 
illuminates one side of the sample, traverses the sample through pore structure, and finally the 
transmitted light is detected on the other side of the sample. The light takes tortuous path through the 
sample and is being reflected or refracted on the solid-air interfaces of the pores. Those optical 
phenomena are repeated multiple times and as a resul, the effective pathlength is several orders of 
magnitude higher compared to the nominal one. The intensity of the detected signal is usually quite 
weak and noisy, so it requires the use of very sensitive detectors. Specular reflection occurs at the 
surface of the sample where the angle of the reflected light is equal to the angle of the incident light. 
Transmission measurement mode is usually applied for the liquid and transparent samples. The 
sample shouldn`t be opaque and the scattering should be negligible. Transflection measurement mode 
combines transmission and reflection principles. Incident light is transmitted through the sample and 
reflected back from a reflective surface, which could be from teflon, ceramic or other reflective 
material. In this work, diffuse reflectance and diffuse transmittance measurement modes were applied 
for the measurement of the powder and tablet samples (Cozzolino D. and Murray I., 2002; Siesler H. 
W., et al., 2008). 
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Figure 2: Diagram showing the types of light interaction in the NIR region with particulate solids. In practice, only 
diffuse reflection and transmission are observed 
 
 
1.2.4 Diffuse Reflectance (DR) Measurement Mode 
 
Reflectance of certain material is represented by the ratio of the  light intensity reflected from a 
diffusely reflecting surface, I0, and light reflected from the measured sample, IS. Reflectance is usually 
reported in absorbance units, log (1/R). Apparent absorbance spectra recorded in diffuse reflectance 
measurement mode establish linear correlation with the concentration of the analyte, according to 
Lambert - Beer's law. The deviations fom the law (nonlinearities) are disregarded if insignificant or 
dealth with by adding additional factors to the calibration model or nonlinear terms (Wendlandt W. 
W. and Hecht G. H., 1966; Fuller M. P. and Griffiths P. R., 1978). 
 
The first theory on diffuse reflection was given by Bouguer in the middle of 18th century. Bouguer 
assumed diffuse reflection as a sum of mirror-type reflections from the microcrystalline faces 
statistically distributed over all possible angles.  
 
Lambert established a cosine law in 1760. Describing the relation between the intensity of an incident 
light beam, angle of incidence and the angle of an observation. The shortcoming of the theory was 
the fact that an ideal diffuse reflective surface, which was postulated in the theory has never been 
found and thus, failed to succeed in practice. 
 
Diffuse             
Reflection 
 
Diffuse             
Transmission 
 
Specular             
Reflection 
 
Transmission 
 
            
Transflection 
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In 1888, Seeliger and the coworkers came up with an idea of diffuse reflectance radiation penetrating 
the surface of materials. One portion was assumed to be absorbed by the material and part returned to 
the surface through reflection, diffraction or refraction from the microstructure of the surface layer of 
the material. 
 
In 1908., Mie set a theory described elastic scattering phenomenon and the relationship with the 
frequency of radiation. The main assumption of the theory was that the scattering is associated with 
isolated, spherical particles. According to this theory, scattering is not distributed isotropically but 
rather follows a complex pattern with forward scattering being more probable than the reverse 
scattering (Simmons E. L., 1975; Steinke J. M. and Shepherd A. P., 1988). 
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                     Equation 1: Mie Theory 
 
 
λ – Single wavelength 
IƟscat – Intensity of scattered radiation at distance R and angle π from the center of the scattering 
particle 
i1, i2 - Complex functions of the angle of the scattered radiation, the spherical harmonics, or their 
derivatives with respect to the cosine of the angle of scattered radiation, the refractive index of both 
the sphere and surrounding medium, and the ratio of the particle circumference to wavelength 
 
Equation 1 shows that as the wavelength increases, the intensity of the scattered radiation 
increases. This could explain the baseline upscaling observed in the NIR absorbance of the solid 
samples. Mie theory suffered from several drawbacks. Particles in real solid samples could not be 
considered isolated but are rather in contact with one another. The theory also didn`t consider 
multiple scattering phenomena.  
 
Kubelka and Munk, in 1931., came up with a simplified solution of the radiation transfer equation. 
The equation 2 shows that the measured diffuse reflectance (R∞) is dependent on the ratio of the 
absorption coefficient (K) and the scattering coefficient (S). Kubelka and Munk's equation is widely 
accepted explanation of the diffuse reflectance since it is a equation consisted of the two constants 
and could be experimentally tested (Kubelka P., 1948; Nobbs J. H., 1985).  
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          Equation 2: Kubelka – Munk Equation 
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1.2.5 Diffuse Transmittance (DT) Measurement Mode 
 
Interaction between NIR radiation and solid particles is characterized by the relatively weak 
absorbance with high scattering. This feature allows the NIR light to penetrate the solid samples with 
little or no requirements for sample preparation. The diffuse transmission measurements of solid 
samples are unique for the NIRS compared to MIR and UV spectroscopy. Transmittance of a sample 
is defined as the ratio of light intensity transmitted through an empty path, I0, and light transmitted 
through an equal distance of a sample, Is. Transmittance of a sample can be reported in the form of 
Beer-Lambert law (Zaccanti G. and Bruscaglioni P., 1988; Langhals H. G. et al., 2000): 
 
 =  =  = !                 Equation 3: Beer – Lambert Law 
 
For a single wavelength, λ: 
A – Beer-Lambert optical absorbance 
T – Transmittance ratio 
a – absorption coefficient, cm-1 
b – pathlength (or sample thickness), cm 
c – concentration of absorbing material 
 
Transmittance of NIR radiation through a solid sample composed of tightly packed particles, deviate 
nonlinearly from the Beer-Lambert`s law, unlike UV or VIS absorption spectroscopy. In case of 
spectroscopy through clear liquids where the nonlinear deviations from Beer`s law are due to changes 
in absorption coefficients across the concentration range, in case of diffuse transmission through solid 
sample, incident photons are scattered or reflected either forward or backward relative to the direction 
of propagation of the incident beam, I0. The incident photons are not transmitted directly through the 
sample but rather take a tortuous path with multiple scattering phenomena. 
 
Diffuse transmittance NIR spectroscopy shows the most important features is in the third overtone 
region, between 780-1100 nm. The absorptivity, reflectance, and scattering properties of a solid 
samples such as powders, granules or tablets, are dependent on various sample properties such as 
particle size and morphology, bulk density and index of refraction.  The effective pathlength and the 
nonlinear deviation from the Beer's law is, however, difficult to predict in practice. 
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1.2.6 NIR Instrumentation 
 
Instrumentation dedicated to NIR spectroscopy differs from the other spectroscopic instruments in 
the applied spectral range and specificity of the applications that it is dedicated for. Required 
resolution of NIR spectrometers is not as high as for the UV or MIR because NIR spectra appear as 
combinations and overtones of primary absorption bands of fundamental MIR vibrations. Spectral 
acquisition in NIR spectral region is often challenging. Measurements made in a field or on the 
factory production line are typical of NIRS. In laboratory, measurements are usually done in situ, 
with little or no sample preparation. Samples that are analysed by NIR spectroscopy are often 
heterogeneous, solid or opaque samples, with significant scattering properties. Large light spot area, 
high sample throughput and a fast spectra aquisition are prerequisits for high quality NIR 
measurements. 
 
Interference-filter spectroscopy, Fourier-transform spectroscopy and acousto-optic tuneable filter 
spectroscopy are well known technologies suitable for NIR spectroscopy. Specific measurement 
cells and NIR sampling geometry are used in NIR spectroscopy for improving the acquisition 
efficiency of diffuselly reflected light. 
 
NIR spectrometers could be optically set up as pre-dispersive or post-dispersive depending on the 
position of the wavelength selection element in the light path from the source of the radiation, sample 
to the detector (figure 3). In case of pre-dispersive spectrometers, sample is illuminated with 
monochromatic light. Light that is scattered back from the sample surface or transmitted through the 
sample is collected and brought to the detector. Stray light that hits the sample is also collected are 
delivered to the detector. Since stray light can represent a large portion of the total detected light 
signal, it is a major source of error in pre-dispersive NIR spectroscopy. Stray light effect can be 
reduced by protecting or covering the sample in order to reduce the ambiental light sample 
illumination. 
 
In case of post-dispersive NIR spectrometers, sample is illuminated directly from the source of NIR 
radiation. Light that is scattered back from the sample or transmitted through the sample is dispersed 
and then delivered to the detector. As it is a case with the NIR pre-dispersive spectrometers, stray 
light that hits the sample is also being collected. The difference is that in case of post-dispersive 
instruments, only stray light of the same wavelength as that being detected is added to the signal 
resulting from the instrument’s illumination of the sample. For that reason, the stray light represents 
only a small portion of the total light signal measured by the detector (Workman J. J. and Burns D. A., 
2001; Osborne B. G. et al., 1993). 
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Figure 3: Pre-dispersive (above) and Post-dispersive Spectrometers 
 
 
1.2.6.1 Filter instruments 
 
Filter instruments consists of a set of 10-20 interference filters mounted on a rotating wheel 
positioned between the collection lenses and a detector (figure 4). It is possible to have very fast 
measurements, comparable to diode array spectrometers, by spinning the filter wheel at a rate of 
several thousands oscilations per minute. Fast Fourier transformation of the detected signal can be 
applied to separate the spectral data from the instrument noise. Filter instruments have simple and 
robust design and are suitable for not too demanding applications. Filter based instruments are often 
applied as an on-line moisture gauges. The main drawback of the filter instruments is the limited 
wavelength accuracy and low spectral resolution (Shenk J. S. and Westerhaus M. O., 1985). 
 
 
 
 
Figure 4 : Rotating wheel with interference filters 
 
1.2.6.2 Light Emitting Diodes - based instruments 
 
Light Emitting Diodes (LED) technology is used in some applications where it is important to reduce 
the size of the instrument. LED-based instruments are characterized by a band width of around 30 - 50 
nm. The instruments are employing multiple LEDs as sources of narrow band NIR radiation which is 
Light Source Dispersive Element Sample Detector 
Light Source Dispersive Element Detector Sample 
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then dispersed by using common dispersive elements such as gratings or interference filters. LED-
based NIR instruments operating at wavelengths higher than 1100 nm are still quite expensive 
(Malinen J. et al., 1998). 
 
1.2.6.3 AOTF instruments 
 
NIR spectrometers based on Acousto-Optical Tunable Filter (AOTF) technology have design with 
no moving parts, capable of reaching high scanning speed over a broad range of NIR region (figure 
5). Scan speeds of up to 2000 wavelengths per second, is the advantage of AOTF technology in 
process analysis where fast acquisition is of critical importance. AOTF instruments are made of a 
birefringent TeO2 crystal, cut in a special angle, and a piezoelectric material attached to one end of the 
crystal.  TeO2 crystal is excitated by an external radio frequency signal, producing an acoustic wave 
which propagates through the crystal and produces a variation of refractive index of the crystal. 
The frequency of the generated acoustic wave is determined by the radio frequency signal. The 
usuall radio frequency range in AOTF NIR spectroscopy is from 50 to 120 MHz. The interaction of 
the electromagnetic wave and the acoustic wave causes the crystal to refract narrow wavelength 
bands from the NIR light source. The birefringent TeO2 crystal produces two monochromatic l ight 
beams and both or only one diffracted beam can be used by NIR instruments (figure 5). The fact that 
there are no moving parts makes the AOTF NIR spectrometer a good candidate for the 
implementation in field or production environment. The scan speed enables the on-line or in-line 
process-monitoring (Pasquini C., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 : Scheme of the AOTF instrument 
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1.2.6.4 Dispersive instruments 
 
Diffraction grating dispersive instruments are one of the earliest N IR  technologies (Figure 6). 
These instruments have a relatively low cost compared to the other scanning instruments employing 
modern technologies. The main disadvantages is the slow scan speed and low wavelength accuracy and 
precision. Wavelength instability deteriorates over time due to mechanically driven mechanism 
fatigue, which causes the unreliability of the dispersive instruments for the use in production 
environments (Armstrong P. R. et al., 2006).  
 
 
 
Figure 6: Diffraction Grating NIRS. 
 
 
The incident light is delivered by a concave mirror on to the diffraction grating, where it is spatially 
split into the narrow spectral bands. A second concave mirror focuses the spectral bands of the light 
onto the Charge Coupled Device detector, and in that way, capturing the sample spectrum in a single 
acquisition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Diode array instrument 
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λ
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Recent evolution in detector technology enabled dispersive instruments to be more efficient. 
Construction of linear arrays of PbS and InGaAs detectors containing up to 256 independent elements 
allow scanning the entire spectrum in a few milliseconds (figure 7). Additionally, the innovative 
design eliminated the moving parts of the diode - array NIR spectrometers (Cozzolino D. et al., 2004). 
 
1.2.6.5 Fourier-transform (FT) NIR Spectrometers 
 
FT-NIR spectrometers offer several advantages in comparison to the other NIR technologies especialy 
when the high-resolution capabilities are important or if the spectrometer needs to have many options 
for sample presentation. The spectral resolution of FT-NIR spectrometers is constant across the spectral 
range and is adjusted by varying the length of the interferogram. In case of a Michelson interferometer, 
the length of the interferogram, i.e. the spectral resolution corresponds to the displacement of the 
moving mirror. Scanning speed is for that reason impared compared to e.g. diode-array spectrometers. 
 
The FT spectrometers have a combination of three theoretical advantages, which make this technology 
advantages: 
 
• All wavelengths are detected simultaneously (Fellgett's advantage) 
• Wavelength accuracy is constantly maintained by a built-in laser (Connes advantage) 
• High optical throughput compared to the other technologies (Jacquinot's  advantage) 
 
The resolution needed for the most NIRS applications for the analysis of pharmaceutical solid dosage 
forms is 8-16 cm
-1
. This is due to the fact that the absorption bands in NIR region, originating from 
the combination and overtone vibrations, are broad and overlapping.  
 
Polarization interferometer is based on a two-piece birefringent crystal wedge polarizer and 
birefringent compensator to modulate optical light beam in the pattern of a Fourier interferogram. 
Figure 8 shows that randomly polarized radiation passes through a linear polarizer and a 
birefringent crystal, which separates the light into two orthogonally polarized parallel light beams 
with a phase shift, thereby slightly rotating the plane of polarization. The phase-shifted beams are 
transmitted through the two-piece wedge polarizer, which then rotates the plane of polarization in 
the opposite direction, reducing the phase shift. The angle of polarization rotation is dependent on 
the effective pathlength through the wedge polarizer, and wavelength. At the initial position, the 
thickness of the wedge polarizer is set so that the polarization rotation angle perfectly offsets the 
compensator, resetting the polarization state to that of the first polarizer. In this state, the maximum 
light energy at all wavelengths will pass through the second polarizer. As the thickness of the wedge 
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polarizer varies, the polarization angle incident on the second polarizer will vary following a 
sinusoidal pattern between 0 and 100% transmittance; the frequency of the sinusoidal pattern will 
vary according to optical frequency. Therefore, the sum of the components incident on the detector 
will produce an optical interferogram. The optical efficiency of the device is limited by absorption 
in the beam path, especially as the thickness of the wedge polarizer reaches a maximum (which 
will limit the maximum resolution). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Scheme of the polarization interferometer. A sample is placed after the last lens and before the detector. A 
second lens then is needed to compensate for signal divergence through the sample. (Ciurczak 2005) 
 
 
Because there is only a single optical path through the instrument (compared with the dual path of 
Michelson, Sagnac, or Mach-Zender interferometers), the polarization interferometer is less 
affected by small misalignments, which makes it more suitable form at-line applications. 
Additionally, simple design is more cost-effective and can be produced with a smaller footprint 
(Siesler H. W. et al., 2008). 
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1.3 Chemometrics 
 
Chemometrics is a science that uses different mathematical and statistical methods to perform 
calculations on a large amount of chemical data and exctract the information relevant for the analysis 
of interest. The common meaning of the chemometrics refers to using linear algebra calculations, to 
make either quantitative or qualitative analysis of chemical data such as NIR spectra. The science of 
chemometrics provides to spectroscopists different ways to solve the calibration problem for analysis 
of spectral data. Chemometrics is the bridge between connecting the state of a chemical system to the 
measurements of the same system. It has become an essential part of the modern industry. 
Chemometric software packages have been widely used by product development scientists, process 
engineers, PAT specialists, and QA/QC scientists to build reliable models, ensure product quality, 
classify raw material and to monitor the process in real-time (Vandeginste B. G. M. et al., 1988). 
 
1.3.1 Regression Methods 
 
Regression methods are a useful tool for the investigation of the relationships between variables. 
Usually, the investigator is looking for the causal effect of one variable upon another. For example, 
the effect of a calorie intake on a body weight, or the effect of changes in the money value upon the 
inflation rate. To explore such relationships, the investigator performs regression analysis to estimate 
the quantitative effect of the causal variables upon the variable that they influence. The investigator 
also typically assesses the statistical significance of the estimated relationships, that is, the degree of 
confidence that the true relationship is close to the estimated relationship. 
 
1.3.1.1 Multiple Linear Regression 
 
Multiple Linear Regression (MLR) is a method used to model the linear relationship between a 
dependent variable and one or more independent variables. The dependent variable is also called 
predictand, and the independent variables, predictors. MLR is based on least squares theory. The 
model is fit in a way that the sum-of-squares of differences of observed and predicted values is 
minimal. The predictors in any regression problem could be inter-correlated. Inter-correlation of 
predictors does not prevent the use of regression, but can make difficult or impossible to assess the 
relative importance of individual predictors from the estimated coefficients of the regression equation. 
Extremely high inter-correlation of predictors, or multicolinearity, exacerbates any difficulty of 
interpreting the regression coefficients, and may call for combination of subsets of predictors into a 
new set of less inter-correlated predictors. Regression models are generally not intended to be applied 
to predictor data outside the range encountered in the calibration period (Aiken L. S. et al., 2003). 
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The model expresses the value of a predictand variable as a linear function of one or more predictor 
variables and an error term: 
 " = 	$ + $% + $
%
 +⋯+ $'%' + (      Equation 4: Multiple Linear Regression 
 
 
xk – value of kth  predictor  
bo – regression coefficient 
bk – coefficient on the kth predictor 
K – total number of predictors 
y – predictand  
e – error term 
 
In NIR spectroscopy there are usually fewer calibration samples compared to the recorded 
wavelengths. Consequently, MLR often leads to unstable estimates of the response. MLR model could 
fit the calibration set well, but if the regression vector is unstable, small random errors in future 
samples could be enlarged. This may result in large prediction error in future samples during routine 
use of a method.  
 
In case of the applications from the filter-based instruments, where few wavelengths are available, 
MLR could be a suitable regression method. The same holds for the cases where there are sharp and 
well defined absorption peaks, e.g., in case of some organic solvents, chemicals or active 
pharmaceutical ingredients (APIs). In such cases, MLR could perform better compared to more 
advanced regression methods like Partial Least Squares (PLS) or Principal Component Regression 
(PCR). 
 
1.3.1.2 Principal Component Regression 
 
Principal Component Analysis (PCA) is a method of data analysis for building linear 
multivariate models of large amount of data. PCA models are developed using orthogonal vectors 
(loadings), usually called principal components. PCA aims at eliminating the principal 
components associated with noise, reducing the dimensionality of complex data sets and 
minimizing the effect of a random measurement error. 
 
PCA is a chemometric method that explains the covariance structure of a  data by a relatively 
small number of new variables (principal components). These components are linear combinations of 
the original variables that allow the interpretation and a better understanding of the different sources 
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of variation in a data set. PCA as a data compression tool is widely used for the analysis of high-
dimensional systems which are frequently encountered in chemometrics. PCA is usually the first 
step in a data analysis, followed by classification, cluster analysis, or other multivariate regression 
methods.  
 
The most important step in PCA is to select the principal components that carry most of the 
information relevant to the analysis. The first principal component corresponds to the direction in 
which the projected observations have the largest variance. The second component is orthogonal to 
the first one and again maximizes the variance of the data points projected on it. Continuing in this 
way, PCA produces all the principal components, which correspond to the eigenvectors of the 
empirical covariance matrix. 
 
This method is sensitive to anomalous observations. The first components are often attracted toward 
outlying points and thus may not capture the variation of the regular observations which are relevant 
for the analysis. Therefore, data reduction based on PCA becomes unreliable if outliers are present in 
the data set (Jolliffe I., 2005). 
 
1.3.1.3 Factor Selection 
 
Selection of the number of principal components in a PCA model is critical because retaining more 
factors than needed would only add more noise to the model and would deteriorate its predictive 
ability. On the other hand, if less than optimal number of factors is kept, meaningful information 
would not be included in the model and that would results in suboptimal model. There are a number of 
ways to ensure the correct selection of the model dimensionality. 
 
1.3.1.4 Predicted Residual Error Sum of Squares (PRESS)  
 
One of the best ways to determine how many factors to use in a PCR calibration is to generate a 
calibration for every possible number of factors and use each calibration to predict the property of 
interest in a set of independent validation samples. The predicted residual error sum of squares, or 
PRESS, is calculated for each calibration and the calibration that provides the best results is chosen. 
The number of factors used in that calibration is the optimal number for that system. 
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1.3.1.5 Cross-validation 
 
Sometimes, a sufficient set of independent validation samples to calculate PRESS is not available. In 
such cases, the original training set can be used to simulate a validation set. This approach is called 
cross-validation. The cross-validation is performed in a way that a calibration is calculated using all of 
the training set samples except for one sample or group of samples. Calibration is then used to predict 
the concentration of the analyte in the sample that was left out of the training set. In the next step, the 
sum of squared differences (errors) between the expected and the predicted concentrations for the 
sample that was left out is calculated. Excluded sample is then returned to the training set, and another 
sample is left out. New calibration is calculated for the new subset of the original training set. New 
PRESS value is calculated and added to the one calculated so far. When all `leave-one-out` 
combinations are computed and overall PRESS value calculated the process is repeated for every 
possible number of factors. The PRESS is examined for each of the calibrations to choose the one that 
gives the best results. The number of factors used in that calibration is the rank of the system. This 
procedure is known as "leave one out" cross-validation. This is not the only cross- validation method, 
but rather the most popular although it tends to generate the models with unrealistically small model 
error (Standard Error of Cross Validation), which is not representative of the future predictions. 
Cross-validation with leaving out the calibration (property) range segments instead of the single 
samples was used in this work as it is suggested by many authors as the one giving the most realistic 
models. The calibration range is divided in ten to twenty segments and the segments are left out in 
iterative cross-validation steps. This method tends to generate the calibration models with higher 
Standard Error of Cross Validations but is better estimate of the error to be expected in routine 
analysis (Kohavi R., 1995). 
 
1.3.1.6 Spectra Reconstruction and Model Calculation 
 
By discarding the principal components that carry the noisy information, it is possible to remove a 
portion of the noise from the spectra. The spectra that are generated after the noise removal are 
called reconstructed spectra. When principal component regression is applied to the data set, there is 
not really a separate, explicit data regeneration step. When the PCR model is developed and applied 
to the unknown data set, the spectra are automatically reconstructed excluding the noise information 
by using the factors that explain the spectral variation related to the change in the property under 
study. When the model is applied to an unknown sample, the predicted property is calculated as the 
product of the measured spectrum of the sample and the calibration matrix.  
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1.3.1.7 PCA as a Multivariate Data Exploratory Tool 
 
First few principal components usually represent a relevant part of the total data variance. Thus, 
when plotting pairs of principal component scores, the data structure can be visually inspected in 
two dimensions in order to identify groups of objects. PCA transforms the data matrix X, 
containing data for n objects with m variables, into a matrix of lower dimension T. In the 
matrix T, each object is characterized by a relative small number of PCA scores. Score ti of the ith 
object xi is a linear combination of the variables of vector xi and the vector components (loadings) of 
a PCA loading vector p. The score vector tk of PCA component k contains the scores for all n 
objects; T is the score matrix for n objects and a components; P is the corresponding loading matrix.
 
PCA is usually the first choice to visualize multivariate data by scatter plots and transform 
highly correlating variables into a smaller set of uncorrelated variables. Outliers may heavily 
influence the result of PCA and diagnostic plots help to find outliers (leverage points and 
orthogonal outliers) falling outside the hyper-ellipsoid which defines  the  PCA  model. 
 
1.3.1.8 Partial Least Squares Regression 
 
PLS is a variation of PCR that takes its concept one step further by using a different way to find 
a coordinate system that can have advantages over the coordinate system used for PCR. This 
strategy involves finding factors for both the spectral and the reference data. 
 
The reason behind this approach is the following:  First, to utilize the noise removal capabilities of 
PCA and remove some of the noise from the reference data. Second, and because the noise in the 
spectral data will deflect each eigenvector slightly out of the plane containing the theoretical, noise-
free data in some randomly different direction than the deflection of the corresponding spectral 
eigenvector (since noise in the reference and spectral data are independent from each other). PLS 
rotates the vectors back, towards each other until they are aligned and provide better noise removal by 
bringing the vectors closer to the ideal planes, containing the noise-free spectral and reference data. In 
addition to the set of new coordinate axes for the spectral data (the x- block), we also find a set of 
new coordinate axes for the referencing data (the y-block).  These reference data are expressed as 
projections onto the concentration factors in a way similar to expressing the spectral data as 
projections onto the spectral factors. 
 
Each pair of factors is rotated towards each other on a factor-by-factor basis to maximize the fit of the 
linear regression between the projections of the spectra onto the spectral factor with the projections of 
the reference data onto the concentration factor. The calibration (regression) coefficients are then 
 Vranic Z. Branko PhD Thesis Page 38 
 
calculated using linear regression between the projections of the spectra on each individual 
spectral factor with the projections of the reference data on each corresponding referencing factor of 
the same order. 
 
The prediction step for PLS is also slightly different than for PCR where it is also performed 
on a rank-by-rank basis using pairs of spectral and reference factors. Taking predicting 
concentration as an example, for each component, the projection of the unknown spectrum onto the 
first spectral factor is scaled by a response coefficient to become a corresponding projection on the 
first concentration factor. This yields the contribution to the total concentration for that component 
that is captured by the first pair of spectral and concentration factors. The process is then repeated 
for the second pair of factors, adding its concentration contribution to the contribution from the 
first pair of factors, and continued until all of the factors in the basis space have been used. 
 
PLS will search for a single vector, W, that represents the best compromise between the spectral factor 
and the reference factor, which is not necessarily the factor that lies exactly half-way between 
them. It is, instead, the factor that maximizes the linear relationship between the projections 
(scores) of the spectral points onto the factor and the projections (scores) of the corresponding 
reference points onto this same factor and maximizes the covariance between the two (Geladi P. and 
Kowalski B. R., 1986). 
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1.3.2 Spectral Pre-processing 
 
The successful application of multivariate calibration methods is negatively affected by the 
presence of uninformative variance in NIR spectra. Baseline effects may occur from small changes in 
sample properties (packing density, surface texture, temperature and humidity, inhomogeneities, etc.). 
In addition, uninformative variance may be introduced into a data set by changes in the operational 
parameters of the NIR spectrometer. 
 
One approach to minimize these effects is to apply mathematical pre-treatments to the raw spectra. 
There are many types of pre-treatments, some of which are commonly indicated for certain 
conditions (like derivatives to exclude baseline shifts) while in many cases their use is sample- and 
application-dependent. 
 
1.3.2.1 Mean Centering 
 
Mean centering is applied by subtracting the mean spectrum of the data set from every spectrum in 
the data set, equation is given below: 
 

,*+ = 
,* − ∑ 
,*..*/               Equation 5: Mean Centering 
 
R = Spectrum j in an array of J spectra 
i = wavelength data point 
 
Mean Centering translates the collection of data to the origin of the multivariate space where 
analysis will be performed. The practical consequence of mean-centering data is often a more 
simple and interpretable regression model. In effect, mean centering removes the need for an 
intercept from the regression model. Consequently, since fewer terms in the regression model 
may need to be estimated, estimated analyte concentrations may be more precise following mean 
centering of the data (Seasholtz M. B. and Kowalski B. R., 1992). 
 
1.3.2.2 Smoothing 
 
With smoothing, it is possible to improve the signal-to-noise ratio of a spectrum, for example, as a 
function of time or more commonly, wavelength. 
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Caution must be used when smoothing data. Strong smoothing gives better signal-to- noise ratios 
than weak smoothing, but strong smoothing may adversely reduce the resolution of the signal and 
hence affects methods involving spectra with sharp peaks or shoulders. 
 
The simplest method of smoothing is to calculate a running average for a narrow window of 
points. The smoothed spectrum is generated by using the average value from the window. This causes 
problems at the endpoints of the curve, and numerous authors have described different methods for 
treating them. 
 
The most commonly used type of smoothing is polynomial smoothing, also called Savitzky-
Golay smoothing. Polynomial smoothing works by fitting of a smooth polynomial function to the data 
in a sliding window of width w, where w is usually an odd number. Smoothed points are generated 
by evaluating the polynomial function at its midpoint. The window is moved to the right by 
dropping the oldest point from the window and adding the newest point to the window until the 
entire curve has been smoothed. The degree of smoothing is controlled by varying the width of the 
window, w, and by changing the degree of the fitted polynomial function (Savitzky A. and Golay M., 
1964). 
 
1.3.2.3 Derivatives 
 
Taking the derivative of a continuous function can be used to remove baseline offsets, because the 
derivative of a constant is zero. In practice, the derivative of a digitized curve can be closely 
approximated by numerical methods to effectively remove baseline offsets.  
 
The derivative transformation is linear, and curves produced by taking the derivative retain the 
quantitative aspects of the original signal. The most commonly used method is based on polynomial 
smoothing. As in polynomial smoothing, a sliding window is used; however, the coefficients for the 
smoothing operation produce the derivative of the polynomial function fitted to the data. As in 
polynomial smoothing, the frequency- response function of these types of filters is not ideal, and 
it is possible to introduce distortions and artefacts if the technique is misused. Zero crossing points 
can be used to identify the location of peaks in the original spectra (Faber N. M., 1999). 
 
1.3.2.4 Normalization 
 
Here, each spectrum is normalized to constant area, thus removing the effect of the fluctuating 
signal. The simplest normalization technique is to simply set the sum of squares for each 
 Vranic Z. Branko PhD Thesis Page 41 
 
spectrum to 1, i.e., each spectrum has unit length. This procedure is similar to variance scaling, 
except the method is applied to rows in the data matrix rather than columns. Many other 
normalization schemes can be employed, depending on the needs dictated by the application. 
Normalisations by height, local band area or largest peak are other methods commonly used in 
spectroscopy. 
 
1.3.2.5 Multiplicatice Scatter Correction and Standard Normal Variate 
 
MSC is used a method to correct differences in baseline offsets and path length due to differences in 
particle-size distributions in near-infrared reflectance spectra of powdered samples.  
 
In NIR reflectance measurements, there are two components of reflected light that reach the detector: 
specular reflectance (light reflected without being absorbed or interacting with the sample) and 
diffuse reflectance (light that is reflected by the sample after penetrating the sample particles, 
where some of the light is absorbed by the chemical components present in the particles). Powdered 
samples with very small uniform particles tend to pack very efficiently compared to samples with 
large, irregularly shaped particles. Samples with small, efficiently packed particles give a greater 
intensity of specular reflectance, and after transformation as log (1/reflectance), the higher levels of 
specular reflectance appear as increased baseline offsets; thus samples with smaller particle-size 
distributions tend to have larger baseline offsets. Beam penetration is shallow in samples with 
small, efficiently packed particles; thus these kinds of samples tend to have shorter effective path 
lengths compared to samples with larger irregularly shaped particles. MSC attempts to compensate 
these two measurement artefacts by making a simple linear regression of each spectrum against a 
reference spectrum. The mean spectrum of a set of training spectra or calibration spectra is usually 
used as the reference. The least-squares coefficients are first estimated and then used to calculate the 
MSC-corrected spectrum. 
 
MSC has been shown to work well in several empirical studies, which showed an improvement 
in the performance of multivariate calibrations and a reduction in the number of factors in PCA.  
 
However, in SNV transformation, the mean of each spectrum is subtracted and the length is 
normalized to 1, and it produces results similar to MSC in many cases, which sometimes makes it 
difficult to choose between the two methods. In practice, it is best to try both methods and select the 
pre-processing method that gives superior performance (Isaksson T. and Naes T., 1988; Barnes R. J. et 
al., 1989). 
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1.4 Calibration Model Development and Optimization 
 
NIR instruments determine the analytes by measuring the intensity of reflected or transmitted 
radiation which then needs to be correlated to the amount of the same analyte determined by some 
other method called a reference or standard method. Establishing this relationship by using a set of 
samples of known composition is called calibration of an NIR method. The relationship between the 
NIR radiation intensity and values obtained by reference method always involve certain form of 
regression equation. 
 
The success and acceptance of NIR analysis depend in large part on the power of the mathematics 
used in the calculation of the calibration models. 
 
Multivariate calibration methods lead to a generation of a regression model, providing a high 
dimensional vector of estimated coefficients. The coefficients weigh the spectrum and provide the 
estimated response. In order to develop a model, a set of calibrated concentrations (response) and the 
corresponding spectra are collected at discrete intervals. Usually, there are many more regressors than 
training observations so the classical linear regression can`t be applied and special methods like 
Principal Component Regression or Partial Least Squares Regression, need to be used. 
 
1.4.1 Data Sets and Representative Sampling 
 
Calibration samples should include representation of every responding chemical species in a system 
under study. Spectral shifts and changes in instrument response for mixtures due to interactions 
between components, changes in pH, temperature, ionic strength, and index of refraction are well 
known. The use of mixtures instead of pure standards during calibration development enables 
multivariate calibration methods to generate linear models for the estimation of the analyte of interest 
with the present interactions. 
 
The calibration samples should cover a sufficiently broad range of sample composition. For simple 
systems, it is usually possible to prepare mixtures according to experimental design, where 
concentrations for all ingredients are varied over a suitable range. Because it is more desirable to 
make interpolations rather than extrapolations when making predictions from a calibration model, 
the range of concentrations in the calibration standards should exceed the working range expected 
during routine use. Calibration sample compositions should give a fairly uniform coverage across the 
range of interest. However, if the range is too large, deviations from linearity could begin to appear. 
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The recommended minimum number of calibration samples is 30 to 50, although this depends on the 
complexity of the problem. 
 
It is very important that validation sets do not contain samples or subsamples used for calibration 
development. The validation sample set should be independent from the calibration set. Another 
important point is that the composition of validation samples should be designed to lie at points in 
between calibration points and should well represent the future sample profile expected to be analyzed 
during routine use of the method. 
 
Different validation sets should be prepared to investigate every source of expected variation in the 
instrument response, operational environment changes, as well as expected sample variability. 
 
Proper design of calibration sets yields calibrations that are performing well in terms of precision 
and accuracy. The complexity of calibration development has not allowed, yet, completely automated 
mathematical modeling in any current software. In any case, the most critical step in calibration is 
the proper collection of samples to represent the population for routine analysis (Shenk J. S. and 
Westerhaus M. O., 1991). 
 
1.4.2 Developing a Calibration Model 
 
Development of a NIR calibration model depends on the variety and flexibility of the data treatments 
and experience of the person doing the development.  
The first step in the development process is recording the NIR spectra and collecting the reference 
values on the sufficient number of calibration samples. Number of samples necessary for building the 
robust calibration model depends on the complexity of the analytical problem and ranges from 30 up 
to couple of hundreds. The feasibility study , that should be always carried out before the method 
development, aims at identifying the sources of variability and facilitates the design of the sample sets 
that will be used for the method development. 
The second step is to determine the sampling and reference method errors. Reproducibility or standard 
error of laboratory (SEL) may include the sampling error and can be determined as the standard 
deviation (SD) of the differences between reference measurements on duplicate samples. The tests 
should duplicate both sample preparation and analysis. NIR method can`t correlate to a reference 
method better than the reference method correlates to itself. That means that the SEL is the lowest 
achievable limit for the standard error of calibration (SEC) which is the calibration model error. 
Third step in the development process would be to choose the chemometric parameters in order to 
achieve the acceptable SEC which is usually up to two times standard error of laboratory (SEC < 2 X 
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SEL). After developing the calibration with sufficient SEC it is necessary to validate the develop 
method to test for overfitting, which happens when calibration model approximates non-representative 
features of the particular samples used for developing the calibration model. Common indicators of 
the overfitting are: 
 
1. SEC much lower than SEL. It is usually the case when too many principal components/factors 
were used for building the regression model. The other possibility is that calibration sample set 
was too small. 
2. Validation set BIAS is significant compared to the SEC/SEP 
3. BIAS is insignificant but SEP is larger than two times SEL, usually due to significant sampling 
error 
 
The following important step in calibration model development is to understand why it works. Why 
certain wavelengths, pretreatments and principal components were chosen. In that step, regression 
coefficients plots are observed, loading vectors, score plots and various other chemometric inspection 
tools available in common chemometric software packages. Calibration that has not been justified 
spectroscopically is very likely to fail when applied in routine analysis even though it has been 
properly validated. 
 
1.4.3 Model Evaluation 
 
Several parameters are used to judge the calibration performance. Many chemometric software 
packages offer automatic calibration development with implemented criteria to judge the quality of 
the developed calibration model. Nevertheless, manual observation of the figures of merit is often 
needed due to the particular variety and complexity of the analytical tasks. 
 
1.4.3.1 Coefficient of Determination  
 
Also termed total explained variation, this statistic described by equation 6, allows us to determine 
the amount of variation in the data that is adequately modeled by the calibration equation as a total 
fraction of 1. Thus r2 = 1.00 indicates the calibration equation models 100% of the variation 
within the data, while an r2 = 0.50 indicates that 50% of the variation in the difference between the 
actual values for the data points and the predicted or estimated values for these points are explained 
by the calibration equation (mathematical model), and 50% is not explained. r2 values approaching 
1.00 are attempted when developing calibration. 
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RSQ = r2 = 0 ∑1123324∑112
∑332
5
       Equation 6: Coefficient of Determination 
 
 
1.4.3.2 Student`s t value  
 
This statistic is used to determine of the correlation between X and Y data. It can be used to determine 
whether there is a true correlation between an NIR value and the primary chemical analysis for that 
sample. It is used to test the hypothesis that the correlation really exists and has not happened only 
by chance. A large t value indicates a real (statistically significant) correlation between X and Y. 
 
When used for residuals, the test allows evaluating criteria for assessing the variation between an 
NIR value and its primary chemical value, and t values greater than 2.5 are considered significant and 
such predictions may possibly be outliers. Most often, high t- test values here indicate poor laboratory 
results or a problem with sample presentation and positioning. 
 
1.4.3.3 Standard Error of Calibration  
 
This statistic described by equation 7, is the standard deviation for the residuals due to differences 
between actual (primary wet laboratory analytical values) and the NIR predicted values for 
samples within the calibration set. It is an indication of the total residual error due to the particular 
regression equation to which it applies. The SEC will generally decrease with higher number of 
wavelengths (independent variable terms) used within an equation, indicating that increasing the 
number of terms will allow more variation within the data to be explained, or "fitted". 
 
67 = 89 1:; 	3
:                  Equation 7: Standard Error of Calibration 
 
The SEC statistic is a useful estimate of the theoretical "best" accuracy obtainable for a specified set of 
wavelengths used to develop a calibration equation. 
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1.4.3.4 Standard Error of Prediction  
 
The SEP is also termed the standard error of performance, is the standard deviation for the residuals 
due to differences between actual (primary wet chemical analytical values) and the NIR predicted 
values for samples outside of the calibration set. The SEP is calculated from equation 8 using 
validation instead of calibration samples. It allows for comparison between NIR-observed predicted 
values and wet laboratory values. 
 
6< = 89 1:; 	3=
:                   Equation 8: Standard Error of Prediction 
 
 
The SEP is generally greater than the SEC but could be smaller in some cases due to chance alone. 
When calculating the SEP, it is critical that the constituent distribution be uniform and the wet 
chemistry be very accurate for the validation sample set. If these criteria are not met for validation 
sample sets, the calculated SEP may not have validity as an accurate indicator of overall calibration 
performance. 
 
1.4.3.5 Root Mean Squared Error of Prediction 
 
Root Mean Squared Error of Prediction is the measure of the total error of NIR method and is 
described by equation 9. It is the measure of both systematic (Bias) and random (SEP) measurement 
error. The relation between the RMSEP, Bias and SEP can be expressed by equation 10. 
 

>6< = 89 1:; 	3
:                Equation 9: Root Mean Squared Error of Prediction 
 

>6<	 = 	4=
 	+	6<
            Equation 10: Relation Between RMSEP, SEP and Bias	
 
 
 
1.4.3.6 Standard Error of Cross-Validation  
 
The calculation of SECV is a method for determining the "best" number of independent variables to 
use i n building a calibration equation. The SECV method is based on an iterative (repetitive) 
algorithm that selects samples from a sample set population to develop the calibration equation 
and then predicts on the remaining unselected samples. Some procedures for calculating SECV may 
calibrate using two-thirds of the samples while predicting on the remaining one-third of the 
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samples. The SECV is an estimate of the SEP and is calculated as SEP or SECV as the square root 
of the mean square of the residuals for N - 1 degrees of freedom, where the residual equals the actual 
minus the predicted value (equation 11). 
 
67? =	8∑ 13
:;:@          Equation 11: Standard Error of Cross-validation 
 
p - number of PCs 
 
 
1.4.3.7 Standard Deviation 
 
Standard Deviation is a measure of the dispersion of the population or a sample from an average 
value. In this work, it was used as a measure of the spread of the prediction residuals or the reference 
values (equation 12). 
 
A = 89 1:; 1B2 
:        Equation 12: Standard Deviation 
 
 
1.4.3.8 Standard Error of the Predicted y-value from each x in Regression 
 
RSDyx returns the standard error of the predicted y-value for each x in the regression. The standard 
error is a measure of the amount of error in the prediction of y for an individual x and is calculated 
according to equation 13. 
 
 

A31	 = C :
 D∑ 3 − 32
:/ − E∑ 112:; 332F
∑ 112
:; G        Equation 13: Standard Error of the Prediction 
 
 
1.4.3.9 Ratio of Performance to Deviation 
 
Ratio of performance to deviation (RPD)  expresses the ratio of standard error of prediction to 
standard deviation of the parameter to be predicted (equation 14). 
 
RPD = 4
H           Equation 14: Ratio of Performance to Deviation 
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1.4.3.10 Predicted Residual Sum of Squares 
 
This statistic calculates the error sum square (between predicted and reference values) as a function of 
the number of factors (eigenvectors, principal components or principal factors). The optimum number 
of PC is always given by the smallest number of PC where the PRESS function for the calibration and 
validation sets is approximately equal and minimal (equation 15). 
 
<
6 = 	∑ 1 − 3
:/         Equation 15: Predicted Residual Sum of Squares 
 
 
1.4.3.11 Consistency 
 
Consistency is described as the ratio of the Standard Error of Calibration and Standard Error of 
Prediction. SEC much higher than SEP indicates over-fitting of the model to the calibration samples. 
 
1.4.3.12 Bias 
 
This is the average deviation between the calibration and validation predictions, calculated from 
equation 16. 
 
= = 	∑ 1	3:;:                 Equation 16: Bias 
 
 
1.4.3.13 Regression Coefficient, Slope and Intercept  
 
Absolute  regression  coefficient  near  1.0  shows  that  two  properties  are  linearly dependent. 
Slope should be as close as possible to 1.0 and intercept to 0 (equations 17-19). 
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1.4.3.14 Significance of Bias 
 
Standard Student`s t test for checking the significance of Bias calculated for a validation or test set, 
compared to SEP. If the t calculated is greater than the critical t value at the 95% confidence level, 
there is evidence that the bias included in the multivariate model is significant compared to SEP 
(equation 20). 
 
!_! = =
J
KL =CM∑ N1O3P
:;::O QR
ST     Equation 20: Significance of Bias 
 
1.4.3.15 Significance of Slope 
 
The test checks if the slope of the regression line is different from 1. It is based on the standard 
Student`s t test and is calculated according to equation 21. 
 
!_@U = =@U − CM: −  VA3W
E
A31F
Q             Equation 21: Significance of Slope 
 
 
1.4.3.16 Confidence Interval of Standard Error of Prediction 
 
Test is based on the standard statistical F test and sets the confidence interval for the SEP. The 
interval is calculated based on the equation 22. 
 
F_sep = 6<	67? × YZ        Equation 22: Confidence Interval of Standard Error of Prediction 
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1.4.3.17 Durbin-Watson Statistic 
 
This statistic can be used to assess the lack of inter-correlation between data points in the regression. 
Since the correlation coefficient R only describes the tendency of the line, not the trueness of fit to a 
linear model. If there is no inter-correlation of the residuals described by the Durbin-Watson 
statistic, then a linear model is appropriate and may be used. A value closest to 2 indicates good 
linear correlation referenced and predicted values. The statistic is calculated according to equation 
23. 
 
[\ = ∑ UUO
];
∑ U
];             Equation 23: Durbin-Watson Statistic 
 
 
1.4.3.18 Predicted Residual Sum Squared Over All Principal Components 
 
X – PRESS - Predicted residual sum of squares expresses the summed up and squared difference 
between the pretreated spectrum and reconstructed spectrum (equation 24). 
 
X-PRESS = V@ZUZUU[	. −+U]	.+ZU × <7 +⋯+ ZU × <7W
         Equation 24: X-PRESS 
 
 
1.4.3.19 Leverage 
 
The concept of leverage in statistics is comparable to the physical model of a lever. The hinge for the 
calibration line lies at the center of the x-values. Calibration samples close to the mean of the x-values 
tend to exert little force on the slope of the calibration curve. Calibration samples farthest from the 
mean of the x-values can put forth a greater force on the slope of the calibration curve, so that 
their residuals are made as small as possible. Leverage plots can be used to find optimal factors or to 
detect outliers. 
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1.4.4 Method Validation 
 
Validation of a calibration model is a crucial step that should take place prior to implementation of 
the method in a routine use. Many official monographs, standards, papers and published guidelines 
exist, directed both to NIR use in general, or specific for pharmaceutical release purposes. Of 
these, the most notable guidelines are through: 
 
1. USP 30 NF 25, 2007 – Chapter 1119 - Near-infrared spectrophotometry  
2. Chapter 1225  -  Validation of compendia procedures EP and BP (BP 2007, EP 5.5) 
3. Ph. Eur. method 2.2.40 - Near-infrared spectrophotometry  
4. SC III F. Validation of analytical procedures 
5. EMA - "Note for guidance on the use of near infrared spectroscopy by the pharmaceutical 
industry and the data requirements for new submissions and variations", 2003. 
6. ICH guidelines - Q2 (R1) "Validation of analytical procedures: text and methodology"  
7. PASG - Guidelines   for   the   development   and   validation   of   near   infrared   (NIR) 
spectroscopic methods, 2001 
 
In order to insure the quality and reliability of the data generated by the analytical method the 
following criteria should be met: validation of the software, validation of the hardware and validation 
of the NIR spectroscopic method (or any analytical method). NIR software and hardware 
manufacturers provide automated suitability tests using approved standards in order to validate NIR 
software and hardware. 
 
The purpose of method validation is to determine the reproducibility of the developed calibration, 
its bias against a known method or target values and its long-term ruggedness (robustness). 
Although many guidelines and standards on the method validation exist, multivariate calibration 
model validation is still very complex task. 
 
Method validation refers to the establishment of appropriate data and documentation to certify that 
the NIR multivariate method performs as intended. Once the instrument and software validation have 
been established, NIR method validation can be achieved by observing the points outlined below.  
(FDA, 2005; European Medicines Agency, 2012; PASG NIR Subgroup, 2001). 
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1.4.4.1 Specificity 
 
Specificity is the ability to assess unequivocally the analyte in the presence of components that are 
present in a sample/matrix. One of the difficulties in analysis of solid dosage forms by NIR 
spectroscopy is the fact the analysis is performed without extracting the analyte from the matrix. On 
the other hand, this fact makes NIR attractive because the dissolution/extraction step is not necessary.  
 
NIR spectra represent all chemical species present in the formulation, including the sample 
physical attributes such as density, particle size, particle shape etc. This makes specificity one of 
the major validation issues to be overcome. 
 
In the common chemometric software packages, there are various tools that could help in judging 
the specificity of the developed calibration model such as regression coefficient plots, loading 
plots, score plots, spectral residuals, etc. 
 
1.4.4.2 Linearity 
 
Linearity of NIR spectroscopic method is determined by calculating the correlation coefficients (r) 
of the NIR predicted values of the calibration or validation set with respect to reference values. 
Linearity assessment with r as single figure of merit is usually insufficient. Other supporting 
statistics is needed. 
 
Durbin-Watson statistic can be used to assess the inter-correlation between data points in the 
regression. The Durbin-Watson statistic is checking if there are signs of nonlinearity, calculated 
from residuals obtained from fitting a straight line.  
 
If successive residuals are positively serially correlated, that is, positively correlated in their 
sequence, d will be near zero. If successive residuals are negatively correlated, d will be near 4, so 
that 4 - d will be near zero. The distribution of d is symmetric around 2. 
 
1.4.4.3 Range 
 
The ICH guidelines recommend a minimum range of 80% to 120% of the nominal/target value 
for the assay of a drug substance or a finished product and 70% to 130% of the test concentration for 
content uniformity. 
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Production samples are spanning normally very narrow drug content range which brings the need for 
out-of-specification samples to extend the range to the requited one. The major problem is the fact that 
it is very difficult if not impossible, to provide out-of-specification products in the production 
environment. Out-of-specification samples could be manufactured in laboratory or pilot plant. 
Although the identical raw materials are used, the process signature is often significantly different 
from laboratory to pilot scale to production that significant calibration model errors will arise.  
 
1.4.4.4 Robustness 
 
The robustness of an analytical method is its ability to perform without significant changes when the small, 
deliberate variations in the environmental, instrumental, or procedural conditions as well as sample 
changes are introduced. Method developers should consider tests to evaluate the method/model 
stability during the development and validation process. 
 
In case of NIR analysis of solid dosage forms, this issue is of prime importance. The variation in 
physical parameters as a result of small process variability, e.g., change in pre-compression, 
compression force or tableting speed, can introduce significant prediction errors if not considered 
during method development phase. 
  
The evaluation of robustness should be considered during the development phase and depends on the 
type of procedure. It should show the long-term reliability of a method with respect to deliberate 
variations in method parameters.  
 
1.4.4.5 Accuracy 
 
The accuracy of an analytical procedure expresses the closeness of agreement between the values which 
are accepted either as true values or reference values and the values found (trueness). There are 
several methods of determining accuracy (ICH 2005): 
 
1. Application of the analytical procedure to synthetic mixtures of the drug product 
components to which known quantities of the drug substance to be analyzed have been 
added. 
2. Comparison with the results obtained from a second, standard analytical method whose 
accuracy is defined. 
3. Accuracy may be inferred once precision, linearity and specificity have been established. 
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1.4.4.6 Precision 
 
Precision of analytical procedure describes how close is the agreement between a series of 
measurements obtained from multiple sampling of the same homogenous sample under the 
prescribed conditions. The precision of an analytical procedure is usually expressed as the 
variance, standard deviation or coefficient of variation of a series of measurements and can be 
described in terms of: 
 
1.4.4.6.1 Repeatability 
 
This is precision under the same operating conditions over a short interval of time. Repeatability 
is assessed using minimum of 9 determinations covering the specified range for the procedure, e.g., 3 
concentrations with 3 replicates each or minimum of 6 determinations at 100% of the nominal 
content.  
 
1.4.4.6.2 Intermediate precision 
 
Intermediate precision expresses within-laboratories variations and reflects the effects of random 
events on the precision of the analytical procedure. Typical variations to be studied include days, 
analysts, equipment, etc.  
 
1.4.4.6.3 Reproducibility 
 
Reproducibility describes the precision between laboratories usually applied in order to standardize 
the analytical procedure/method. 
 
1.4.4.7 Detection and quantification limits 
 
The detection limit of an individual analytical procedure is the lowest amount of analyte in a sample 
which can be detected but not necessarily accurately quantified, while the quantification limit is the 
lowest amount of analyte in a sample which can be quantitatively determined with suitable 
precision and accuracy.  
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1.5 Sources of Error in NIR Spectroscopy 
 
Error in NIR measurements comes from various different sources which could be assigned to three 
main categories: 
 
1. Sampling Error 
2. Reference Method Error 
3. NIR Method Error 
 
1.5.1 Sampling Error 
 
Sampling error is usually the biggest source of error in NIR measurements. This is especially true due 
to the fact that the instrumentation today is very advanced, allowing very accurate and precise 
measurements. Sampling error is caused by the lack of homogeneity of the analyzed material. If the 
three powder subsamples are withdrawn from one kilogram of the well mixed powder, the amount of 
moisture that is measured by some analytical technique will differ between the subsamples. The 
difference comes from the error associated with the analytical technique but, as well, from the 
differences in the subsamples themselves. The actual difference between the subsamples will dictate 
the lower limit that could be reached for the SEC of the NIR calibration model developed on these 
samples (subsamples). Sampling errors occur at several steps of the calibration or validation process: 
• Reference and NIR method usually analyze different subsamples 
• The methods are usually looking at the different amounts of material. If one method is using 
four times more material than the other method, it will have around half of the sampling error 
of the second method. 
• The NIR measurement can introduce a sampling error due to the fact that only up to 2 mm of 
the samples is scanned in the diffuse reflectance measurement mode whereas, in diffuse 
transmittance, the light penetrates throughout the whole sample (assuming that the samples is 
transparent for NIR light). The difference in the predicted values in this case could be 
considered primarily as a sampling error. 
 
It is usually very difficult to measure accurately all the sampling errors in one analytical procedure but 
it is certainly very important to know in which steps of the procedure the sampling error is significant 
and to which extent it contributes to the overall sampling error. With this knowledge, one can know 
where in the procedure to repeat the sampling. 
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1.5.2 Reference Method Error 
 
Every reference method has certain measurement error. The error of the reference method is 
commonly called Standard Error of Laboratory (SEL). It is defined as the standard deviation of the 
differences between measurements of duplicate samples. It can be determined as intermediate 
precision or reproducibility. If this is not possible, the repeatability of the reference method could be 
useful estimation as well. SEL is used for comparison and evaluation of the precision of the NIR 
method. SEL is compared with SEP of the validation or test set. The precision of the developed NIR 
calibration model is acceptable if the SEP is 1.4 – 2.0 times higher than SEL. This is, of course, the 
empirical rule that could be found in literature but should not limit the use of NIR, i.e., if the SEP is 
more than 2 times larger than SEL, the developed NIR calibration model could be still used if the 
magnitude of the SEP fulfills the requirements/specifications of the user for particular application. 
 
1.5.3 NIR Method Error 
 
This type of error is caused by the spectral measurement errors, lack of intrinsic correlation between 
NIR and reference method data and finally, from the poor or wrong choice of the data treatments 
(spectral pretreatments, regression methods, selection of factors and variables, etc.). NIR Instrument 
related errors are usually far below the sampling error level. Still, there is certain error contribution 
from the spectral noise that could originate from the imperfections in the detector response or the 
suboptimal NIR sampling geometry. NIR instrumentation design has advanced in the last few decades 
but the errors originating from x axis instability (repeatability/reproducibility of the wavelength) and 
the y axis instability (variations in the detected light intensity) could be significant in comparison to 
the sampling error. Rounding error and error associated with the use of smoothing algorithms in the 
commercially available chemometric software packages could contribute to the overall error as well 
(Shenk J. S. et al., 2001). 
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1.6 Design of Experiments Methodology 
 
1.6.1 Experimental Design 
 
Experimental design is how to conduct and plan experiments in order to extract the maximum amount 
of information from the collected data in the presence of noise. The basic idea is to vary all relevant 
factors simultaneously, over a set of planned experiments, and then connect the results by means of a 
mathematical model. This model is then used for interpretation, predictions and optimization. 
 
1.6.2 Objectives of Experimental Design 
 
During the investigation the following questions need to be answered: 
Which factors have a real influence on the responses (results)? 
Which factors have significant interactions (synergies or antagonism)? 
What are the best settings of the factors to achieve optimal conditions for best performance of a 
process, a system or a product? 
What are the predicted values of the responses (results) for given settings of the factors? 
An experimental design can be set up to answer all of these questions. 
 
1.6.3 Screening Designs 
 
Screening is the first stage of an investigation where the goal is just to identify the important factors. 
An important factor is a factor that causes substantial changes (effects) in the response when it varies. 
In the screening stage one uses simple models (linear or linear with interactions), and experimental 
designs that allows the identification of the factors with the largest effects in the fewest possible 
number of experimental runs. 
 Examples of such designs supported by MODDE software that was used in this research are: Full 
Factorial, Fractional factorial, L-designs, Plackett Burman, Rechtschaffner, Onion, and D-optimal 
designs for screening experiments. 
 
1.6.4 Response Surface Modeling  
 
After screening, the goal of an investigation is usually to approximate the response by a quadratic 
polynomial (model) in order to: 
• Understand in more detail how the factors influence the response; get a map of the system. 
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• Make predictions, optimize or find a region of operability. 
Examples of such designs are: Three-level full factorial, central composite, (CCC and CCF), Box 
Behnken, Rechtschaffner, Doehlert, Onion, and D-optimal designs for RSM investigations. 
 
1.6.5 Fit Methods 
 
The data collected by the experimental design is used to estimate the coefficients of the model. The 
model represents the relationship between the response Y and the factors X1, X2, etc. 
MODDE software uses multiple linear regression (MLR) or Partial Least Squares (PLS) to estimate 
the coefficients of the terms in the model. PLS is suggested when the investigation has a high 
condition number. 
 
1.6.5.1 Multiple Linear Regression  
 
With Multiple Linear Regression the coefficients of the model are computed to minimize the sum of 
squares of the residuals, i.e. the sum of squared deviations between the observed and fitted values of 
each response. The least squares regression method yields small variances for the coefficients and 
small prediction errors. It is important to note that MLR separately fits one response at a time and 
hence assumes them to be independent. 
 
1.6.5.2 Partial Least Squares  
 
PLS deals with many responses simultaneously, taking their covariances into account. This provides 
you with an overview of how all the factors affect all the responses. 
PLS contains the multiple regression solution as a special case, i.e. with a single response or different 
models, and a given number of PLS dimensions, the PLS regression coefficients are identical to those 
obtained by multiple regression. 
PLS finds the relationship between a matrix Y (response variables) and a matrix X (model terms). 
The PLS model consists of a simultaneous projection of both the X and Y spaces on a low 
dimensional hyper plane with new coordinates T (summarizing X) and U (summarizing Y), and then 
relating U to T. 
This analysis has the following two objectives: 
 
1. To well approximate the X and Y. 
2. To maximize the correlation between X and Y in the projected space (between u and t). 
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The dimensionality, number of significant PLS components, is determined by cross validation (CV), 
where PRESS (Predictive Residual Sum of Squares) is computed for each model dimension. Software 
MODDE selects automatically the number of PLS dimensions that give the smallest PRESS. PRESS 
is then re expressed as Q2 = (1 - PRESS/SSY), where SSY is the sum of squares of Y. 
 
1.6.6 Results 
 
Both MLR and PLS computes regression coefficients for each response. Thus Y is expressed as a 
function of the X's according to the selected model (i.e. linear, linear plus interactions, or quadratic). 
 
1.6.7 D-Optimal Designs 
 
D-Optimal designs are computer generated designs, tailor made for a specific problem. They allow 
great flexibility in the specifications of the problem. They are particularly useful when one wants to 
constrain the region and no classical design exists. 
“D-Optimal” means that these designs maximize the information in the selected set of experimental 
runs with respect to a stated model. 
D-Optimal designs are constructed by selecting N runs from a candidate set. This candidate set is the 
discrete set of “all potential good runs”. 
Software MODDE generates the candidate set as follows: 
For a regular process region, the candidate set consists of one or more of the following sets of points 
(depending on your model and the number of factors): 
• The full factorial for up to 10 factors, reduced factorial for up to 32 factors. 
• Centers of edges between hyper-cube corners 
• Centers of the faces of the hyper-cube. 
• Overall centroid 
For constrained regions of mixture and/or process factors, the candidate set consists of one or more of 
the following set of points: 
• The extreme vertices of the constrained region 
• The centers of the edges 
• The centers of the various high dimensional faces 
• The overall centroid. 
MODDE has implemented an algorithm to compute the extreme vertices, center of edges, center of 
faces etc. as described by Piepel (1988). 
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1.6.8 Model Evaluation 
 
1.6.8.1 Variation Explained by the Model 
 
R2 is the percent of the variation of the response explained by the model. R2 is a measure of fit, i.e. 
how well the model fits the data. 
A large R2 is a necessary condition for a good model, but it is not sufficient. One can have poor 
models (models that cannot predict) with a large R2. This is particularly true when you have few 
degrees of freedom for the residuals. 
R2 is usually poor when the reproducibility is poor (poor control over the experimental error) or poor 
Model validity (the model is incorrect). 
 
1.6.8.2 Response Variation Predicted by the Model 
 
Q2 is the percent of the variation of the response predicted by the model according to cross validation. 
Q2 tells how well the model predicts new data. A useful model should have a large Q2 
Q2 is usually poor when the reproducibility is poor (poor control over the experimental error) and/or 
poor Model validity (the model is incorrect). 
When the R2 is good, model validity moderate, and a design with many degrees of freedom of the 
residuals, then a poor Q2 is usually due to insignificant terms in the model. 
If there are many correlated Y’s (responses), one should only remove the terms insignificant to all the 
Y’s.  
 
1.6.8.3 Model Validity 
 
This is a measure of the validity of the model. When the Model Validity is larger than 0.25, there is no 
lack of fit of the model (the model error is in the same range as the pure error). 
A Model Validity of 1 represents a perfect model. 
When the Model Validity is less than 0.25 there is a significant lack of fit and the model error is 
significantly larger than the pure error (reproducibility). 
 
1.6.8.2 Reproducibility 
 
This is the variation of the response under the same conditions (pure error), often at the center points, 
compared to the total variation of the response.  
Reproducibility = 1 - (MS (Pure error) / MS (total SS corrected)) 
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MS = Mean squares, or Variance. 
When the Reproducibility is 1, the pure error is 0. This means that under the same conditions the 
values of the response are identical. 
When the Reproducibility is 0, the pure error equals the total variation of the response.  
If the reproducibility is below 0.5, there is a large pure error, poor control of the experimental set up 
(the noise level is high), and the validity of the model needs to be assessed. This results in low R2 and 
Q2.  
 
1.6.9 The Coefficient Plot  
 
It displays the regression (MLR) or PLS coefficients with confidence intervals.  
MODDE software displays the coefficient plot with centered and scaled data. The scaling of the data 
makes the coefficients comparable. The size of the coefficient represents the change in the response 
when a factor varies from 0 to 1, in coded units, while the other factors are kept at their averages. 
The coefficient is significant (different from the noise), when the confidence interval does not cross 
zero (Eriksson L., 2008) 
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1.7 Pharmaceutical Tableting 
 
Tablets are solid preparations containing a single dose of one or more pharmaceutical active 
ingredients (APIs) and obtained by compressing powders or granulated materials. One of the 
definitions of the tablets stated by British Pharmacopoeia is: “Tablets are solid dosage forms circular 
in shape with either flat or convex faces and prepared by the compression or compaction of suitably 
prepared medicament by means the tablet machine”. Tablets are intended for oral administration. 
They are usually swallowed as a whole, some are chewable, some dissolved or dispersed in water 
before being applied and some are retained in the mouth where the API(s) is released. 
 
Tablets are the most common and inexpensive dosage forms. They are prepared by forcing particles 
into close proximity to each other by compaction process, which enables the particles to cohere 
into a solid specimen. The compaction process takes place in a die of the tablet press, whereby upper 
and lower punches are applying compressive force on the powder bed or granulated material. 
Intermolecular bonds are formed between the particles when the compression force is applied and this 
provides the coherence to the powder, i.e., tablet is formed. 
 
 
Figure 9: Stages of tablet manufacture 
 
Irrespective of the press type used, a complete tablet manufacturing cycle occurs in the following 
steps described in figure 9: (i) the die is filled and adjusted (scraped), (ii) the tablet is compacted, 
and (iii) the tablet ejected from the die. (Levin M., 2001; Sinka I. C. et al., 2009; Marshall K., 1963). 
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1.7.1 Compaction Mechanisms 
 
The compaction process consists of a series of phases starting from particle rearrangement, particle 
deformation and finally formation of inter-particulate bonds. When the compression force is applied to 
the powder bed, the volume of the powder in a dye is being reduced. The particles become closer to each 
other. At certain point, further reduction in compact volume results in deformation of the particles. 
Particle deformation can be elastic, viscoelastic, plastic or brittle. Elastic deformation has reversible 
character whereas plastic deformation is irreversible. Particle fragmentation characteristic for brittle 
substances results in smaller particles which further decreases the compact volume. As a consequence of 
the particles being in closer proximity, inter-molecular bonds will be formed. Three types of bonds 
could be formed between the particles during the compaction process: mechanical interlocking 
between particles with irregular shape, inter-particulate attraction forces (Van der Waal forces, 
hydrogen and electrostatic forces) and melting solid bridges. It should be bear in mind that all materials 
show certain degree of elastic, plastic or brittle behavior. Which deformation behavior will 
predominate depends on the parameters such as temperature or compaction rate (Sheikh-Salem M. 
and Fell J. T., 1981). 
 
1.7.2 Tablet Formulation 
 
Excipients as inactive substances play a major role in formulation development apart from active 
pharmaceutical ingredients (table 1). Pharmaceutical excipients are substances other than the 
pharmacologically active drugs or pro-drugs which are included in the manufacturing process or are 
contained in a finished pharmaceutical dosage form. 
 
In addition to transporting the API to the site in the body where the drug is intended to exert its action, 
excipients play an important role in the manufacturing process. They may also be important for 
keeping the drug from being released in places in organism where it could damage the sensitive tissue 
and create gastric irritation or stomach upset. 
 
Other excipients promote the tablet disintegration into particles small enough to reach the blood 
stream more quickly and some are increasing the API stability. In addition, some excipients are used 
to aid the identification of a drug product. 
 
Some excipients are used to improve the product taste and appearance. This improves patient 
compliance, especially in case of children. Although excipients are pharmacologically inactive, they 
are essential components of a modern drug product. In many products, excipients make up the bulk of 
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the total dosage form. Apart from the API, other essential components include diluents or fillers, 
binders, disintegrants, lubricants and coloring agents. Diluents or fillers are inert ingredients that can 
significantly affect the chemical and physical properties of the final tablet thus affecting the 
biopharmaceutical profile (Kesavan J. G. and Peck G. E., 1996). 
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Table 1: Common Excipients used in Tablet Formulations 
 
Common excipients used in tablets 
Excipient Function Examples 
Diluents 
Provide bulk and enable accurate dosing of 
potent ingredients 
Sugar compounds e.g. lactose, dextrin, 
glucose, sucrose, sorbitol 
Inorganic compounds e.g. silicates, 
calcium and magnesium salts, sodium or 
potassium chloride 
Binders, 
compression 
aids, granulating 
agents 
Bind the tablet ingredients together giving 
form and mechanical strength 
Mainly natural or synthetic polymers e.g. 
starches, sugars, sugar alcohols and 
cellulose derivatives 
Disintegrants 
Aid dispersion of the tablet in the 
gastrointestinal tract, releasing the active 
ingredient and increasing the surface area for 
dissolution 
Compounds which swell or dissolve in 
water e.g. starch, cellulose derivatives 
and alginates, crospovidone 
Glidants 
Improve the flow of powders during tablet 
manufacturing by reducing friction and 
adhesion between particles. Also used as anti-
caking agents. 
Colloidal anhydrous silicon and other 
silica compounds 
Lubricants 
Similar action to glidants, however, they may 
slow disintegration and dissolution. The 
properties of glidants and lubricants differ, 
although some compounds, such as starch and 
talc, have both actions. 
Stearic acid and its salts (e.g. magnesium 
stearate) 
Tablet coatings 
and films 
Protect tablet from the environment (air, light 
and moisture), increase the mechanical 
strength, mask taste and smell, aid 
swallowing, assist in product identification. 
Can be used to modify release of the active 
ingredient. May contain flavors and colorings. 
Sugar (sucrose) has now been replaced 
by film coating using natural or synthetic 
polymers. Polymers that are insoluble in 
acid, e.g. cellulose acetate phthalate, are 
used for enteric coatings to delay release 
of the active ingredient. 
Coloring agents 
Improve acceptability to patients, aid 
identification and prevent counterfeiting. 
Increase stability of light-sensitive drugs. 
Mainly synthetic dyes and natural colors. 
Compounds that are themselves natural 
pigments of food may also be used. 
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1.7.3 Factors Affecting Tableting Process 
 
Compaction process is affected by numerous factors. Factors can be related to formulation of the 
product, equipment/process or to the environment. Below are listed and briefly explained the 
most significant factors affecting compressibility and compactibility of the granulated materials. 
 
1.7.3.1 Crystalline Form 
 
Polymorphism, pseudo-polymorphism, and the crystal ordering of APIs and excipients are affecting 
their densification behavior and the final compact attributes. Crystalline materials usually undergo 
brittle fragmentation whereas amorphous materials undergo plastic deformation (Sun C. and Grant 
D. J. W., 2001). 
 
1.7.3.2 Porosity and Bulk Density 
 
The relative density and porosity vary largely among pharmaceutical materials. These factors may 
change significantly during processing. The initial porosity determines the extent to which the 
porosity can be reduced during compression step in a certain tablet press. Porosity of the granules 
themselves also influences the compressibility behavior. Increase in granule porosity results in 
increase of the compressibility (Berggren J. and Alderborn G., 2001). 
 
1.7.3.3 Particle Size and Shape 
 
Particle size, shape and particle size distribution are important determinants of the deformation 
behavior of pharmaceutical granulated materials. Increasing the irregularity and roughness of 
granules changes the compaction behavior from plastic deformation towards a more complex 
process including fragmentation and attrition of the particles. Compressibility is generally better if 
the particle size is larger due to a greater degree of densification. This is attributed to increased 
frictional and cohesive forces associated with the smaller size range; which tends to restrict particle 
flow and thus reduce densification (Sun C. and Grant D. J. W., 2001). 
 
1.7.3.4 Pre-compression and Compression Force 
 
Compression force is the major factor influencing densification process. The compression force rate 
affects the way particles deform and also determines to high extent the integrity (crushing strength) 
of the formed compact. There is a positive correlation between compression force and compactibility 
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of the granulated material up to a certain threshold beyond which either the crushing force of the 
compact remains unchanged, decreases or results in manufacturing problems like capping or 
lamination. Pre-compression force usually increases the integrity of the compact by promoting the 
particle rearrangement and excluding the entrapped air in the powder bad. The effect of the pre-
compression force on the mechanical properties of the final compact is formulation dependent (Stiel 
D. M, 1978; Vezin W. R. et al., 1983). 
 
1.7.3.5 Tableting Speed 
 
Some pharmaceutical materials show time-dependent compaction properties and the nature of this time 
dependency is related to the compaction mechanism of a given material. Viscoelastic or viscoplastic 
materials show higher speed sensitivity (time dependent compaction properties). Brittle materials are 
much less speed dependent. Particle size and particle size distribution of the powders or granules 
have also an important role in the speed sensitivity due to their effect on the deformation mechanism. 
Speed sensitivity of pharmaceutical materials effects significantly final tablet attributes. The effect of 
punch velocity is particularly significant when the tableting process is transferred from single punch 
laboratory tablet press to pilot or production rotary tablet press. Materials that exhibit plastic 
deformation upon compaction tend to show decrease in tablet crushing strength when the tableting speed 
is increased. Capping or lamination might occur as well (Tye C. K. et al., 2005). 
 
1.7.3.6 Formulation Factors 
 
Fillers, compression aids or binders bind the tablet ingredients together giving form and mechanical 
strength to the compact. These substances are mainly natural or synthetic polymers e.g. starches, 
sugars, sugar alcohols and cellulose derivatives. The development of direct compression as an 
alternative method to wet granulation has stimulated the development of the fillers and binders used in 
direct compression tableting. Addition of compression aid component to a tablet formulation changes 
the surface properties of the coarse compound particles as they are covered by the small compression 
aid particles. It was proposed that this surface coverage increases the surface area available for inter-
particulate bonding, thus increasing the number of bonds and also possibly creating stronger bonds, 
with a subsequently increased mechanical strength.  
 
Lubricants are added to tablet formulations to reduce die-wall friction but are also improving flow 
properties of the granulated materials. The amount of lubricant in formulation and the duration of 
mixing a lubricant are affecting flow properties, deformation behavior, crushing strength and drug 
release properties. It is well known that increase in lubricant concentration in a tablet formulation 
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results in tablet crushing strength decrease. This effect is attributed to a decrease in the degree of 
cohesiveness between the particles as well as decrease of friction effects at the punch faces and die-
wall. 
 
Glidants are improving the flow properties of granulated materials by decreasing surface roughness 
of the particles by forming a uniform coating around them. Some glidants are acting as physical 
barrier between particles which reduces attractive forces between them. Finally, some glidants are 
absorbing moisture from the surface of the particles and improving the flow properties in that way 
(Lin S. Y., 1988). 
 
1.7.3.7 Moisture 
 
Moisture affects powder flow and compactibility as well as physical - chemical and 
microbiological stability of the pharmaceutical powders and granules. Water molecules can form 
hydrates or pseudo-hydrates when they are incorporated into the solid`s crystalline structure. The other 
way of interacting with solids is when the water is absorbed at the surface of the solid or into the 
material acting as a plasticizer which is common in case of amorphous or semi-crystalline substances. 
Absorbed moisture increases the compactibility especially in case of polymeric substances by 
facilitation of the temporary transition of material from glass to rubbery state (Sebhatu T. et al., 
1994). 
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1.7.4 Tablet Presses  
 
1.7.4.1 Eccentric tablet presses 
 
Eccentric tablet presses use an eccentric shaft connected to a rotating wheel to control the displacement 
of the upper punch (figure 10). Displacement rate is controlled by adjusting the rotation rate of the 
eccentric wheel. Lower punch is stationary during the compaction and has the function to enable 
uniform die filling with the granulated material and ejection after the compact is formed. In case of 
eccentric tablet presses compaction process is single-sided whereas with rotary presses it is double-
sided.  
 
 
Figure 10: Eccentric tablet press 
 
1.7.4.2 Rotary Tablet Presses 
 
Rotary presses have high output rate of tablet production (figure 11). They operate with a number 
of sets of dies and punches. The dies are mounted on the die table and both rotate together during 
operation of the tablet machine. Punch movement is controlled by tracks that pass over cams and rolls 
are controlling the volume of powder that is fed into the die and the pressure applied during 
compaction. Powder is stored in a hopper whose lower opening is located right above the die table. 
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The powder flows freely and is fed into the die by a feed frame. Both punches are involved in 
compaction process. 
 
 
 
Figure 11: Rotary tablet press 
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1.7.5 Direct - compression Tableting 
 
Direct compression, in contrast to tableting process which involves granulation as a unit process, 
consists of fewer operations of the powder treatment. Direct compression tableting involves two 
operations, powder mixing and tableting. Direct compression reduces the production costs in 
comparison to the process that involves granulation. Direct compression formulations require the use 
of fillers and binders with special properties compared to traditional ones. Stability of the tablets 
manufactured by direct compression method is usually better since heating and water are not involved 
in production process. Release of the drug substance from the direct compression formulations is 
generally faster since the tablets disintegrate into primary particles. 
 
In order to apply direct compression a powder needs to have acceptable flowability and bulk 
density as well as large enough particles which could be a technological problem. Large particles 
could be difficult to mix to acceptable homogeneity and such particulate systems may be prone to 
segregation. Compactibility of the powder mixture is certainly the critical characteristic which 
highly depends on the drug load since the APIs are usually poorly compactible. When simplicity 
of the formulation and processing is taken into account, direct compression tableting is certainly 
the tableting method of choice and is applied as well in this research (Kanig J. L., 1975). 
 
1.7.5.1 Powder Compressibility Assessment 
 
In the third project of the thesis, the compaction results have been fitted using Heckel-Plot (Heckel, 
1961; Heckel, 1961), the modified Heckel-Plot (Kuentz, et al., 2000) and the Leuenberger equation 
(Leuenberger et al., 1984; Leuenberger, 1982). 
 
Heckel- Plot 
 
Heckel – Plot is the most commonly used equation in the pharmaceutical compaction studies. It was 
published by R.W. Heckel in 1961 (Heckel, 1961; Heckel, 1961). In this equation, the first-order 
kinetics type of reaction behaviour of the voidage reduction with applied pressure has been explained. 
 
  
1 
                                                 
where D is the relative density of a powder compact at pressure P. Constant k is a measure of the 
plasticity of a compressed material. The Constant A is related to the die filling and particle rearrangement 
 Vranic Z. Branko PhD Thesis Page 72 
 
before deformation and to a bonding of the discrete particles. 
 
Modified Heckel- Plot 
 
The pressure susceptibility (χp) is defined as the decrease of porosity under pressure. This term is 
assumed to be constant in Heckel-Plot. Kuentz and Leuenberger (Kuentz, et al., 2000) incorporated the 
pressure susceptibility term in the equation and developed a modified Heckel-Plot: 
 
Where ρ is the relative density, σ is the pressure, ρc is the critical density and C is a constant, which 
represents the compressibility of a powder. 
For the powder compressibility calculation, the constant K from Heckel equation and the constant C 
from the modified Heckel equation can be determined. 
Well compressible, ductile and soft powders have higher C and K values compared to poorely 
compressible, brittle and hard powders. 
The parameter ρc is defined as rigidity threshold. It represents the critical relative density, producing 
a negligible mechanical resistance between the punches. With a geometrical focus, this threshold 
represents the transition point between dispersed solid in air and voids in a solid matrix. 
 
Leuenberger Equation 
 
This equation was developed and published in the early 1980s by H. Leuenberger (Leuenberger, et 
al., 1984; Leuenberger, 1982). 
 
 
σtmax is the tensile strength (kg/cm2) when P (compression pressure) → ∞ , ρr → 1, and γ is 
compression susceptibility, characterizing the compressibility of the powder. 
This equation describes the powder compressibility and in a second step the compactibilty, defined as 
the ability of the powder to be compressed to a tablet of a  specific strength. Each  of  the  three  
equations  contain  a  factor  which  characterizes the compressibility of the powder. By fitting the 
measured and calculated compaction data to the three equations, the above mentioned technical factors 
(k, C, γ) can be calculated and evaluated. 
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1.7.6 Compaction simulators 
 
Besides instrumented tablet presses, compaction simulators can be used for the investigation of the 
compaction process. All compaction simulators have load frame, hydraulic unit and data 
acquisition system. There are many variables of a tableting process which could be simulated. 
Compaction forces, punch velocity, tableting speed, dwell time, relaxation, etc. Usually small 
amount of powder is used for investigation of the feeding setup in a compaction simulator which 
makes it difficult to simulate the powder supply in an industrial press (Celik M. and Marshall K., 
1989). 
 
1.7.6.1 Presster™ 
 
Presster is a linear tablet press simulator. It offers many advantages of a conventional compaction 
simulator such as ease of use and flexibility. Presster was developed by Metropolitan Computing 
Corporation Inc. NJ, USA in the late 1990s and has the ability to simulate almost all commercially 
available rotary tablet presses (figure 12). The main feature of the Presster is that it uses the 
compression rolls of the same dimensions as those of the simulated tablet press. In that way, the 
compression profiles resemble closely those of the simulated tablet press. 
The design resembles a single station rotary press with all its parts with the difference that the 
movement of the single station is not circular but linear instead. Main instrumentation sensors are on 
the pair of punches and one die. A turret-analogue carriage with the tooling set is the central 
part of the machine. This carriage is driven horizontally through the machine. It passes the dosing 
cam, the upper and lower rollers of the pre-compaction, the roller set of the main compaction 
station, ending at the ejection cam and the take-off bar. The instrument functions by measuring the 
position of a core rode inside the cylinder relative to a predefined position. The resulting voltage is 
proportional to the object displacement. 
 
Presster is connected to an electronic data acquisition system governed by the software which allows 
all the experimental parameters to be set on a personal computer. In this way, parameters like 
gap, compaction force, dwell time, ejection angle, could be adjusted fast and easy, allowing the 
operator to investigate the influence of these parameters on the resulting tablet (Neuhaus T., 2007). 
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Figure 12 : Schematic view of the PressterTM 
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2. Results and Discussion 
 
2.1 Research Project I: Effect of Simulated Precompression, 
Compression Pressure and Tableting Speed on an Offline Diffuse 
Transmittance and Reflectance Near-infrared Spectral 
Information of Model Intact Caffeine Tablets 
 
2.1.1 Introduction  
 
Near infrared Spectroscopy (NIRS) is fast and non-destructive analytical technique based on the 
measurements of the absorbed radiation spanning the spectral range of 780 – 2500 nm (12,800 – 
4000 cm
-1
). NIRS is used in the cases where multicomponent analysis is required in the presence of 
interfering substances. The near infrared spectra consist of overtones and combination bands of the 
fundamental molecular absorptions found in the mid infrared spectral range. Near infrared spectra 
consist of overlapping vibrational bands that may appear non-specific and poorly resolved and for that 
reason, chemometric data processing methods are commonly applied to calibrate for qualitative or 
quantitative analysis. Ease of use, speed and no requirement for sample preparation make this 
technique an excellent process analytical technology (PAT) tool. In line with the quality by design 
(QbD) concept, NIRS as one of the major PAT tools, plays an important role in real-time release 
testing and in that way minimizes the overall drug product quality risk and increases the productivity 
by shortening the production cycles. 
Q8 guideline on pharmaceutical development from International Conference on Harmonization (ICH) 
suggests a careful risk assessment of the variables such as raw material attributes, process parameters, 
environmental conditions, analytical method characteristics, etc., on the critical to quality attributes 
(CQAs) of the final drug product (figure x). As analytical method being one of the important variables 
of the overall quality risk assessment matrix, it is important to insure the complete understanding of 
the factors influencing its performance. NIRS applications in pharmaceutical industry are most often 
based on the statistical correlations and predictions of the parameters of interest rather than on direct 
determination. Another feature of the NIRS analysis of the solid dosage forms is the fact that the 
physical attributes of the sample such as particle size, density, hardness, or porosity, dominate the 
NIR spectrum. Physical attributes of the sample are determined by the formulation and the 
manufacturing process factors. Formulation of the drug product is mostly constant over time but the 
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manufacturing process factors and its effect on the NIR spectrum of the drug product need to be well 
understood and controlled. 
Specificity of analytical method is a characteristic and a validation parameter determined at the onset 
of method development process in the course of a feasibility study. It needs to be demonstrated that 
the signal that originates from the analyte can be distinguished from the matrix and that the analytical 
technique is adequate for the intended purpose. The other critical validation parameter is the analytical 
method robustness. Robust method needs to be able to provide stable measurements over extended 
period of time with all possible variations of environmental and process conditions as well as small, 
deliberate changes in the analytical procedure itself.  Robustness needs to be inherently built into an 
NIR method during the development phase. Systematic and science-based study of the factors 
influencing NIR spectral response and performance of the NIRS method at the onset of the 
development phase is critical to enable long-term stability of the method and to lower-down the 
overall risk to the drug product quality. In the development of the robust calibration models, in this 
study, the global calibration model approach was accepted. In the case of conventional method 
development and validation, robustness is frequently assessed after the method has been developed, 
and may not be built in during method development (PASG NIR Subgroup, 2001). This may increase 
the overall risk to the drug product quality.  
Instead of most frequently used empiric approach to defining the critical factors affecting NIR 
spectral response and calibration model performance, systematic and science-based approach such as 
design of experiments (DoE) is suggested to be used at the onset of method development in 
accordance with the ICH Q8 and Q9 guidelines. All the process, formulation, environmental and NIR 
acquisition parameters that affect the NIR method performance should be identified and included in 
the NIRS method development from the outset. These factors should be treated as a potential risks to 
the quality of the final drug product and as such, included in the quality risk assessment matrix (figure 
13). 
 
Figure 13: Fishbone diagram with the variables influencing the quality of a tablet 
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2.1.2 Reports - NIRS Applications in Pharmaceutical Industry 
 
Near-infrared spectroscopy has gained a lot of attention in the pharmaceutical industry in the last two 
decades (Luypaert, J. et al., 2007). Numerous applications have been reported among which 
identification of raw materials is the most common one (Gemperline et al., 1987; Candolfi, A., et al., 
1999; Blanco M. et al., 2001). Quantification of pharmaceutical active ingredients in different 
pharmaceutical products has proven its usefulness in the latest decade (Blanco M. et al., 2006; Blanco 
M. et al., 1996; Chalus P. et al., 2007; Mantanus, Jérôme, et al. 2010). NIRS in monitoring powder 
blending process is becoming an efficient PAT tool to ensuring solid dosage form uniformity in 
pharmaceutical industry (Moes, J. et al., 2008; Sulub Y. et al., 2009; Lyon, Robbe C., et al., 2002; Ely 
D. et al., 2006). Determination of tablet hardness by NIR spectroscopy was shown to be an alternative 
to conventional tablet hardness testing (Morisseau K. M. et al., 1997; Donoso M. et al., 2003). NIRS 
coupled with PLS and artificial neural networks, was proven be a useful tool to monitor average 
particle size in real-time (Santos A. F. et al., 1998). Prediction of moisture content in different 
pharmaceutical drug products is quite frequently applied in drug product quality control (Zheng Y. et 
al., 2008) as well as a process monitoring tool (Rantanen J. et al., 1998). Diffuse reflection NIRS 
studies of film coating process in fluidized bed and pan coater were reported by several authors 
(Andersson M. et al., 2000; Pérez-Ramos, D., et al., 2005; Roemer M. et al., 2008; Lee M. J. et al., 
2011). NIRS studies on crystalline structure and polymorphic forms of APIs and excipients are quite 
common in pre-formulation stage of the drug product development. Several studies on this topic were 
reported in literature (Aldridge K. et al., 1997; Blanco M. et al., 2005; Otsuka M. et al., 2001). 
 
2.1.3 Reports - API Content Prediction in Tablets by Diffuse Reflection 
NIRS 
 
Prediction of content of active pharmaceutical ingredients in intact tablets is one of the most 
frequently reported applications of NIRS in pharmaceutical industry apart from raw material 
identification. Silvia S. Rosa et al. (Silvia S. Rosa et al., 2007) has described the strategy for 
development and validation of NIRS calibration model for Ranitidine content in tablets in diffuse 
reflectance measurement mode. The authors stressed the necessity for suitability test at the onset of 
method development in order to find out if the NIRS analysis of the parameter of interest is feasible. 
Schneider C. et al. have analyzed the ecstasy tablets with NIR diffuse reflectance and transmittance 
measurement mode (Schneider C. et al., 2003). Transmittance mode was shown to perform better. 
Trafford D. et al. have developed NIRS model for paracetamol content prediction in tablets by using 
MLR algorithm (Trafford D. et al., 1999). Validation results indicated the performances comparable 
to UV spectroscopic assay procedure from British Pharmacopoeia 1993. Chalus P. et al. have studied 
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the influence of different spectral pretreatments and regression methods on the accuracy of the NIR 
method for the API content prediction in intact low dose tablets. SNV and second derivative spectral 
pretreatments together with PLS regression method provided the best results (Chalus P. et al., 2005). 
Feng, Y. et al. developed universal quantitative models for the analysis of two APIs in tablets from 
different Chinese manufacturers (Feng, Y. et al., 2006). The models were validated according to ICH 
guidelines. 
 
2.1.4 Reports - API Content Prediction in Tablets by Diffuse Transmission 
NIRS 
 
Dyrby M. et al. have developed quantitative calibration models based on transmittance NIR and 
Raman spectroscopy (Dyrby M. et al., 2002). The authors have applied PLS algorithm for creation of 
the calibration model of the API which contains C≡N functional group. NIR diffuse transmittance 
sampling has proven its effectiveness compared to (microscopic) surface sampling of the Raman 
procedure. Gottfries J. et al. compared the NIRS models for metoprolol content predictions developed 
in diffuse reflectance and transmittance measurement mode (Gottfries J. et al., 1996). NIRS 
reflectance has shown to be more sensitive to inhomogeneity whereas diffuse transmittance mode 
scans larger portion of the tablet. The study indicated that the diffuse transmittance mode is more 
suitable for NIRS tablet analysis. Meza C. P. et al. developed an NIR calibration model for prediction 
of API content present in less than one percent in tablet formulation (Meza C. P. et al., 2006). Mark 
H. et al. have developed the strategy to successfully validate the NIR transmittance spectroscopic 
procedure according to ICH guidelines with special attention to the relevant statistical figures of merit 
(Mark H. et al., 2002). 
 
2.1.5 Reports - Factors Affecting NIR Spectra of the Tablets 
 
Laasonen M. et al., developed a NIRS model for caffeine content determination in intact tablets 
(Laasonen M. et al., 2003). Authors have found that there was non-uniformity of caffeine repartition 
within each tablet. Tablets were scanned on both sides to account for that phenomenon. Method was 
found to be unaffected by the light source replacement but the positioning of the tablet in the sample 
holder was shown to have significant influence on the results. Abrahamsson C. et al. have applied 
time-resolved transmission NIR spectroscopy for the analysis of intact tablets in order to overcome 
the disadvantage of conventional NIR transmission spectroscopy being sensitive to physical attributes 
of the sample (Abrahamsson C. et al., 2005). The applied technique separates the absorption 
properties of the sample from the scattering properties. Saeed M. et al. assessed the effect of the 
compression force on the accuracy of the developed NIRS calibration model for API content 
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prediction of intact tablets (Saeed M. et al., 2009). The authors stressed the need for the careful design 
of the calibration sample set for the successful NIRS model development. Ito M. et al. developed the 
calibration models for the acetaminophen and caffeine content in intact bilayer tablets (Ito M. et al., 
2010). The initially developed models exhibited poor performances because the tablet thickness 
varied excessively. The proper control of the tablet thickness led to NIR models with satisfying 
accuracy and linearity. Unlike Laasonen M. et al., the authors have shown that the control of the 
irradiated side of the tablet was not necessary. Xiang D. et al. developed a robust method for content 
uniformity test of complex tablet formulation (Xiang D. et al., 2009). Robustness assessment involved 
challenging the model with tablets that varied in hardness, excipient vendor, excipient content and 
particle size. Xiang D. et al., assessed different measurement modalities, namely diffuse reflectance, 
diffuse transmittance and diffuse reflectance with fiber optic probe to analyze intact tablets (Xiang D. 
et al., 2009). Diffuse transmittance mode exhibited the best performances due to larger illumination 
spot. Diffuse reflectance mode have shown the sensitivity to tablet engraving. Ito M. et al. developed 
a NIRS calibration model for caffeine content prediction in intact tablets, robust towards the variation 
in tablet design, namely tablet thickness, shape, scored line and embossing. Analysis was done in 
diffuse reflectance and transmittance mode. The global calibration model approach was adopted for 
development of robust method, namely, the sources of variance were included in the model and that 
resulted in increase of the predictability of the models. Transmittance model exhibited better 
performances compared to reflectance model. Borer M. et al. assessed the potential sources of 
variability in the measurement of solid oral drug products in diffuse reflectance mode, using design of 
experiment (DoE) methodology (Borer M. et al., 1998). The authors stressed out the need of the 
careful construction of the calibration set and the control or inclusion of all significant sources of 
variability. The parameters that were evaluated in this study were number of scans averaged per 
spectra, data treatment settings such as the segment used for second derivative calculation, design of 
the library such as the number of dose units scanned, position of the iris i.e. the position of the 
aperture used to center the samples on the platform of the analyzer used in the study and to control the 
level of stray light, orientation of the sample platform, number of days and reference spectrum 
collection frequency. The authors reported some of the major influential factors that were not included 
in the study, namely, lot-to-lot variability in manufacturing, within-lot variability and temperature. 
Plackett - Burman design was applied. The studied responses reflected the ability of the library to 
differentiate the different strengths of the studied tablets, i.e. the performances of the library. Wu W. 
et al. have studied the effect of different design of the training set for artificial neural network 
classification modeling (Wu W. et al., 1996). Four different designs were compared. The presented 
results demonstrated that selection methods based on Kennard-Stone and D-optimal designs showed 
better performances compared to the designs based on Kohonen self-organized mapping and on 
random selection methods. Rutan S. et al. have assessed the influence of different sources of 
variability on the quantitative predictions, combining design of experiments and principal component 
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analysis (Rutan S. et al., 1998). The study was accomplished by comparing the variations in a set of 
the measured, replicate spectra to the spectra with simulated variations. The three-level factorial 
design was applied. The results indicated that the most significant sources of variation were due to 
variable cell path length and a variable curved background. Correction of these errors resulted in 58% 
reduction in SD of the predictions. Blanco M. et al. have studied the influence of physical factors on 
the accuracy of NIRS calibration models (Blanco M. et al., 2010). The authors have evaluated the 
effect of compression force, particle size, galenic form and coating thickness on the accuracy of the 
developed calibrations. The authors have used weight values as reference values to build the 
calibrations. Principal component analysis and cluster analysis was applied to classify the samples 
according to the stage of the manufacturing process and the physical attributes. The models were built 
with laboratory samples and tested with production samples. The factors shown to have significant 
effect on the NIR predictions were included in the initially developed models to improve the 
predictive ability. 
 
2.1.6 Study Aims 
 
The aim of this study was to systematically assess the influence of the main parameters of the 
tableting process, namely, pre-compression pressure, compression pressure and tableting speed on the 
near infrared spectra and performance of the developed calibration models for the prediction of 
caffeine content in intact tablets. Study was performed in diffuse reflection and diffuse transmission 
measurement mode. Design of experiments methodology was applied as a science - based approach to 
studying the effects of the above mentioned tableting parameters on the spectral features represented 
by the response Average Euclidean Distance (AED) and the performance of the developed NIRS 
calibration models represented by the response root mean squared error of prediction (RMSEP). The 
conclusions of the DoE study were challenged by testing the developed calibration models with the 
tablet test sets that included the variability of the three studied tableting factors. The tableting factors 
shown to have a significant influence on the studied responses in the DoE study were considered in 
the development of the robust calibration models towards the three studied factors by following the 
global calibration model approach. 
 
Research Project I is summarized in a manuscript titled “Effect of simulated precompression, 
compression pressure and tableting speed on an offline diffuse transmittance and reflectance near-
infrared spectral information of model intact caffeine tablets” published in the Journal of 
Pharmaceutical Development and Technology (DOI: 10.3109/10837450.2014.949267).
http://informahealthcare.com/phd
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Abstract
Near-infrared spectroscopy (NIRS) is used in the pharmaceutical industry for monitoring drug
content during the tablet manufacturing process. It is of critical importance to understand the
effect of process factors on NIRS performance. Design of Experiments (DoE) methodology was
applied in this work for the systematic study of the effects of compression pressure,
precompression pressure and tableting speed on an average Euclidean distance (AED), which
reflects spectral features of the tablets, and root mean-squared error of prediction (RMSEP) as
key performance indicator of NIRS calibration models. Caffeine tablets were manufactured in 17
experimental runs in accordance with D-optimal design. Developed diffuse transmittance (DT)
and diffuse reflectance (DR) calibration models were tested on five independent test sets to
confirm the conclusions of the DoE. Compression pressure and tableting speed have shown
significant effect on the studied responses in DT mode, whereas all three studied factors have
shown a significant effect in DR mode. Significant factors were considered in the development
of the global calibration models. The authors suggest further study of RMSEP and AED
responses to draw reliable conclusions on the effects of tableting process factors. The global
calibration model in DT mode has shown superior performance compared to DR mode.
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Introduction
The Q8 guidance on pharmaceutical development from the
International Conference on Harmonization (ICH) suggests a
careful risk assessment of variables (such as raw material
attributes, process parameters, environmental conditions, analyt-
ical method characteristics and so on) on critical to quality
attributes (CQAs) of a final drug product1. As the analytical
method is one of the most important variables of an overall
quality risk assessment matrix, it is important to ensure the
complete understanding of factors influencing its performance.
The physical attributes of a sample are determined by both
formulation and manufacturing process factors. Formulation of a
drug product is generally constant over time but manufacturing
process factors may change; these changes and their effect on the
NIR spectra of a drug product need to be well understood and
controlled.
Rather than the more commonly used empirical approach to
defining critical factors affecting NIR spectral response and
calibration model performance, the ICH Q8 and Q9 guidelines
suggest that a systematic and science-based approach such as
design of Experiments (DoE) should be used from the start of
method development where all process parameters that affect NIR
method performance should be identified and included in the
model1,2. These factors should be treated as potential risks to
quality of a final drug product and as such, included in a quality
risk assessment matrix.
The aim of this study was to systematically assess the
influence of precompression pressure (p.p.), compression pressure
(c.p.) and tableting speed (t.s.), on near-infrared spectra (NIRS)
and the performance of the developed NIR calibration models for
the prediction of caffeine content in intact tablets. The secondary
aim was to compare diffuse transmittance (DT) and diffuse
reflectance (DR) measurement modes in terms of suitability for
tablet analysis.
Materials and methods
Materials
Caffeine anhydrous was supplied by BASF AG (Ludwigshafen,
Germany), with a mean particle size of 76 ± 1.4mm and moisture
content of 0.42 ± 0.1%. Microcrystalline cellulose (Avicel
PH 102) was purchased from FMC BioPolymer, Philadelphia,
PA; the mean particle size was 111.6 ± 0.7mm and moisture
content 4.8 ± 0.2%. Magnesium stearate with a mean particle size
of 27 ± 6.3 mm and moisture content of 2.3 ± 0.4% was supplied
by Sandoz AG, Risch, Switzerland. Sodium starch glycolate
(mean particle size 47 ± 2.3 mm) was supplied by DMV-Fonterra
Excipients GmbH, Germany.
Address for correspondence: Branko Z. Vranic, Department of
Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50,
CH-4056 Basel, Switzerland. Tel: + 41 762739727. E-mail: branko.
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Equipment
An XS 204 Analytical Balance (Mettler Toledo AG, Greifensee,
Switzerland) was used for weighing the powder components.
Powders were mixed in a tumbling mixer, a Turbula T2A (Willy
A. Bachofen AG Maschinenfabrik, Basel, Switzerland). A
Malvern Mastersizer X (Malvern Instruments, Worcestershire,
UK) was used to determine average particle size. The infrared
balance used to determine moisture content was an LP 16 M
(Mettler Toledo AG, Switzerland). Direct compression tableting
was done on Presster tablet press simulator (Metropolitan
Computing Corporation, East Hanover, NJ). A NIRFlex N-500
FT-NIR spectrometer (BU¨CHI Labortechnik AG, Flawil,
Switzerland), with DT and DR measurement cells, was used for
spectra acquisition. Reference analysis was performed on a
Beckman DU530 UV-Vis spectrometer. BUCHI NIRCal 5.4
chemometric software was used for generating the PLS calibration
models, and MODDE 9.0 software was used for DoE.
Methods
Preparation of powder and tablet samples
Tablet formulations covering the caffeine content range of 82.4–
122.0% of the nominal caffeine content (where 100% was 50 mg)
were manufactured by direct compression method. Sodium starch
glycolate and magnesium stearate were constant in the studied
formulations at 3% and 1%, respectively. The amount of
microcrystalline cellulose was added to each formulation to the
constant tablet weight of 200 mg. Formulation components
without added magnesium stearate were accurately weighed on
the analytical balance and then transferred to a glass jar to be
mixed for 5 min in a tumbling mixer. After a first mixing cycle,
the powder mixture was screened through a 0.125-mm sieve, 1%
of magnesium stearate added to the mixture and a second mixing
cycle lasting 2 min was performed. About 200 mg of the final
powder mixture was accurately weighed on the analytical balance
and manually fed into the single die of the tablet press simulator.
Direct compression tableting was done on a Presster tablet press
simulator, which was used to simulate an industrial rotary tablet
press (Korsch PH336 with 36 stations) by replicating the tableting
speed, precompression and compression pressure. Tableting speed
was simulated by replicating tablet punch speeds at a given rates
expressed as tablets per hour where precompression and com-
pression force were adjusted indirectly through setting the gap
between upper and lower punch of Presster single tableting
station. A set of flat face punches with 10 mm diameter were
used, and the weight of the tablets was kept constant at 200 mg.
For the DoE study, one batch of the powder mixture was
prepared with a total weight of 200 g. Tablets were manufactured
in 17 experimental runs in accordance with the DoE model. For
each of the 17 DoE runs, 20 tablets were produced (340 tablets in
total) following tableting factor adjustments suggested by
the DoE.
For the development of the local NIR calibration models for
the prediction of caffeine content in intact tablets, 11 concentra-
tion levels were prepared covering the nominal caffeine content
range of 80–120%. Tablet weight was 200 mg. Total weight was
50 g per concentration level. About 220 tablets were produced,
196 were used to build the local calibration models and 24 tablets
were excluded due to cracks, picking, coloration or erroneous UV
reference measurements. Tablets were manufactured using target
tableting parameters, i.e. 76 MPa compression pressure, 25 MPa
precompression pressure and tableting speed of 100 000 tablets
per hour (tph). Tablets were stored for 24 h in the desiccator
before the NIR and reference analysis by UV-spectrophotometry
were performed.
For the extension of the local calibration model, (that is for the
development of a global model), 80 additional tablets were
manufactured. Five different concentration levels were prepared
covering the nominal caffeine content range of 84–116%.
Compression pressure ranged from 38 to 114 MPa, precompres-
sion pressure from 13 to 38 MPa and simulated tableting speed
from 10 000 to 200 000 tph.
Testing of the developed calibration models was done by
manufacturing five tablet test sets. Each test set was composed of
30 tablets. Nominal caffeine content in the tablets spanned the
range of 88–112%.
Test set 1 was manufactured with the target tableting
parameters. In case of the other four test sets, two out of three
tableting factors were kept at the target values while the third one
was varied. Test set 2 had higher (95 MPa) and test set 3 had lower
(57 MPa) compression pressure. With test set 4, precompression
pressures of 13, 18, 25, 32 and 38 MPa were used to manufacture
the tablets. Six tablets for each of the five precompression
pressures were prepared. The tablets of test set 5 were
manufactured by simulating the tableting speeds of 10 000,
50 000, 100 000, 150 000 and 200 000 tph. Six tablets were
produced for each tableting speed.
Acquisition of NIR spectra
The NIRFlex N-500 FT-NIR spectrometer with DT and DR
measurement cells was used for spectra acquisition. DT meas-
urements were done with spectral resolution of 16 cm1. Digital
resolution was 4 cm1. The wavenumber range was 11 520–
6000 cm1. Each spectrum was the average of 64 scans. Ambient
air was measured as a background for calculating the spectra. DR
measurements were carried out with 8 cm1 optical resolution,
and digital resolution was 4 cm1. The wavenumber range was
10 000–4000 cm1. Each spectrum was average of 32 scans.
Spectralon was used as an external reference.
Diffuse reflectance measurements require shorter acquisition
times compared to DT mode but probe only the tablet surface,
whereas DT mode probes larger portion of the tablet but is more
sensitive to variations in tablet physical properties. The compari-
son between the two measurements mode has been carried out.
UV spectrophotometric reference analysis
Distilled water was used to dissolve each tablet and the filtered
solution was measured in a 10-mm cell at 273 nm. The UV
calibration line was obtained in the same medium with a
coefficient of determination of 0.993. Obtained standard error
(SE) was 0.5 mg which corresponds to 1% of the nominal caffeine
content, thereby validating the UV spectrophotometric method.
NIR method development
Calibration models for the prediction of the caffeine content in
intact tablets were developed using the PLS method. Available
data were divided into calibration and validation sets, where two-
thirds were used to develop the NIRS model and one-third to
validate it. The number of principal components was chosen
based on the sum of squares of the spectral residuals (X-PRESS),
assuring an adequate reconstruction of spectra by the model and,
additionally, predicted residual error sum of squares based on a
validation set (V-set PRESS). The developed NIRS models were
judged based on coefficient of determination (RSQ), standard
error of calibration (SEC), validation set Bias and standard error
of prediction (SEP). Linearity was assessed by evaluating the
slope and the intercept of the calibration line and by calculating
the RSQ. Bias and slope of the validation and test sets were tested
for significance based on Student’s t-test. The Durbin–Watson test
was applied to the prediction residuals to check for evidence of
2 B. Z. Vranic & T. F. Vandamme Pharm Dev Technol, Early Online: 1–9
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serial correlations between them. Every model was tested for
outliers in both the calibration and validation sets by visual
inspection of the scatter plot of the reference against NIR
predicted values, scores plot, leverages and spectral residuals. The
ultimate performance indicator of the developed models was the
root mean squared error of prediction (RMSEP) of the test set,
and the ratio of performance to deviation (RPD).
Local NIR calibrations were developed with 196 spectra of the
tablets manufactured with the target tableting parameters (76 MPa
compression pressure, 25 MPa precompression pressure and
simulated tableting speed of 100 000 tph). An additional 79 spectra
of the tablets, prepared with variable compression pressure,
precompression pressure and simulated tableting speed were
added to extend the local models, i.e. to develop the global
calibration models. Local and global calibration models were
tested with five independent test sets, each composed of 30 tablet
samples.
Design of experiments
Compression pressure, precompression pressure and tableting
speed were studied to examine the effect on NIRS and the
subsequent predictions of the developed calibration models. The
tableting process factors to be studied by the DoE were chosen
based on the screening experiments DoE is summarized in Tables
1 and 2.
The variability of the three studied tableting factors was
beyond the normal variability of the tableting process. This was
done intentionally to highlight the inefficacy of the currently
available spectral pretreatments to completely remove non-linear
spectral scaling effects, and to emphasize the need for careful
design of the calibration data set.
The aim of studying the effects of these tableting parameters
on NIR spectra was to evaluate their effect on the prediction
performance of an NIR calibration model. The most appropriate
figure of merit used to judge the performance of NIR calibration
models is the RMSEP, as shown in equation (1). It is a measure of
a total NIR error incorporating both systematic (Bias) and random
error (SEP):
RMSEP ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiPN
i¼1 ðxi  yiÞ2
N
s
ð1Þ
where N is the number of samples, xi is the reference value and yi
is the NIR predicted value. RMSEP was selected as the first
Table 1. Design of experiments – diffuse transmittance study.
Experiment no. Run order
Compression
pressure [MPa]
Precompression
pressure [MPa]
Tableting
speed [tph] RMSEP [%] AED
4 1 38 38 10 000 2.41 0.068065
2 2 114 13 10 000 2.02 0.254038
16 3 114 38 200 000 2.11 0.235421
17 4 114 38 200 000 2.06 0.213638
12 5 76 25 200 000 1.04 0.140521
7 6 76 13 100 000 0.96 0.152458
13 7 38 38 200 000 2.58 0.050159
15 8 114 38 200 000 2.17 0.229461
9 9 114 38 100 000 1.96 0.235979
5 10 76 38 10 000 0.94 0.162516
14 11 114 38 200 000 2.17 0.232987
11 12 114 13 200 000 2.31 0.21575
3 13 114 25 10 000 2.09 0.254562
8 14 38 25 100 000 2.51 0.06223
6 15 114 38 10 000 2.01 0.260523
1 16 38 13 10 000 2.47 0.057639
10 17 38 13 200 000 2.56 0.056411
RMSEP, root mean squared error of prediction; AED, average Euclidean distance.
Table 2. Design of experiments – diffuse reflectance study.
Experiment no. Run order
Compression
pressure [MPa]
Precompression
pressure [MPa]
Tableting
speed [tph] RMSEP [%] AED
4 1 38 38 10 000 2.21 0.003316
2 2 114 13 10 000 2.06 0.011902
16 3 114 38 200 000 2.17 0.010305
17 4 114 38 200 000 2.24 0.010043
12 5 76 25 200 000 1.48 0.005643
7 6 76 13 100 000 1.39 0.005551
13 7 38 38 200 000 2.27 0.004691
15 8 114 38 200 000 2.17 0.011557
9 9 114 38 100 000 2.12 0.011169
5 10 76 38 10 000 1.52 0.007444
14 11 114 38 200 000 2.13 0.011205
11 12 114 13 200 000 1.84 0.008277
3 13 114 25 10 000 1.92 0.012509
8 14 38 25 100 000 2.19 0.004032
6 15 114 38 10 000 2.05 0.012065
1 16 38 13 10 000 2.08 0.003529
10 17 38 13 200 000 2.00 0.002271
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response in the DoE study. For obtaining the RMSEP response
values, two local calibration models were developed for caffeine
content prediction in DT and DR measurement mode. Seventeen
test sets manufactured according to DoE (composed of 20 tablets
each) were predicted by the developed local calibration models,
and RMSEP response values were calculated to provide the inputs
for response surface modeling (RSM).
Average Euclidean distance (AED) was introduced as a second
response for the DoE study3–5. It is not dependent on calibration
model parameters, i.e. on the selected pretreatments but rather
reflects the effect of the studied factors on the spectral features
since the spectral pretreatments were not included in the
calculation. Equation (2) shows how the AED was calculated:
dða, bÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
½ðx1  y1Þ2 þ ðx2  y2Þ2 þ    þ ðxn  ynÞ2
q
ð2Þ
where xn is a single wavelength of spectrum a, yn
single wavelength of spectrum b, a – spectrum ‘‘a’’ composed
of n wavelengths, b – spectrum ‘‘b’’ composed of n wave-
lengths and d (a, b) is Euclidean distance between the spectrum a
and b.
Average Euclidean distance was introduced as a distance
between the average spectrum of the 20 tablets of the test set
manufactured according to DoE, and the reference spectrum
which was the average spectrum of the 20 tablets manufactured
using the ‘‘target’’ tableting parameters (Figure 1). Here, target
parameters correspond to the mean of the design space, and were
defined with a compression pressure of 76 MPa, precompression
pressure of 25 MPa and tableting speed of 100 000 tph. AED
response values were calculated for both studied NIR measure-
ment modes.
Target values of the studied tableting parameters were chosen
based on the recommendations of the United States Pharmacopeia
(USP) and the European Pharmacopoeia (EP)6,7. USP chapters
512164 and 512174 and EP chapter 52.9.84, which refer to
the mechanical properties of tablets, were considered when
developing the experimental design space. A tableting speed of
100 000 tph was set as a target parameter to be simulated. The
selected target parameters resulted in tablets with appropriate
mechanical properties, with no signs of capping, lamination,
cracking or chipping.
The two chosen responses were approximated by quadratic
polynomial models in order to understand how the tableting
factors influence them. Response surface modeling was applied
for evaluating the effects of precompression pressure, compres-
sion pressure and tableting speed on the RMSEP and AED
responses. D-Optimal design (chosen for its flexibility and ability
to target a specific problem), used with a quadratic model and 17
experimental runs, was chosen to model and optimize the effects
of the three tableting factors on the two responses in both studied
measurement modes. Multiple linear regression (MLR) was used
to fit the data. The models that were developed were assessed
based on the variation expressed by the coefficient of determin-
ation (R2), the response variation predicted by the model (Q2), the
model validity and the reproducibility.
Results and discussion
Local NIR calibration models
The local calibration models in DT and DR measurement mode
were developed using 196 tablet samples manufactured with the
target tableting conditions. The aim was to have optimized
calibration models which would be used to obtain the RMSEP
response values for the DoE study. The test set tablet samples,
manufactured in accordance with DoE, were predicted by the
local calibration models and the RMSEP was calculated for each
test set for both measurement modes. PLS regression was used to
calculate the model. SNV spectral pretreatment was used to
reduce the path length differences in both measurement modes.
The wavenumber range 7000–11 520 cm1 was used for the
calculation in DT mode and 4000–10 000 cm1 in DR mode.
Spectra were divided into calibration and validation sets, where
two-thirds of the data were assigned to a calibration and the
remaining third to a validation set. Four principal components
were selected to build the calibration models in both measurement
modes. The property range covered was 82.4–122.0% and 81.4–
123.5% of the nominal caffeine content for DT and DR mode,
respectively. Both local models exhibited an RSQ of 0.99 and an
SEC of 1.07% and 1.55% for DT and DR mode, respectively. The
local calibration models were validated and a summary of the
figures of merit is shown in Table 3. The validated local
calibration models were tested on a set of independent test
samples. Test set 1, made up of 30 tablet samples manufactured
using the target tableting parameters, was used for testing the
model. NIR predictions were plotted against reference values and
the RSQ was 0.92 and 0.84 for DT and DR mode, respectively.
Slope and bias of the regression lines were tested for significance
using Student’s t-test and were shown to be not significant
(the significance level was 0.05). The RMSEP for DT mode was
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Figure 1. Average Euclidean distance in DT and DR measurement mode.
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0.92% and 1.43% for DR mode. Exhibited performance was
comparable to the validation results.
The observed performance indicated that the developed local
calibration models in DT and DR measurement modes were
optimized and suitable for obtaining the NIR predictions neces-
sary for calculating the RMSEP response values for the DoE
study.
Diffuse transmittance DoE study – response RMSEP
The obtained model with the stated RMSEP had nine terms. Each
term was analyzed and the fact that the confidence interval had
not crossed the zero line indicated that the term was statistically
significant. The fitted model has shown a high level of prediction
performance and validity. The model exhibited R2 of 0.99 and
Q2 of 0.94. The validity of the model was found to be 0.76 and
reproducibility 0.99. The high R2 value indicated a high percent of
variation of the response explained by the model; the Q2 was also
fairly high. The presence of insignificant model terms was shown
by the moderate model validity; removing these terms would
increase the prediction ability of the model as initially calculated.
The high levels of model reproducibility were due to the low
variation of the responses under the same experimental condi-
tions. All insignificant equation terms were kept in the model in
order to facilitate the physical interpretation of the model; this
was acceptable since the aim was not to optimize the predictive
ability of the model.
Compression pressure (c.p.), tableting speed (t.s.) and squared
compression pressure (c.p.2) have shown significant effect
(confidence level 0.95) on the response RMSEP. Figure 2 shows
the MLR regression coefficients with the confidence intervals of
the model for the response RMSEP. Coefficients were scaled and
centered in order to make them comparable. The size of the
coefficient represents the change in the response when a factor
varies from zero to one, in coded units, while the other factors are
kept at their averages.
The compression pressure and RMSEP have shown squared
dependency. An increase or decrease of a compression pressure,
as compared to the target compression pressure value, led to
increase of RMSEP (Figure 3). The tablets manufactured using
higher or lower compression pressure as compared to the target
value, resulted in a higher RMSEP due to the fact that the
respective physical variability was not included in the NIR
calibration model which was used to generate the caffeine
predictions and RMSEP values. Tableting speed has shown a
positive correlation with the response RMSEP, where increase in
tableting speed led to increase of RMSEP (Figure 3). This
phenomenon could be attributed to the fact that increase of
tableting speed changes the structural properties of a tablet which
consequently affects scattering and the optical path length in the
tablet precompression pressure (p.p.) has shown no significant
effect on RMSEP response.
Table 3. Validation statistics – local diffuse transmittance (DT) and reflectance (DR) models.
NIR % nominal¼ f (Reference % nominal)
NIR % nominal Reference % nominal DT DR
N DT (58) DR (63) DT (58) DR (63) Alpha 0.05 0.05
Average 101.52 101.63 101.45 101.56 T value 2.00 2.00
Min 83.36 82.56 82.56 81.82 F value 1.57 1.54 Probability
Max 121.79 121.88 121.88 122.79 DT DR
SD 13.13 12.75 13.03 12.92 Tobs_Bias 0.52 0.43 ns 0.608 0.671
DT DR
RMSEP 0.998 1.382 F_sep 1.57 2.14 ns
BIAS 0.068 0.075
SEP 1.004 1.391 Tobs_slope 0.45 0.56 ns 0.653 0.573
RSDyx 1.011 1.399
Slope 1.005 1.008 MAE 0.69 0.89
Intercept 0.403 0.877
RSQ 0.994 0.988 Quartile75 1.16 1.66
RPD 13.098 9.311
N, number of samples; DT, diffuse transmittance; DR, diffuse reflectance; SD, standard deviation; RMSEP, root mean squared error of prediction;
SEP, standard deviation of the prediction residuals; RSDyx, standard error of the predicted y value for each x in regression model; RSQ, coefficient of
determination; RPD, ratio of performance to deviation; Alpha, significance level; T value, T critical value of the Student’s T test; F value, F critical
value of the F test; Tobs_Bias, T observed value returned from the BIAS significance testing according to ISO 12099; F_sep, SEP (SECV) of the
validation set multiplied with F critical value for SEP (SECV) confidence limits estimation according to ISO 12099; Tobs_slope, T observed values
returned from slope significance testing according to ISO 12099; probability: probability for the Student’s T distribution calculated for the T observed
values; MAE, mean of absolute errors; Quartile75, third quartile value for the absolute errors; ns, non-significant.
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Figure 2. Scaled and centered coefficients of the model for the response
RMSEP – diffuse transmittance.
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Diffuse transmittance DoE study – response AED
The model for AED also had nine terms. Compression pressure
and tableting speed showed a significant effect (confidence level
0.95) on the response AED (Figure 4). The fitted model has
shown a high degrees of both accuracy of prediction and validity.
The model for the response AED was characterized by an R2
of 0.99, a Q2 of 0.97, a model validity of 0.94 and reproducibility
of 0.99.
Figure 5 shows the main effects on the studied response and
the interdependency of the studied factors. The positive linear
correlation between compression pressure and AED could be
explained by the fact that an increase of compression pressure
results in a decrease in the thickness of the tablet, and an optical
path length which is reflected as spectra up-scaling relative to the
intensity of diffusely transmitted NIR light. There was a negative
linear correlation between the tableting speed and the response
AED, which could be explained by the fact that an increase of
tableting speed decreases particle bonding in the powder bed,
which makes it less dense and therefore increases the optical path
length.
Diffuse reflectance DoE study – response RMSEP
The model for the response RMSEP had nine terms, three of these
were single factor effects, three were squared effects and three
were interaction effects. Four of the nine terms have shown a
significant effect on the response, with a confidence level of 0.95.
The most significant model terms were compression pressure
(c.p.), squared effect of compression pressure, precompression
pressure (p.p.) and the interaction term between precompression
pressure and tableting speed (Figure 6). The R2 value was 0.98
and the Q2 value was 0.77; model validity was 0.70 and the
reproducibility was 0.97.
The compression pressure has shown a negative effect on the
response RMSEP, whereas the squared effect of the compression
pressure was positive and the most significant term in the model.
This can be attributed to the fact that tablets manufactured with
low compression pressure have high porosity which facilitates the
NIR light scattering, contributing to the increase of the prediction
error, i.e. RMSEP. The precompression pressure has shown a
positive effect on the response RMSEP: an increase in
precompression pressure from 13 to 38 MPa resulted in an
increase of the response RMSEP. The interaction term between
precompression pressure and tableting speed showed a positive
effect on the response RMSEP although tableting speed alone did
not show a significant effect. The combined effect could be
attributed to the fact that an increase of tableting speed (i.e. a
decrease in the contact time between the punch tip of the tablet
press simulator and the powder bed) resulted in a density
inhomogeneity throughout the tablet, and together with the effect
of precompression pressure and its interaction with the compact
formation stage, increased the RMSEP value.
Figure 7 summarizes the behavior of the response RMSEP
when the three studied factors vary from its low to its high level.
The plot shows the trend of the response RMSEP when one factor
varies and the others are kept at their average value.
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Figure 4. Scaled and centered coefficients of the model for the response
AED – diffuse transmittance.
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Figure 3. Contour plots for the response RMSEP – diffuse transmittance.
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Compression pressure affected RMSEP with a squared
dependency. On all three plots shown in Figure 7, the lower and
the upper parts of the graph indicate that where the compression
pressure is low or high relative to the target value of 76 MPa,
RMSEP is high (colored in red). It can be seen that with an
increase of precompression pressure from 13 MPa (low) to
38 MPa (high), this effect is more pronounced, confirming the
positive effect of the precompression pressure on RMSEP. On the
first and the second plot in Figure 7, it can be seen that tableting
speed had no effect on RMSEP. The third plot shows an increase
of RMSEP with an increase of tableting speed when the
precompression pressure is high (38 MPa). This demonstrates
the positive effect of the interaction in the DoE model between
precompression pressure and tableting speed on RMSEP.
Diffuse reflectance DoE study – response AED
The model for the response AED consisted of nine terms. Five out
of the nine terms have shown significant effect on the response
(with a confidence level 0.95). The significant terms were
compression pressure (c.p.), precompression pressure (p.p.),
tableting speed (t.s.), the interaction term between precompres-
sion pressure and tableting speed, and the interaction term
between compression pressure and tableting speed (Figure 8). The
R2 value was 0.99 and the Q2 value 0.97. Model validity was 0.98
and reproducibility 0.97.
Figure 9 shows the effects of three factors on the response
AED. The compression pressure has shown positive effect on the
response AED. An increase in compression pressure could result
in a decrease of smoothness of a tablet surface, which could
increase surface scattering effects and consequently decrease the
intensity of the NIR reflectance signal, which was observed.
A positive correlation was shown between precompression
pressure and AED. The effect of precompression pressure is
formulation dependent and depends mostly on the deformation
behavior of the filler (plastic, elastic, visco-elastic or brittle). The
tableting speed has shown a negative effect on the AED. With an
increase in precompression pressure, the effect of tableting speed
on AED was more pronounced (a positive effect of the interaction
term between precompression pressure and tableting speed).
An increase in compression pressure increased the negative
effect of tableting speed on the AED; tableting speed affects
the tablet smoothness and the looseness of the tablet
surface layers, and therefore contributes to surface light scattering
effects.
The conclusions from the DoE study were subjected to further
evaluation. The initial local calibration models in DT and DR
measurement mode that were used for obtaining the predictions
and RMSEP response values for the DoE study were tested
against five test sets. The calibration models were then extended
to include the variability factors shown by the DoE study to have a
significant effect on the responses, and tested again against the
same test sets. The prediction errors (RMSEP) of the test sets
were evaluated and compared in order to confirm the conclusions
of the DoE study.
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Figure 6. Scaled and centered coefficients of the model for the response
RMSEP – diffuse reflectance.
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Figure 8. Scaled and centered coefficients of the model for the response
AED – diffuse reflectance.
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Figure 7. Contour plots for response RMSEP – diffuse reflectance.
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Global NIR calibration models
The local calibration models were extended with the spectra of the
79 tablet samples. Raw DT and DR spectra were pretreated using
log function and multiplicative scatter correction (MSC) pretreat-
ment. The wavenumber range was the same as that used in the
local NIR calibration models. Two principal components (PCs)
were used to calculate the DT global calibration model, and three
PCs were used for the calculation of the DR global model. The
global DT model exhibited an RSQ of 0.99 and an SEC of 1.35%.
The DR model was characterized with an RSQ of 0.98 and an
SEC of 1.72%. Both global calibration models were validated, and
a summary of the validation figures of merit is shown in Table 4.
Confirming the conclusions of the DoE study – DT
measurement mode
The developed local calibration model in DT mode was tested
against five independent test sets (Table 5). The RMSEP for test
set 1 was found to be 0.92%, and the prediction error was lower
than the RMSEP of the validation set (1%). The RMSEP for
the test sets 2 and 3 was 2.33% and 2.57%, respectively;
high prediction errors for test sets 2 and 3 have indicated that the
DT measurement mode is sensitive to variations in the physical
properties of the samples (such as thickness, porosity, optical path
length and so on). The prediction errors of test sets 4 and 5 were
not different when compared with the RMSEP of the validation
set. This observation corresponded with the conclusions of the
DoE study. Further tests were done on the global calibration
model to confirm these conclusions.
Improvements in performances were apparent in case of global
DT model. The RMSEP of test set 1 was higher when compared
with the validation set RMSEP, possibly due to an increase in a
variability included in the model after the calibration extension.
The RMSEP of test sets 2, 3 and 5 was significantly decreased,
while the RMSEP of the test set 4 was increased confirming that
precompression pressure has not shown any significant effect on
NIR predictions, whilst the compression pressure and tableting
speed have shown a significant effect. The overall RMSEP value
calculated for the 150 tablets of the five test sets was 1.21%. The
calculated RMSEP values are summarized in Table 5.
Confirming the conclusions of DoE study – DR measure-
ment mode
The developed local and global calibration models in DR mode
were tested against the same five test sets. The local calibration
model exhibited an RMSEP of 1.43% for test set 1, compared with
the validation set RMSEP of 1.35%. The RMSEP of test set 2 was
1.81% and the RMSEP for test set 3 was 2.07%. Predictions
of test sets 4 and 5 resulted in RMSEPs of 1.59% and 1.54%,
respectively. It was evident that prediction errors increased
significantly when the model was tested on tablets manufactured
with a compression pressure different from that used for the
manufacturing of the calibration samples. The prediction error
was particularly high for the low compression pressure test set
(test set 3). This can be attributed to the strong influence of light
Table 4. Validation statistics – global diffuse transmittance (DT) and reflectance (DR) models.
NIR % nominal¼ f (Reference % nominal)
NIR % nominal Reference % nominal DT DR
N DT (84) DR (91) DT (84) DR (91) Alpha 0.05 0.05
Average 101.17 101.10 101.09 101.28 T value 1.99 1.99
Min 82.56 81.53 81.94 82.56 F value 1.35 1.34 Probability
Max 121.88 123.86 121.31 121.88 DT DR
SD 12.80 12.92 12.71 12.89 Tobs_Bias 0.65 1.06 ns 0.515 0.293
DT DR
RMSEP 0.996 1.541 F_sep 1.35 2.01 ns
BIAS 0.071 0.172
SEP 0.999 1.540 Tobs_slope 1.22 0.39 ns 0.225 0.702
RSDyx 0.996 1.547
Slope 0.990 0.995 MAE 0.55 1.17
Intercept 0.984 0.321
RSQ 0.994 0.994 Quartile75 1.19 1.87
RPD 12.832 8.399
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Figure 9. Contour plots for the response AED – diffuse reflectance.
Table 5. RMSEP of the test sets for local and global DT and DR models.
Test
set no.
DT local
RMSEP (%)
DR local
RMSEP (%)
DT global
RMSEP (%)
DR global
RMSEP (%)
1 0.92 1.43 1.03 1.39
2 2.33 1.81 1.19 1.63
3 2.57 2.07 1.42 1.71
4 1.06 1.59 1.13 1.46
5 1.21 1.54 1.11 1.48
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scattering in the high porosity tablet samples, because low
compression pressure results in tablets that are highly porous,
liable to light scattering and photon attenuation phenomena which
cause the deviation from Beer–Lambert law. Test sets 4 and 5,
with variable precompression pressure and tableting speed,
exhibited higher RMSEPs than test set 1; the observed difference
was assumed to be either due to random error effects or the effect
of precompression pressure and tableting speed. This was left to
be confirmed with the predictions made by the global model.
The hypothesis was that the difference could originate from the
systematic effect of the tableting factors and not from random
effects only if the RMSEP of test sets 4 and 5 decrease when the
test sets are predicted by the global model which has the
incorporated variability present in the respective test sets.
The global calibration model developed in DR mode was
tested with the same five test sets. The RMSEP of test set 1 was
lower than the local model test results. The RMSEP of test sets 2
and 3 were 1.63% and 1.71%, respectively, showing the decrease
of 11% and 17% relative to the local model. The RMSEP for the
test sets 4 and 5 decreased significantly, confirming that the three
studied tableting parameters had a significant effect on NIR
predictions in DR mode. The overall RMSEP value calculated for
the 150 tablets of the 5 test sets was 1.54%. Table 5 summarizes
the calculated RMSEP values.
Conclusion
A systematic and science-based approach to studying the critical
factors in the tableting process that affect NIR spectra and
calibration model performance was proposed in this work. The
DoE study was carefully designed with particular attention to the
studied responses. The authors suggest the use of AED as a
response reflecting the influence of tableting process parameters
on NIR spectral features. The effects of the studied factors on
AED are independent of the spectral pretreatments or other
parameters used during the calibration development. The disad-
vantage of evaluating the factor effects based on AED is that it
does not directly reflect the performance of the developed NIRS
model. The second studied response was the RMSEP. RMSEP
values reflect the performance of NIRS calibration model but are
dependent on the spectral pretreatments and parameters chosen
during the modeling phase (number of principal components,
wavenumber range and so on). The authors suggest the use of both
responses in the interpretation of the effects of the tableting
factors on the NIR spectral information of tablets.
Response surface modeling showed that compression pressure
and tableting speed have a significant effect on the RMSEP
and AED responses when DT measurement mode was used.
The effect of precompression pressure was insignificant.
Compression pressure, precompression pressure and tableting
speed have all shown a significant effect on the responses RMSEP
and AED in DR measurement mode. RMSEP and AED were not
always affected in the same way by the three studied factors. For
that reason, the authors suggest studying the two responses and
drawing the conclusions on the significance of factor effects based
on interpretation of the both proposed response models. The
effects of the studied factors on the RMSEP of the five
independent test sets of caffeine tablets, which were predicted
by the developed local and global calibration models, confirmed
the conclusions of the DoE study.
The developed global calibration model for the prediction of
the caffeine content of tablets in DT measurement mode exhibited
an RMSEP of 1.21% calculated on the five test sets composed of
150 tablets. The global calibration model in DR mode performed
with an RMSEP of 1.54% when tested on the same five test sets.
Direct comparison clearly confirms the superior performance and
better suitability of DT measurement mode in tablet analysis. The
reason for this could be the larger sampling area in case of DT
mode. However, both global models exhibited comparable
performances to the UV-spectrophotometric reference method
which performed with the standard error of 1%. For increased
reliability of the results a larger data set would be needed: the sets
used for the DoE study were based on 20 samples per
experimental run which is considered to be the minimum
statistically relevant number of observations. However, it should
be pointed out that such a data set size might still not be sufficient
for a validated method accepted by the regulatory authorities.
D-optimal design was chosen for this study for its great
flexibility and customisability. However, the authors suggest that
the study should be repeated using classical designs in order to
compare the results.
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2.2 Research Project II: Preliminary Study of an Offline 
Simultaneous Determination of Metoprolol Tartrate and 
Hydrochlorothiazide in Powders and Tablets by Reflectance 
Near-infrared Spectroscopy 
 
 
2.2.1 Introduction 
 
Near infrared spectroscopy (NIRS) belongs to vibrational spectroscopy. It covers the wavelength 
region of 750 – 2500 nm. The NIR signal is a consequence of the absorbance of light due to molecular 
vibrations (overtones and combinations of fundamental mid – IR vibrations) of hydrogen bonds like 
C-H, N-H, O-H, S-H. The benefits of NIRS are well recognized. It is fast, nondestructive, noninvasive 
analytical technique requiring minimal or no sample preparation. It is able to analyze various 
pharmaceutical dosage forms. Apart from the number of applications in drug development and quality 
control, NIRS has proved its efficiency as Process Analytical Technology (PAT) tool in monitoring 
the critical-to-quality attributes (CQAs) during the manufacturing process.  
Existing guidelines on the development and validation of analytical methods (European Medicines 
Agency, 2012; PASG NIR Subgroup, 2001) suggest that the feasibility study should be done at the 
onset of analytical method development process. Feasibility study should reveal if the quantitative 
analysis is possible by initial assessment of the analyte concentration and the NIR spectral response. 
Linearity of the NIR response should be evaluated by correlating the spectral data with the reference 
values obtained from the primary analytical method, by using multivariate data analysis methods such 
as partial least squares regression (PLSR). Sample handling and presentation is investigated at this 
stage of method development. Repeated measurements of the same sample or representative 
subsamples should provide a first estimation of the random error and sampling error component of the 
NIR measurements. In the feasibility study, sample collection should be done to cover the necessary 
range of the analyte of interest and the variability expected during the routine use of the method. 
Factors that influence NIR spectral response should be studied, preferably using DoE methodology. 
Sample size should be suitable to provide the adequate performances of the method. Acquisition 
parameters should be optimized to give the NIR spectra with suitable signal-to-noise ratio and 
adequate repeatability on the same sample or the representative subsamples. 
  
 Vranic Z. Branko PhD Thesis Page 91 
 
2.2.2 Reports – Simultaneous NIRS Quantification of Two APIs 
 
Dou Y. et al. developed a method for simultaneous determination of paracetamol and 
diphenhydramine hydrochloride in powders using NIR spectroscopy and artificial neural networks 
(NN) (Dou Y. et al., 2005). The developed NN models based on the pretreated spectra, were 
compared with the PLS models. The NN models based on first derivative NIR spectra have shown 
superior performances. Dou Y. et al. have combined NN and  principal component analysis (PCA) to 
simultaneously quantify aminopyrin and phenacetin in tablets (Dou Y. et al., 2006). The authors 
applied PCA to the pretreated NIR spectra and subsequently, the scores of the principal components 
were used as inputs nodes for the input layer instead of spectral data. The adopted approach was 
compared with the NN model based on the spectral data. The PC-NN model provided the best results. 
Blanco M. et al. developed a NIRS calibration models for simultaneous determination of five active 
principles in a pharmaceutical preparations (Blanco M. et al., 2006). The authors applied PLS1 
algotithm for model development. It was reported that the selection of the calibration samples was 
crucial for the successful NIRS model development in complex matrices. Sample homogeneity was 
defined as one of the major difficulties to overcome. The methods have been validated according to 
ICH and EMA guidelines and have shown to be a good alternative to existing HPLC and redox 
titrimetric methods.  
 
2.2.3 Reports – Simultaneous Quantification of HTZ and MTP 
 
Garg G. et al. have developed UV-spectrophotometric and HPLC method for simultaneous 
determination of MTP and HTZ in tablets (Garg G. et al., 2008). The first method was created with 
seven mixed standards and the absorption maxima at 223 and 271 nm, respectively. Methanol was 
used as a medium. The developed HPLC method used reverse-phase C18 column with UV detection 
and methanol-water (95:5) as a mobile phase. Rawool N. D. et al. developed a method for 
simultaneous determination of HTZ and MTP using reverse-phase HPLC (Rawool N. D. et al., 2011). 
The authors have used C18 mobile phase with slightly different detection wavelength compared to 
Garg G. et al., and phosphate buffer – methanol mixture (60:40) as a mobile phase. Gupta K. R. et al. 
developed UV-spectrophotometric method for HTZ and MTP quantification (Gupta K. R. et al.,2008). 
The authors have used the absorption peaks at 257.8, 282.9 and 315 nm whereas, first two peaks were 
specific for MTP and the last one for HTZ. Gao F. et al. have reported the method for simultaneous 
determination of HTZ and MTP in human plasma by combined liquid chromatography – mass 
spectrometry (Gao F. et al., 2010). Stolarczyk M. et al. applied derivative spectrophotometry for 
simultaneous determination of HTZ and MTP in pharmaceutical preparations (Stolarczyk M. et al., 
2006). Ramadan N. K. et al. reported a miniaturized membrane sensors for potentiometric 
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determination of HTZ and MTP (Ramadan N. K. et al., 2012). Alnajjar A. O. et al. developed 
capillary electrophoresis assay method for HTZ and MTP combined dosage form with the aid of 
multivariate data analysis tools (Alnajjar A. O. et al., 2013). 
 
2.2.4 Study Aims 
 
Simple and fast method was proposed in this work for the simultaneous determination of metoprolol 
tartrate and hydrochlorthiazide in powders and tablets by NIR reflectance spectroscopy. The proposed 
method was shown to be suitable for the feasibility study that should be undertaken and the onset of 
NIRS method development, indicating the suitability of NIRS method for the intended purpose. The 
use of the compaction simulator Presster
®
 enabled the fast and cost-effective sample collection by 
mimicking the industrial rotary tablet press and enabled the robust design of the calibration data set 
for the NIR method development. Gravimetrical reference method – Balance Reference Method 
(BRM) was introduced as a quick and cost-effective alternative to compendial methods such as UV 
spectrophotometry or HPLC which are traditionally used for API content determination. BRM has 
shown adequate performances which enables it to be used at the stage of a feasibility study. 
Pharmaceutical Analytical Science Group (PASG) suggests that the gravimetrical data from the input 
ingredients could be used as reference values for NIRS method development (PASG NIR Subgroup, 
2001). 
With the proposed approach, the crucial information for the analytical method development could be 
gathered in a fast, simple and cost-effective way. 
 
Research Project II is summarized in a manuscript titled “Preliminary study of an offline simultaneous 
determination of metoprolol tartrate and hydrochlorothiazide in powders and tablets by reflectance 
near-infrared spectroscopy” published in the Journal of Pharmaceutical Development and Technology 
(DOI: 10.3109/10837450.2014.949268). 
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Abstract
A preliminary study of the feasibility of using near-infrared spectroscopy (NIRS) for the offline
simultaneous determination of metoprolol tartrate (MTP) and hydrochlorothiazide (HTZ) in
powders and tablets has been carried out. An industrial tableting process was simulated using
an instrumented tablet press replicator – Presster. Conventional reference analytics were
replaced with gravimetric analysis. The NIRS models for powder and tablet analysis were
developed using 55 samples, and tested on 80 independent samples. Powder mixture
components were weighed in glass vials to collect reference values, mixed and manually
transferred to a tablet press replicator and compacted to form tablets. NIRS calibration models
were developed using spectral and gravimetric reference data. The two model drugs were
simultaneously quantified exhibiting root mean-squared error of prediction (RMSEP) of 1.69 and
1.31mg for HTZ powder and tablet samples, respectively, and RMSEP of 3.15 and 3.00mg for
MTP powder and tablet samples, respectively. NIRS analysis of MTP and HTZ in powder and
tablet form has not been reported elsewhere.
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Introduction
Near-infrared spectroscopy (NIRS) has been investigated as a
method for the simultaneous offline determination of metoprolol
tartrate (MTP) and hydrochlorothiazide (HTZ) in both powder
and tablet forms in this feasibility study. Existing guidelines on
the development and validation of analytical methods1,2 suggest
that a feasibility study should be done at the onset of any
analytical method development process; in this case, the
feasibility study should reveal if a quantitative analysis is
possible by initial assessment of an analyte concentration and
NIRS response. The linearity of the NIR response was evaluated
by correlating the spectral data with reference values obtained
from the primary analytical method. A compaction simulator
was used for calibration sample design and collection by
mimicking an industrial rotary tablet press. The active pharma-
ceutical ingredient (API) content is traditionally determined
using compendial methods such as UV spectrophotometry or
HPLC; as an alternative to these methods, gravimetric analysis
(balance reference method, BRM) was introduced in this study.
The Pharmaceutical Analytical Science Group (PASG) states
that gravimetric data from the input ingredients could be used as
reference values for NIRS method development2. BRM has
shown in this study suitable performance to be used at the
feasibility stage of a method development. With the proposed
alternative approach, useful information could be gathered for
NIRS method development.
Materials and methods
Materials
The two model drugs, HTZ and MTP were supplied by Sigma–
Aldrich (Switzerland). Mean particle size of the HTZ was
124 ± 1.5mm, with a moisture content of 0.51 ± 0.2%. Mean
particle size of the MTP powder was 64 ± 2.2 mm and moisture
content 0.32 ± 0.1%. Microcrystalline cellulose was supplied by
the company FMC BioPolymer (Philadelphia, PA). The mean
particle size was 106 ± 0.5 mm, and moisture content 4.3 ± 0.1%.
Equipment
The Mettler Toledo AG (Greifensee, Switzerland) XS204 analyt-
ical balance XS 204 was used for weighing the powder
components. Powders were mixed using a tumbling mixer, a
Turbula T2A (Willy A. Bachofen AG Maschinenfabrik, Basel,
Switzerland). A Malvern Mastersizer X (Malvern Instruments,
Worcestershire, UK) was used to determine average particle size.
An LP 16 M infrared balance (Mettler Toledo AG, Greifensee,
Switzerland) was used for moisture content determination. Direct
compression tableting was done on a Presster tablet press
simulator (Metropolitan Computing Corporation, East Hanover,
NJ). A NIRFlex N-500 FT-NIR spectrometer (BU¨CHI
Labortechnik AG, Flawil, Switzerland) with a diffuse reflectance
Address for correspondence: Branko Z. Vranic, Department of
Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50,
CH-4056 Basel, Switzerland. Tel: + 41 762739727. E-mail:
branko.vranic@unibas.ch
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measurement cell was used for spectra acquisition. NIRCal 5.4
chemometric software (BU¨CHI Labortechnik AG, Flawil,
Switzerland) was used for generating the calibration models.
Methods
Preparation of powder and tablet samples
Metoprolol tartrate and HTZ were the drugs chosen for this
study. Microcrystalline cellulose was used as the filler and dry
binder for direct compression tableting using the tablet press
simulator. Microcrystalline cellulose, MTP and HTZ were
weighed on an analytical balance in 4 mL glass vials (15 mm
 45 mm, flat bottom) for each sample separately. About 55
samples covering the nominal drug content range of 60–140%
(i.e. 18–42 mg of HTZ and 96–144 mg of MTP) were prepared
for the NIRS calibration model development, and 80 samples
were prepared separately as an independent test set.
Microcrystalline cellulose was added to the drugs to make the
constant weight of 250 mg. Nominal values of the HTZ and
MTP powder weight were used as reference values for
developing the NIRS calibration models. The powder samples
in glass vials were bound together with a rubber band and
placed in a 200 mL glass jar. This jar was then placed in the
tumbling mixer for 300 s. The moving block of standard
deviation (MBSD) method was applied for the determination
of a mixing end-point3,4. After the mixing process, spectra of the
powder samples were acquired on the NIR spectrometer in
diffuse reflectance measurement mode; the powders were then
manually transferred from the glass vials to the die of the tablet
press simulator and compressed into tablets. Tableting speed was
simulated by replicating tablet punch speeds at a given rates
expressed as tablets per hour. The tableting speed replicated was
10 800 tablets per hour (tph), with a compression force of
6 ± 0.2 kN adjusted indirectly through setting the gap between
upper and lower punch of Presster tableting station, and a set
of flat face punches with 10 mm diameter was used. The weight
of the tablets was kept constant at 250 mg. After the tableting
process, tablets were weighed on the analytical balance to
measure any weight loss and calculate the error component of
the balance reference method (BRM); any weight loss may occur
during the manual powder transfer from the glass vial to the
tableting machine die and due to the tableting process itself.
After weight determination, tablets were stored in a desiccator
for 24 h to allow the post-compaction relaxation to finish. NIR
spectra of the tablets were acquired in diffuse reflectance
measurement mode.
NIR measurements
A NIRFlex N-500 FT-NIR spectrometer with a diffuse reflect-
ance measurement cell and vial and tablet sample holder was
used for the acquisition of the powder and tablet spectra.
Each sample was measured 3 times. Diffuse reflection measure-
ments were carried out with 8 cm1 optical resolution, and the
digital resolution was 4 cm1. The wavenumber range was
10 000–4000 cm1. Each spectrum was the average of 32 scans.
Spectralon5 was used as an external reference. NIRCal 5.4
chemometric software was used for generating the calibration
models. Figure 1 shows the pretreated spectra of the formulation
components.
Balance reference method
Each component of the powder mixture for each sample was
weighed in a glass vial on the analytical balance. The value of the
powder component weight was used as a reference value for the
NIRS calibration model development. The error of the balance
reference method6 was estimated using equation (1):
Total error ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
e2R þ e21 þ e22 þ Bias22
q
ð1Þ
where eR is the repeatability standard deviation of the analytical
balance, e1 the error of powder weighing, e2 the error due to
powder loss during tableting process and the manual transfer from
a vial to a tableting machine die, and bias is the average difference
between the powder mixture weight and tablet weight (average
powder loss). The weighing error for 250 mg powder mixture was
found to be 4.6 mg. The average percentage of HTZ in the powder
mixture was 12%, i.e. the error on weighing HTZ was 0.55 mg.
The average percentage of MTP in powder mixture was 48%, i.e.
the error on MTP weighing was 2.21 mg.
NIR calibration model development and evaluation
Raw spectra were collected by scanning the powders and tablets
on the NIR spectrometer in diffuse reflectance measurement
mode. After selecting the spectral pretreatment, partial least
squares regression (PLSR) was applied for correlating the spectral
data with the drug content reference values for each individual
substance. The NIRS calibration models developed were validated
using a cross-validation method. The calibration set was divided
into five property segments, and each segment was then
iteratively left out of the data set and predicted by the model as
calculated using the rest of the data set. The optimal number of
principal components was chosen by observing the plot of
principal components (PCs) against the standard error of cross-
validation (SECV). The PCs giving the lowest SECV values were
chosen. The models were tested using the independent test set
which was made up of 80 samples. The developed NIRS models
were judged based on the coefficient of determination (RSQ),
standard error of calibration (SEC) and SECV. The Durbin–
Watson test was applied to the prediction residuals to look for
evidence of serial correlation between them. The first loading plot
and the regression coefficient plot of the calibration model under
evaluation were compared with the pretreated spectra of the pure
analyte (MTP or HTZ) to evaluate the specificity of the model.
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Figure 1. Pretreated spectra of microcrystalline cellulose (4), metoprolol
tartrate (3), hydrochlorothiazide (2) and the powder mixture (1).
2 B. Z. Vranic & T. F. Vandamme Pharm Dev Technol, Early Online: 1–6
Ph
ar
m
ac
eu
tic
al
 D
ev
el
op
m
en
t a
nd
 T
ec
hn
ol
og
y 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
21
3.
19
6.
18
2.
99
 o
n 
08
/1
4/
14
Fo
r p
er
so
na
l u
se
 o
nl
y.
The calibration performance was evaluated by calculating the root
mean-squared error of prediction (RMSEP) as a main perform-
ance indicator and the ratio of performance to deviation (RPD).
According to Williams and Sobering, the RPD value can be used
for descriptive calibration performance assessment7. RSQ of the
test set predictions against reference analysis values was used to
assess the linearity. Standard error of prediction (as a measure of a
random prediction error) was calculated with associated confi-
dence interval. The slope of the regression line and bias were
tested for significance based on the Student’s t-test. Population of
the absolute prediction errors of the test set were evaluated, and
the mean absolute error (MAE) and the third quartile of the
respective population were calculated. Median absolute error is a
measure of prediction residual dispersion, and is a robust statistic,
being more resilient to outliers in a data set than a standard
deviation. Quartiles are used to divide the populations into
groups; the third quartile (Quartile75) of the absolute errors is the
middle value between the population median and the maximum
value of the population of the absolute errors. This was used to
provide more information on the distribution of the absolute
errors in the studied population.
Results and discussion
NIRS model for HTZ analysis in powders
The raw spectra of the 55 powder samples were log transformed
and then Standard Normal Variate (SNV) spectral pretreatment
was applied to reduce the optical pathlength differences. The full
wavenumber range was used for the model calculation. The
property range covered was 18.0–42.0 mg of the HTZ content.
Calibration model was calculated on 163 spectra of powder
samples exhibiting an RSQ of 0.95, SEC of 1.89 mg and SECV of
2.1 mg. The Durbin–Watson test result of 1.73 indicated that there
was no significant correlation between the prediction residuals.
The cross-validation property residuals were plotted against the
HTZ reference values and the RSQ was 0.06, confirming good
linearity of the developed calibration model. The developed
calibration model was tested on the independent test set,
consisting of 80 powder samples measured 3 times; the triplicates
were then averaged; the property range was 18–42 mg of HTZ. An
RSQ of 0.957 was achieved, and the RMSEP was calculated as a
measure of the total error of the model and was found to be
1.70 mg. Bias was 0.04 mg and was tested for significance based
on Student’s t-test as described by ISO 120998. The observed
t-value for the bias was smaller than the critical t-value, which
indicated that the bias was not significant with a probability of
0.84 (significance level 0.05), i.e. there was no significant
systematic error observed in the predictions of the test set. The
SEP value as a measure of a random model error was 1.71 mg; the
confidence limit for the SEP was ±2.87 mg (significance level
0.05). RSDyx as the standard error of the predicted y value for
each x in regression was 1.7 mg. Compared to the estimated total
error for HTZ balance reference method – 0.55 mg – prediction
error of the test set for the HTZ calibration model of 1.7 mg was
significantly higher. This could be attributed to inhomogeneity of
the powder mixture, or imperfections in the glass vials which
were used as powder sample holders for the NIR measurements.
The slope of the regression line was 0.972; it was tested for the
significance in accordance with ISO 12099, based on Student’s
t-test. The observed t-value was smaller than the t-critical,
indicating that the slope was not significant with the probability of
0.24 (significance level 0.05). The ratio of performance to
deviation (RPD) was found to be 4.8, which shows that the
calibration performance was fair. The MAE was found to be
1.26 mg. The upper quartile in the studied population was found to
be 2.11 mg.
The prediction residuals of the 80 test set powder samples
were plotted and compared with the ±2SECV limits
(2 1.71 mg) together with the bias in order to show the
prediction performance and the magnitude of the bias. It was
observed that no prediction residual was higher than the
±2SECV limit (Figure 2). The specificity of the model was
confirmed by the fact that the samples with HTZ content of 18 mg
(60%) that contained 142 mg of MTP (140%) were predicted just
as well as the rest of the test set (the RMSEP for the 15
independent test samples was 1.71 mg), indicating that there was
no significant spectral interaction between the two active
pharmaceutical ingredients. Table 1 summarizes the calibration
model test set statistics.
NIRS model for HTZ analysis in tablets
The raw spectra of the tablets used for the development of the
NIRS calibration model were log transformed; SNV spectral
pretreatment and first derivative were then applied to correct for
baseline offsets and optical pathlength differences. The full
wavenumber range was used for the model calculation. Six
principal components were selected for model calculation. The
property range covered was 18.0–42 mg of HTZ. Calibration was
calculated on 151 spectra of the tablet samples exhibiting an RSQ
of 0.988 and SEC of 0.9 mg; the SECV was 1.6 mg. The Durbin–
Watson test result of 1.89 indicated that there was no significant
correlation between the prediction residuals. The cross-validation
property residuals were plotted against HTZ reference values; the
RSQ was 0.03, confirming the good linearity of the developed
calibration model. The developed calibration model was tested
with an independent test set composed of 80 tablet samples
measured 3 times on the NIR spectrometer and subsequently
averaged. The test set tablets were prepared from the powder
samples also used for the HTZ powder calibration model. The
property range was 18–42 mg of HTZ. An RSQ of 0.976 was
achieved, and the RMSEP was found to be 1.31 mg. Bias was
0.29 mg, and was tested for the significance based on the
Student’s t-test. The observed t-value for the bias was lower than
the critical t-value, which indicated that the bias was not
significant, with a probability of 0.051 (0.05 significance level),
i.e. there was no significant systematic error observed in the
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Figure 2. Hydrochlorothiazide test set predictions in powders – predic-
tion residuals and bias versus 2 SECV limits.
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predictions of the test set. The SEP value was 1.28 mg; the
confidence limit for the SEP was ±2.17 mg (level of significance
0.05). RSDyx as the standard error of the predicted y value for
each x in regression was 1.29 mg. The slope of the regression line
was 0.987; it was tested for the significance as described by ISO
12099, based on the Student’s t-test. The observed t-value was
lower than t-critical, indicating that the slope was not significant
with the probability of 0.46 (significance level 0.05). The median
absolute error was found to be 0.79 mg. Upper quartile in the
studied population of the test set prediction residuals was 1.11 mg.
The prediction residuals of the 80 test set tablet samples were
plotted and compared with the ±2 SECV limits (2 1.58 mg)
together with the bias in order to show the prediction performance
and the magnitude of the bias. It was observed that the
two prediction residuals were higher than ±2SECV limit
(Figure 3). Specificity of the model was confirmed by the fact that
the samples with HTZ content of 18 mg (60%) that contain
142 mg of MTP (140%) were predicted just as accurately as the
rest of the test set (the RMSEP for the 15 independent test
samples was 0.88 mg), indicating that there was no significant
spectral interaction between the two active pharmaceutical
ingredients. Table 1 summarizes the test set statistics.
NIRS model for MTP analysis in powders
The calibration model was developed with 55 powder samples.
The raw spectra were pretreated using SNV spectral pretreatment
and first derivative Savitzky-Golay 9 points, gap 0. The
wavenumber ranges of 4000–5080 cm1 and 5440–9000 cm1
were used to calculate the model. The first loading vector of
the initially calculated model indicated that there is a high
correlation between MTP content and the OH group absorption
band of the microcrystalline cellulose and water (5080–
5440 cm1), so the respective wavenumber region was excluded
from the model calculation. Seven principal components were
selected to calculate the model. The property range covered was
96–144 mg of MTP. The calibration was calculated using 143
spectra of powder samples exhibiting an RSQ of 0.99 and an SEC
of 1.46 mg; SECV was 3.1 mg. The Durbin–Watson test statistics
of 1.88 indicated that there was no significant correlation between
the cross-validation residuals. The residuals were plotted against
HTZ reference values, and the RSQ was 0.03, confirming good
linearity of the developed calibration model. The developed
calibration model was tested on the independent test set which
consisted of 80 powder samples measured in triplicate; the
triplicates were then averaged to give a single spectrum. The
property range was 96–144 mg of MTP, and an RSQ of 0.964 was
achieved. Linearity was further assessed by plotting the prediction
residuals against reference values and the NIR predicted values.
Neither linear correlation nor specific pattern among residuals
was observed. The RMSEP was calculated as a measure of the
total error of the model and was found to be 3.24 mg. Bias was
0.62 mg and was tested for the significance based on the
Table 1. Hydrochlorothiazide powder and tablet calibration models – test statistics.
NIR % nominal¼ f (Reference % nominal)
NIR [% nominal] Reference [% nominal]
N¼ 80 Powder Tablet Powder Tablet
Average 29.66 29.92 29.63 Alpha 0.05 0.05
Min 15.56 16.26 18.00 T value 1.99 1.99 Probability
Max 44.34 44.64 42.00 F value 1.37 1.37 Powder Tablet
SD 8.18 8.22 8.23 ns 0.842 0.051
Powder Tablet Tobs_bias 0.20 1.98
RMSEP 1.698 1.309 ns
BIAS 0.038 0.292 F_sep 2.87 2.17
SEP 1.708 1.284 ns 0.235 0.459
RSDyx 1.703 1.288 Tobs_slope 1.20 0.75
Slope 0.972 0.987
Intercept 0.863 0.680 MAE 1.26 0.79
RSQ 0.957 0.976
RPD 4.833 6.425 Quartile75 2.11 1.11
N, number of samples; powder: figures of merit for HTZ predictions in powders; tablet: figures of merit for HTZ predictions in tablets; SD, standard
deviation; RMSEP, root mean-squared error of prediction; SEP, standard deviation of the prediction residuals; RSDyx, standard error of the predicted
y value for each x in regression model; RSQ, coefficient of determination; RPD, ratio of performance to deviation; Alpha, significance level; T value,
T critical value of the Student’s T test; F value, F critical value of the F test; Tobs_bias, T observed value returned from the BIAS significance testing
according to ISO 12099; F_sep, SEP (SECV) of the validation set multiplied with F critical value for SEP (SECV) confidence limits estimation
according to ISO 12099; Tobs_slope, T observed values returned from slope significance testing according to ISO 12099; probability, probability for
the Student’s T distribution calculated for the T observed values; MAE, mean of absolute errors; Quartile75, third quartile value for the absolute
errors; ns, non-significant.
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Figure 3. Hydrochlorothiazide test set predictions in tablets – prediction
residuals and bias versus 2 SECV limits.
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Student’s t-test. The observed t-value for the bias was lower than
the critical t-value which indicated that the bias was not
significant with probability of 0.09 (significance level 0.05), i.e.
there was no significant systematic error observed in the
predictions of the test set. The SEP value as a measure of a
random model error was 3.2 mg. The confidence limit for SEP
was ±4.34 mg (significance level 0.05). RSDyx as the standard
error of the predicted y value for each x in regression was 3.22 mg.
The slope of the regression line was 0.987. It was tested for the
significance according to Student’s t-test. The observed t-value
was lower than the t-critical, indicating that the slope was not
significant with the probability of 0.56 (significance level 0.05).
The median absolute error was found to be 1.12 mg. The upper
quartile in the studied population was 2.18 mg.
The prediction residuals of the 80 test set tablet samples were
plotted and compared with the ±2 SECV limits (2 3.08 mg)
together with the bias. It was observed that six prediction
residuals were higher than ±2SECV limit (Figure 4).
Specificity of the model was confirmed by the fact that the
samples with MTP content of 96 mg (60%) that contain 42 mg of
HTZ (140%) were predicted as accurately as the rest of the test set
(the RMSEP for the 14 independent test samples was 2.86 mg),
indicating that there was no significant spectral interaction
between the two active pharmaceutical ingredients. Table 2
summarizes the calibration model test set statistics.
NIRS model for MTP analysis in tablets
The calibration model was developed with 55 tablet samples. The
raw spectra were pretreated using Multiplicative Scatter
Correction (MSC) pretreatment and first derivative Savitzky-
Golay 9 points, gap 0. The wavenumber ranges 4000–5080 cm1
and 5440–9000 cm1 were used to calculate the model. Eight
principal components were selected to calculate the model. The
property range covered was 96.0–144 mg of MTP. The calibration
was calculated using 143 spectra of the tablet samples, exhibiting
an RSQ of 0.99 and SEC of 1.18 mg; SECV was 3.26 mg. The
Durbin–Watson test statistics of 2.1 indicated that there was
no significant correlation between the cross-validation residuals.
The residuals were plotted against HTZ reference values. The
RSQ was 0.03, confirming good linearity of the developed
calibration model. The developed calibration model was tested
on the independent test, 80 tablet samples measured in triplicate
with triplicates then averaged to give a single spectrum. The
property range was 96–144 mg of MTP. An RSQ of 0.968 was
achieved. Linearity was assessed further by plotting prediction
residuals against reference values and the NIR predicted values.
Neither linear correlation nor specific pattern among residuals
were observed. The RMSEP was found to be 3.05 mg. Bias
was 0.47 mg and was tested for the significance based on
Student’s t-test. The observed t-value for the bias was lower than
critical t-value, which indicated that the bias was not significant
with a probability of 0.17 (significance level 0.05), i.e. there was
no significant systematic error observed in the predictions of the
test set. The SEP value as a measure of the random model
error was 3 mg; the SEP confidence limit was ±4.5 mg (signifi-
cance level 0.05). RSDyx as the standard error of the predicted y
value for each x in regression was 3 mg. The slope of the
regression line was 0.99. It was tested for the significance based
on Student’s t-test, and the Observed t value was smaller than
the t-critical indicating that the slope was not significant, with
the probability of 0.62 (significance level 0.05). The median
absolute error was found to be 0.94 mg. The upper quartile in
the studied population of the test set absolute prediction errors
was 1.65 mg.
The prediction residuals of the 80 test set tablet samples were
plotted and compared with the ±2SECV limits (2 3.26 mg)
Table 2. Metoprolol tartrate powder and tablet calibration models – test statistics.
NIR % nominal¼ f (Reference % nominal)
NIR [% nominal] Reference [% nominal]
N¼ 80 Powder Tablet 120.45 Powder Tablet
Average 121.07 120.92 96.00 Alpha 0.05 0.05
Min 90.72 89.99 144.00 T value 1.99 1.99 Probability
Max 154.45 156.23 16.80 F value 1.47 1.38 Powder Tablet
SD 16.89 16.91 120.45 ns 0.091 0.171
Powder Tablet Tobs_bias 1.71 1.38
RMSEP 3.147 3.046 ns
BIAS 0.624 0.474 F_sep 4.61 4.51
SEP 3.110 3.028 ns 0.556 0.623
RSDyx 3.216 3.043 Tobs_slope 0.59 0.49
Slope 0.987 0.990
Intercept 2.157 1.685 MAE 1.09 0.94
RSQ 0.964 0.968
RPD 5.286 5.592 Quartile75 2.10 1.65
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Figure 4. Metoprolol tartrate test set predictions in powders – prediction
residuals and bias versus 2 SECV limits.
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together with the bias. It was observed that six prediction
residuals were higher than ±2SECV limit (Figure 5).
Specificity of the model was confirmed by the fact that the
samples with MTP content of 96 mg (60%) that contain 42 mg of
HTZ (140%) were predicted as accurately as the rest of the test set
(the RMSEP for the 14 independent test samples was 3.25 mg),
indicating that there was no significant spectral interaction
between the two active pharmaceutical ingredients. Summary of
the calibration model test set statistics is shown in Table 2.
Conclusion
EMA, ICH and PASG guidelines on NIRS method development
and validation suggest that a feasibility study should be carried
out at the start of any method development to evaluate the
suitability of NIRS for the intended analytical purpose.
The authors suggest that the experimental setup for the
development of an offline NIRS method for quantification of HTZ
and MTP in both powder and tablet forms as proposed in this
work shows the feasibility of this method and could be a useful
alternative for the initial stages of NIRS method development.
The proposed approach could be applied for the optimization
of sample presentation and scanning, study of the variables
affecting spectral response, the evaluation of the quality of NIR
scans, the effect of powder inhomogeneity and so on.
However, the studied approach is an offline, preliminary study
of the suitability of NIRS to quantify the two model drugs in one
formulation under controlled circumstances. The processes,
formulation and other variability factors actually seen in com-
mercial scale manufacturing should also be studied.
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Figure 5. Metoprolol tartrate test set predictions in tablets – prediction
residuals and bias versus 2 SECV limits.
6 B. Z. Vranic & T. F. Vandamme Pharm Dev Technol, Early Online: 1–6
Ph
ar
m
ac
eu
tic
al
 D
ev
el
op
m
en
t a
nd
 T
ec
hn
ol
og
y 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
21
3.
19
6.
18
2.
99
 o
n 
08
/1
4/
14
Fo
r p
er
so
na
l u
se
 o
nl
y.
 Vranic Z. Branko PhD Thesis Page 99 
 
2.3 Research Project III: Assessing Compressibility and 
Compactibility of Powder Formulations Using Near-Infrared 
Spectroscopy 
 
2.3.1 Study Aims 
 
In the research project III the authors have proposed an NIRS method as an alternative to the 
conventional determination of tablet relative density and tensile strength. Multivariate prediction 
models for the respective tablet parameters were developed. Powder formulations chosen for the 
study were compressed into tablets with different relative densities and tensile strengths. NIR spectra 
of the produced tablets were collected and subsequently relative density and tensile strength of the 
produced tablets were determined conventionally. Multivariate prediction model for the estimation of 
relative density and tensile strength of the tablets has been developed based on the NIR spectra and 
traditionally determined tablet parameters. The predicted tablets parameters and the traditionally 
determined ones were fitted into mathematical equations used for the evaluation of powder 
compressibility and compactibilit. The outcomes of the two approached were compared.With the 
proposed NIR spectroscopic approach, an alternative method for the assessment of compaction 
properties of powder formulations was established and evaluated. 
 
Research Project III is summarized in a manuscript titled “Assessing compressibility and 
compactibility of powder formulations with Near-Infrared Spectroscopy” published in the Journal of 
Pharmaceutical Development and Technology (DOI: 10.3109/10837450.2012.663388). 
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Introduction
The most common dosage form on the pharmaceutical 
market is the tablet. The production of tablets should be 
as economical as possible and the production should 
only comprise a few working steps.[1] Studies of tablet 
formation by direct compression are focused on single 
powders, powders with small percentage of binder and 
granulated powders. Since it is a big challenge to predict 
the compaction properties of powder mixtures from 
the properties of the individual components, a main 
focus has been set to the development of prediction 
techniques for a successful design of reliable powder 
formulations.[2] The main prerequisite for a reliable for-
mulation is a satisfactory compressibility of the powder 
and tensile strength of the final compact in an accept-
able range.
All the mechanisms and phenomena of powder com-
paction have been the subject of numerous research 
investigations and already a wide variation of compac-
tion parameters and used equipment have been inves-
tigated.[3] Nevertheless, the compaction process is still 
far from being completely understood. Multitudinous 
powder properties and external factors have an impact 
on the quality of the final tablet.[1,4–6]
This leads in the last decades to the choice of many 
different approaches for characterization of powder 
compaction along with the development of numer-
ous mathematical equations. The choice of the most 
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preferable equation out of this wide collection is chal-
lenging because every equation can be applied only to 
a constricted range of compaction force and to a limited 
number of materials.[7,8]
The relative density of a compact and its tensile 
strength can be seen as a basic and crucial tablet quality 
characteristic. The relative density is assumed as the true 
area of contacts between particles as a result of interpar-
ticulate bonds. It is usually calculated with the true den-
sity value of the powder[9] and represents in an inverse 
way the porosity of the compact.
The mechanical strength is a very important tablet prop-
erty since it has crucial impacts on itspharmacokinetical 
and pharmacodynamical behaviour. The strength depends 
on several processing and formulation parameters. An 
essential focus is set on this parameter for characterising 
the mechanical behaviour of a compact, as the tablet must 
possess a minimum mechanical strength to sustain poten-
tial loading during processing and handling.[2,10]
A compaction equation relates compaction elements 
with the applied compaction pressure. The initial step for 
fitting the data to an equation is to linearize the data and 
the corresponding plots. With this approach, compari-
sons between data sets are simplified and also the fitting 
parameters of the applied equations can be used for data 
comparison.
Till today, numerous equations have been proposed 
for the analysis of the compaction process. While 
some seem to have a theoretical basis, for example, the 
Kawakita[11] equation, many of them are purely empirical 
fits of specific limited data and cannot claim any general 
validity.[12]
For a reliable and satisfying application of compac-
tion equation to investigate and compare compression 
of powder formulations, an equation should not only 
linearize the data.[12] The parameters should relate to 
basic physical and mechanical properties of the com-
pacted material. Ideally the equation should be allowed 
to be applied to all materials which are compacted in the 
same way.
The compressibility measurement of powder for-
mulations with support of mathematical equations has 
been since a longer time ago a main target for scientific 
research. The main principle is the analysis of quantita-
tive data like a relation of pressure to volume reduction 
or the relation of the applied pressure to the correspond-
ing porosity.[11] The aim of this calculation step is the 
determination of a linear relation and in a second step 
the comparison between powder formulations.
One of the most known mathematical approaches for 
the evaluation of tablet compressibility is the Heckel-
equation. The detailed evaluation of the Heckel-equation 
was performed and published by J.M. Sonnergaard[11] and 
P.J. Denny.[12]
Celik and Marshall[3] investigated numerous excipi-
ents by developing the corresponding Heckel-Plots. 
Nonlinearity was observed in many of these profiles, 
which were obtained under dynamic conditions.
A modified Heckel equation was designed by Kuentz 
and Leuenberger,[13] which takes into consideration the 
pressure susceptibility, defined as decrease of porosity 
under pressure. The classical Heckel-equation assumes 
a constant pressure susceptibility while in the designed 
modified Heckel-equation the susceptibility corre-
sponds to the relative density. In addition, a term for the 
critical density has been introduced, which represents 
the specific relative density where a rigidity between the 
punches starts to occur.
The ability of a powder formulation to be compressed 
into tablets with specified strength can be expressed as 
the formulations’ compactibility. Leuenberger devel-
oped an equation,[14] which includes one factor for the 
compressibility and one for the compactibility. This 
inclusion of the compactibility term makes this equation, 
the so-called Leuenberger equation, an attractive tool for 
investigating powder formulations.
Near-infrared spectroscopy (NIRS) is an analytical 
technique with various applications in the pharmaceu-
tical field. Major advantages of NIR spectroscopy are its 
non-destructive nature, no need for sample preparation 
and immediate delivery of results. NIRS has proven its 
ability to analyze intact pharmaceutical dosage forms 
such as tablets.
Quantification and qualification of active pharma-
ceutical ingredients and other tablet constituents is well 
established.[15–20] Tablet physical properties, for example, 
relative density and tensile strength, contribute to high 
extent to NIR signal[21] and are usually considered as 
interferences. Various spectral preprocessing methods 
were applied to NIR spectra in order to minimize these 
effects.[22] Variations in compression force during tablet-
ing process have been reflected in variable relative den-
sities and tensile strengths of the tablets. This effect is 
observed in NIR spectra as baseline shift.[23,24] The spectral 
effect caused by varying relative density/tensile strength 
could be used to quantify these tablet parameters.[25,26]
theoretical section
For this study, the compaction outcomes have been plot-
ted with the Heckel-Plot,[27,28] the modified Heckel-Plot[29] 
and the Leuenberger equation.[14,30]
Heckel-Plot
The Heckel-Plot is still one of the most commonly used 
equation in the pharmaceutical compaction studies. It 
was published by R.W. Heckel in 1961.[27,28] In this equa-
tion, the first-order kinetics type of reaction behaviour 
of the voidage reduction with applied pressure has been 
approached.
ln
1
1−
= ⋅ +
D
k P A  (1)
 where D is the relative density of a powder compact at 
pressure P. Constant k is a measure of the plasticity of a 
compressed material.
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The Constant A is related to the die filling and particle 
rearrangement before deformation and to the bonding of 
the discrete particles.
Modified Heckel-Plot
The pressure susceptibility (χ
p
) is defined as the decrease 
of porosity under pressure. This term is assumed to be 
constant in the Heckel-Plot.
Kuentz and Leuenberger[29] incorporated the pressure 
susceptibility (χ
p
) in their calculation and developed a 
modified Heckel-Plot:
σ ρ ρ ρ ρ
ρ
= − − −( )⋅ −
−



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



1
1
1
1c c c c
ln (2)
 ρ is the relative density, σ is the pressure, ρ
c
 is the critical 
density and C is a constant, which is claimed to represent 
the compressibility of a powder.
For the compressibility calculation of powder formu-
lations, the constant K from the Heckel equation and the 
constant C from the modified Heckel equation can be 
determined.
Well compressible, ductile and soft powders have 
higher values for C and K than poor compressible, brittle 
and hard powders.
The parameter ρ
c
 is defined as rigidity threshold. It 
represents the critical relative density, producing a neg-
ligible mechanical resistance between the punches. With 
a geometrical focus, this threshold represents the transi-
tion point between dispersed solid in air and voids in a 
solid matrix.
Leuenberger equation
This equation was developed and published in the early 
1980s by H. Leuenberger.[14,30]
σ σ γ σt t
pe r= ⋅ − − ⋅max ( )1  (3)
 σ
tmax
 is the tensile strength (kg/cm2) when P (compres-
sion pressure) → ∞, ρ
r
 → 1, and γ is compression sus-
ceptibility, expressing the compressibility of the powder 
formulation.
This equation allows the compressibility to be further 
determined and in a second step the compactibility, 
defined as the ability of the powder to be compressed to 
a tablet of specific strength, can be evaluated by focusing 
on the maximum tensile strength σ
tmax
.
Each of these three described equations contains a 
specific factor which is claimed to represent the com-
pressibility of the formulation.
By fitting the measured and recorded compaction data 
to these three mathematical equations, those technical 
factors (k, C, γ) can be calculated and evaluated.
Since these factors represent the similar tablet quality 
parameter, the outcome values were expected to show a 
certain proportionality between each other for the whole 
collection of formulations.
PLS regression for evaluation of NIRS signals
Partial least squares regression (PLS regression) is a 
statistical method to create a linear regression model by 
projecting the predicted variables (y) and the observable 
variables (x) to a new space.[31] PLS finds the fundamental 
relations between the matrix of predictors (X matrix) and 
the matrix of responses (Y matrix), that is, it can be seen 
as a latent variable approach to model the covariance 
structures in these two matrices. The goal of PLS regres-
sion is to predict Y from X and to describe their common 
structure. A PLS model to determine the multidimen-
sional direction in the X space explains the maximum 
multidimensional variance direction in the Y space. PLS 
regression is particularly useful when the matrix of pre-
dictors has more variables than observations, and when 
there is multicollinearity among x values. It can ana-
lyze data with strongly collinear, correlated, noisy, and 
numerous x variables, and also simultaneously model 
several response variables.
aim of the study
In this article, the authors propose a NIRS method as an 
alternative to the conventional determination of tablet 
relative density and tensile strength. Multivariate predic-
tion models for the respective tablet parameters were 
created. Every chosen formulation was compressed into 
tablets with different relative densities.
As next step, the tablet parameters of tensile strength 
and relative density were measured with NIR and also in 
the traditional way. The data set with the values received 
from the NIR spectras and also the data of the traditional 
method were fitted into mathematical equations used for 
the evaluation of powder compressibility and compact-
ibility properties. The outcomes of the two data set evalu-
ations were compared and tested for potential similarity.
With this approach, an alternative method for the 
assessment of compaction properties of powder formu-
lations was established and evaluated.
Materials and methods
Materials
For a reliable study of the compressibility measurement 
with the support of NIRS, favoured excipients differing in 
mechanical properties (compressibility, ductile or brittle 
behaviour under pressure, disposition of sticking, etc.) 
were chosen to be investigated.
Also binary mixtures of a poorly compressible API and 
a well-compressible filler were investigated and evalu-
ated in this study.
An overview list of all investigated formulations is 
given in the following Table 1.
Mefenamic acid (Sigma-Aldrich Inc., Batch 093K1608) 
and Paracetamol (Mallinckrodt, Batch 0048992565) were 
chosen as brittle, poorly compressible API. They have 
both a similar particle size distribution. Mefenamic 
acid[32,33] differs basically from Paracetamol because of 
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its very high tendency to stick on the die wall and the 
punches.
The microcrystalline celluloses MCC 101 L 
(Pharmatrans Sanaq AG, Basel, Switzerland) and MCC 
102G (Pharmatrans Sanaq AG, Basel, Switzerland) were 
chosen as ductile, well compressible excipients. Both are 
known for their high compressibility, even they differ in 
particle size.[34–36]
The directly compressible Mannitol products Parteck 
M200 and Parteck M300 (Merck KGaA, Darmstadt, 
Germany) show a plastic deformation behaviour during 
compaction.[36]
Anhydrous calcium hydrogen phosphate (Emcompress 
anhydrous, JRS Pharma, Rosenberg, Germany) can be 
used as excipient or as a calcium source in nutritional 
supplements. The predominant deformation mecha-
nism for this powder is brittle fracture. This simplifies 
the scale-up to market production since the sensitivity 
to the strain-rate is reduced. However, at higher pres-
sures, capping and lamination can occur. In this study, 
Emcompress anhydrous was chosen for investigating the 
influence of brittle deformation on the compressibility 
prediction with NIR. For the compaction of Emcompress, 
an external lubrification of the punch and die wall with 
Magnesium Stearate (Mg-stearate, Sandoz AG, Basel, 
Switzerland) was performed to keep the sticking ten-
dency of the powder and the tablet ejection force on 
acceptable levels.
Pregelatinized starch (Sta-Rx 1500, Colorcon, 
Idstein, Germany) is a modified starch which is cho-
sen in tablet production as binder, disintegrant and 
diluent[37]. Its compressibility is not very satisfying, but 
a plastic behaviour under pressure is mentioned in the 
literature.[38]
A detailed overview of the individual deformation 
behaviour of the investigated compounds can be seen in 
the Table 2 (information taken from (ref. 38)).
True density measurement
The true density of the investigated powders was measured 
with an AccuPyc 1330 helium pycnometer (Micrometrics, 
Norcross, GA, USA). Values were determined as the mean 
of three or five parallel measurements.
Design of binary powder mixtures
All powders were sieved (mesh size 355 μm) before 
weighting and mixing (Turbula mixer, Type T2A, Willy 
A. Bachofen AG Maschinenfabrik, Basel, CH) for 5 min. 
After the second sieving (mesh size 355 μm), the formu-
lation was mixed for further 5 min.
Methods: Calculation of the true density for binary 
mixtures
The true density of the binary mixtures was calculated 
using the obtained results of the true density measure-
ments for all starting materials (see Equation 4):
ρ
ρ ρ
true mixture
API true API Excipient true Exci
[ ]
[%] [ ] [%] [
=
× + ×C C pient]
100
 (4)
 where C
API[%]
 is the concentration of active ingredient, 
C
Excipient [%]
 is the concentration of the excipient, ρ
true[API]
 
and ρ
true[Excipient]
 are the corresponding true densities.
Particle size distribution
A Malvern Mastersizer X (Malvern Instruments, 
Worcestershire, UK) was applied to determine the aver-
age particle size by laser diffraction. Three measurements 
were performed for each sample. The values of mean and 
median particle size, the span and the specific surface 
area were detected.
Powder compaction
The powder compaction was operated using a mechani-
cal compaction simulator (Presster, Metropolitan 
Computing Corporation, New Jersey, USA). The tablet 
press Korsch PH336 with 36 stations was simulated. A 
flat-faced B-Tooling with 10 mm of diameter was chosen 
for compacting tablets of 300 mg weight. The powder 
feeding was performed manually and an external lubri-
fication was applied to prevent sticking of punches and 
tools during compaction.
In a first step, some preliminary experiments were 
performed to determine the maximal gap, where a robust 
tablet could be produced. Then, the gap was decreased 
continuously in small steps to receive resulting compac-
tion forces from 0.5 kN to 20.0 kN.
For every formulation, two different compaction 
speeds were applied. One was corresponding to 100,000 
Table 1. List of investigated powder formulations.
Formulation Drug load (%)
Single powder  
MCC 101 L  
MCC 102 G  
 Emcompress anhydrous  
  Starch 1500  
Binary mixture  
Paracetamol/MCC 101 L 20
Paracetamol/MCC 101 L 40
Paracetamol/MCC 102 G 30
Mefenamic acid/MCC 101 L 20
Mefenamic acid/MCC 102 G 20
Mefenamic acid/MCC 102 G 40
Paracetamol/Parteck M 200 20
Paracetamol/Parteck M 300 20
Table 2. Deformation mechanisms of investigated powders.
Material
Deformation  
mechanism
Paracetamol Elastic, Brittle
Mefenamic acid Brittle, sticky
Microcrystalline Cellulose powder MCC 101,102 Viscoelastic
Emcompress anhydrous powder Brittle
Parteck M200, M300 Plastic
Sta-Rx 1500 Plastic
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tablets/h (dwell time: 9.6 ms) and the second was cor-
responding to 216,000 tablets/h (dwell time: 4.4 ms). A 
batch of around 40–80 tablets was produced with lower 
speed and one batch of around 40–80 tablets was pro-
duced with application of the higher speed. Every batch 
contained tablets with a uniformly distributed range of 
applied compaction force, from 0.5 kN to 20.0 kN. This 
compaction design led to a wide distribution of the final 
compacts relative density.
Measurement of tablet tensile strength
The breaking force of the produced tablets was measured 
with the Tablet Tester 8 M (Dr. Schleuniger, Pharmaton, 
Switzerland). The tensile strength was calculated accord-
ing to Equation 5.
TS
CS
D T
=
⋅
⋅ ⋅
2
pi
 (5)
 where TS is the tensile strength [N/cm2], CS is the 
crushing force [N], D is the diameter [cm], and T is the 
thickness [cm] of the tablet. The diameter and thick-
ness of tablets were measured with a 3-button digital 
calliper.
NIR measurements
Spectra were recorded in diffuse transmission measure-
ment mode on a Fourier transform near infrared spec-
trometer NIRFlex N-500 (Büchi Labortechnik AG). A 
Diffuse Transmittance measurement module, mounted 
on a polarization interferometer, was equipped with 
tablet sample plate with ten iris apertures. Source of 
radiation was a Tungsten halogen lamp. Temperature 
controlled Indium-Galium-Arsenide (InGaAs) detec-
tor was positioned externally, above the sample 
holder. Each spectrum was an average of 64 scans at 
a resolution of 16 cm−1. Spectra were scanned over the 
spectral range of 11520–6000 cm−1 (870–1660 nm). In 
total, 1381 data points were collected (Data point inter-
val: 4, Apodisation for phase correction: Blackman, 
Photometric dynamic range: 2 AU, Wavelength accu-
racy: ±0.2 cm−1, Signal to noise ratio: 10000, Number 
of scans per second: 2–4, Analog-Digital- Changer: 24 
Bit). 1203 tablet spectra from 22 batches were collected 
by NIRWare software (Büchi Labortechnik AG) and 
further analyzed by NIRCal 5.2 chemometrics software 
(Büchi labortechnik AG). The NIR spectras were mea-
sured 48 h after compression and storage of the com-
pacts in a glass dessicator over white silica gel beads 
(1–3 millimeters layer).
Model development
In the conducted study all tablet samples were prepared 
from the materials that originate from the same lot. For 
preparing the samples, the components were weighed 
in a glass bottle. The tableting mixture was prepared in 
a mix-sieve-mix manner and subsequently compressed. 
The tablet samples for calibration, internal and external 
validation were prepared in a same manner (in a separate 
glass bottles from the components that are from the same 
lot). The total ratio of the samples in a calibration/inter-
nal validation/external validation set was 25%/25%/50%. 
Samples in all the sets were spanning the relative density 
range from 0.5 to 1.0 and tensile strength range from 0.1 
to 9.4 MPa. Spectral preprocessing methods were applied 
to the raw spectra in order to reduce the excessive base-
line variations and ordinate offsets caused by different 
physical properties of the samples and to group the spec-
tra with similar values of analyzed tablet parameters. The 
light scattering information is correlated to the relative 
density and tensile strength of the compacts and enables 
the quantification of these parameters. Standard Normal 
Variate (SNV) and Normalization by Closure (ncl) were 
applied to reduce the scaling of the spectra due to very 
wide range of the compact porosity. Normalisation by 
Closure (ncl) spectral pretreatment is used to reduce the 
baseline variations due to different particle size or pack-
ing density differences.[39] It is a wavelength dependent 
pre-processing method. Savitsky-Golay first derivative (9 
points) was used to correct for the baseline offsets and 
to minimize the noise by imposing the signal smoothing 
effect.
Calibration models for the prediction of relative density 
and tensile strength of the tablets were constructed using 
PLS algorithm. The number of significant latent variables 
(LVs) was chosen based on the value of sum of squares of 
the spectral residuals (X-PRESS) assuring adequate recon-
struction of the spectra by the models and secondly, based 
on the calibration and validation predicted residual error 
sum of squares (C-set and V-set PRESS), as well as on the 
values of the root mean square error of prediction of an 
external validation set (RMSEP), validation set BIAS and 
coefficient of determination (r2). The quality of the models 
was evaluated by calculating the root mean square error 
of calibration (RMSEC) and also the root mean square 
error of internal validation (RMSEV). The most important 
figures of merit were RMSEP of the external validation set 
and the r2. Apart from the r2, linearity was assessed by eval-
uating the slope and the intercept of the calibration line. 
The prediction residuals were tested for the normality. 
Durbin-Watson test was applied to the prediction residuals 
to check if there are some evidences of serial correlations. 
Every model was tested for the outliers in both calibration 
and validation set by visual inspection of the scatter plots 
of the scores, Mahalanobis distances, spectral residuals 
and original vs. predicted property scatter plots. Obtained 
calibration models were fine-tuned by outlier exclusion 
and wavelength selection. Calibration wavelength regions 
were selected by observing the pretreated spectra, load-
ings and PLS regression coefficients.
Equations and concepts of physics for the calculation 
of the outcomes
The obtained data sets of relative density, compaction 
pressure and tensile strength were analyzed and evalu-
ated with the equations of the Heckel-Plot, the modified 
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Heckel-Plot and the Leuenberger equation by using 
Mathematica 7.0 (Wolfram Research Inc., USA), Excel 
(Microsoft, USA), GraphPad Prism (GraphPad Software 
Inc, USA) and OriginPro (OriginLab Corporation, USA). 
For every formulation, there were two data sets evalu-
ated, one of the traditional method application and a 
second data set obtained with the predicted method.
Mathematical comparison of the technical factors
An essential part in this study was the scientific evalua-
tion of the technical factor outcomes obtained with the 
two data sets (traditional measurement vs. NIR) for every 
formulation.
In a first step the obtained values of an equation fac-
tor were plotted on a two-dimensional diagram, where 
the x-axis represents the values calculated with the tra-
ditional method and the y-axis represents the predicted 
values for the different formulations.
The similarity between the outcomes of the two meth-
ods can be declared, if the data points on the diagram can 
be fitted with a high coefficient of determination (r2) on a 
trendline on the form of the following equation 6, with val-
ues for λ preferably close to 1 and a value for ϕ close to 0.
y x= ⋅ +λ φ (6)
Results
True density of components
The following table shows the true density values of 
all pharmaceutical powders used in the investigated 
formulations. Since a main criterion of the component 
choice was the similar range of true density, no big devi-
ation can be noticed between the true density values 
of the chosen components. The only exception here is 
Emcompress anhydrous, whose true density was almost 
double (Table 3).
Particle size measurement
Since the influence of the particle size was a main investi-
gation target in this study, a focus was set on the particle 
size distribution of the investigated material.
In the following table, the mean value and the median 
value (incl. standard deviation) of the handled com-
pounds is shown.
The mean particle size between the investigated 
compounds showed a wide range from 74.13 μm for 
Mefenamic acid up to 248.70 μm for Parteck M 300 
(Table 4).
Powder compaction: technical factor outcomes
The relative density, compaction pressure and tensile 
strength were recorded for every single tablet. The relative 
density was obtained by manual dimension measure-
ment and true density value consideration. The tensile 
strength was measured by the destructive hardness test 
and the compaction pressure was measured during com-
paction with the Presster simulator.
This data set was applied to the Heckel-Plot, the modi-
fied Heckel-Plot and the Leuenberger equation for fit-
ting. With this approach, the technical factors of the plots 
were calculated.
Table 5 shows the values for the factors k (Heckel-
Plot) and C (modified Heckel) of all investigated powder 
formulations.
The formulations Paracetamol/Parteck M200 (20% 
drug load) and Paracetamol Parteck M300 (20% drug 
load) could not be compacted successfully with the 
higher compaction speed since the distinctive sticking 
tendency of the formulations did not allow an applica-
tion of a high compaction speed. Therefore, these formu-
lations are skipped in the part (b) of the table.
For a more convenient analysis and comparison, the 
outcome values were plotted on a bar chart (see Figure 1).
At first sight, it could be noticed that the absolute val-
ues of k were higher than those of C for all investigated 
formulations. This was an expected outcome which fits 
to the literature[13] because the mathematical structure 
of a plot mainly determines the absolute value of its 
factors.
Technical factors gain only explanatory power when 
they are systematically collected and the data sets of dif-
ferent formulations and batches are compared.
The value ratios between investigated formulations 
showed a parallel proportionality for the values C and 
values k.
Some deviations were noticed for the formulations 
with MCC 101 L, compacted with the higher speed. In 
these cases, the value C was decreasing with higher drug 
load. In the meantime, the value k showed higher values 
with increasing drug load.
For the formulations with MCC 102 G and all the other 
single compound formulations, the ratios showed the 
Table 3. True density of components.
Powder True density (g/cm3) SD (g/cm3)
Paracetamol 1.22 0.00
Mefenamic acid 1.16 0.00
MCC 101 L 1.48 0.01
MCC 102 G 1.43 0.00
Emcompress anhydrous 2.49 0.00
Parteck M 200 1.52 0.00
Parteck M 300 1.39 0.00
Pregelatinzed starch 1500 1.50 0.00
Table 4. Particle size distribution of investigated compounds.
Powder
Mean  
(μm)
SD  
(μm)
Median  
(μm)
SD 
(μm)
Paracetamol 82.78 5.79 51.35 1.08
Mefenamic acid 74.13 6.05 38.35 1.83
MCC 101 L 83.35 2.31 73.76 0.88
MCC 102 G 119.74 0.15 114.06 0.53
Emcompress anhydrous 188.02 2.90 181.71 3.02
Parteck M 200 149.22 2.55 131.15 1.99
Parteck M 300 248.70 5.49 179.04 5.38
Pregelatinzed starch 1500 94.90 0.03 86.51 0.16
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expected parallel value trends for the two compaction 
speeds.
In a further step, the evaluation focus was set to the 
factor value comparison between the formulations.
For this study, some single powders, like Emcompress, 
Starch 1500, and a number of binary mixtures with a 
poorly compressible active drug (Mefenamic acid and 
Paracetamol) and Microcrystalline Cellulose (MCC 101 L 
and MCC 102 G) as filler were investigated. The main sci-
entific focus was the evaluation and comparison of the 
technical factor values for different drug loads and for 
different single powders.
For the binary mixtures, a decrease of the compress-
ibility with increasing drug load was expected and also 
noticed during handling. Since the investigated factors 
values k (Heckel-Plot) and C (modified Heckel-Plot) 
have been claimed[28–30,40] to represent the formulation 
compressibility, lower factor values were expected with 
increasing drug loads.
The pure MCC 102 G showed the highest factor values 
of all investigated formulations, followed by binary mix-
tures (20% drug load) of MCC 102 G with Paracetamol or 
Mefenamic acid.
Paracetamol (30%)/MCC 102 G showed higher factor 
values than Mefenamic acid (20%)/MCC 102 G. This out-
come allowed us to assume a stronger negative  influence 
of Mefenamic acid to the compressibility of a binary mix-
ture than Paracetamol.
The binary mixtures with MCC 101 L showed a 
confusing outcome: For the formulation with 40% of 
Paracetamol some higher factor values were noticed 
than for the formulation with 20% of Paracetamol.
By assuming the factor values to represent compress-
ibility, this outcome would show a better compress-
ibility of a binary mixture after increasing the poorly 
compressible compound. Such a behaviour would not 
be realistic and could not be supported with literature 
findings. Also physical aspects, like the occurrence of 
percolation cannot provide an explanation for such a 
behaviour.
Powder susceptibility γ
The data set of all investigated formulations was fitted to 
the Leuenberger equation. Leuenberger et al.[30] claimed 
the parameter γ (powder susceptibility) of this equation 
to represent the compressibility of a formulation.
Therefore, the outcome values for γ were expected to 
be somehow proportional to the calculated values for 
factors k and C.
The powder susceptibility values for the investigated 
formulations are depicted in the following bar chart.
The factor calculation showed a high susceptibility 
for low speed compaction of single powder MCC 101 L 
and the high speed compaction of Mefenamic acid/
MCC 101 L (20% drug load). For the other formulations, 
their values were in a range between 0.0020 and 0.0060, 
Table 5. Technical factors of the investigated formulations: (a) low speed; (b) high speed.
 
 
Value k (Mpa−1) Value C (Mpa−1)
tra SD tra SD
Low speed
MCC 101 (100%) 0.01289 0.0001598 0.00886 0.0009103
Paracetamol/MCC 101 L (20%) 0.009729 0.0002309 0.002869 0.0001015
Paracetamol/MCC 101 L (40%) 0.0101 0.0001972 0.004342 0.0000955
Mefenamic acid/MCC 101 L (20%) 0.01352 0.0003581 0.006664 0.0002033
MCC 102 G (100%) 0.01623 0.0002451 0.01273 0.0004921
Mefenamic acid/MCC 102 G (20%) 0.01439 0.0003148 0.006273 0.000537
Mefenamic acid/MCC 102 G (40%) 0.01048 0.0003815 0.00507 0.0002348
Paracetamol/MCC 102 G (30%) 0.0128 0.0001163 0.007499 0.0002061
Paracetamol/Parteck M200 (20%) 0.005413 0.000332 0.002054 0.0001315
Paracetamol/Parteck M 300 (20%) 0.006301 0.0001224 0.002524 0.0000963
Emcompress (100%) 0.00162 0.0006309 0.000247 0.0000097
Starch 1500 (100%) 0.005043 0.0001389 0.001017 0.0000446
High speed
MCC 101 (100%) 0.0126 0.0002089 0.0064 0.0001462
Paracetamol/MCC 101 L (20%) 0.009018 0.0002466 0.00526 0.0001813
Paracetamol/MCC 101 L (40%) 0.0107 0.0002046 0.00488 0.0001953
Mefenamic acid/MCC 101 L (20%) 0.01296 0.0004983 0.00466 0.000369
MCC 102 G (100%) 0.016 0.000709 0.01021 0.0009444
Mefenamic acid/MCC 102 G (20%) 0.01025 0.0004969 0.003378 0.0003149
Mefenamic acid/MCC 102 G (40%) 0.007095 0.0005402 0.002355 0.0003452
Paracetamol/MCC 102 G (30%) 0.01556 0.000161 0.009738 0.0004921
Emcompress (100%) 0.001657 0.0000608 0.000245 0.000106
Starch 1500 (100%) 0.003842 0.0001623 0.001073 0.000216
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whereas a quiet significant standard deviation was 
noticed for the most formulations.
Even though, the single compounds of Microcrystalline 
Cellulose are known for their high compressibility the fit-
ting outcome values were in the same order of magnitude 
as the biggest part of the formulations.
A crucial finding was the fitting limitation for 
some formulations. The tensile strength values of the 
Figure 2. Powder susceptibility γ: (a) low speed; (b) high speed.
Figure 1. Values k and C of investigated formulations: (a) low 
speed; (b) high speed.
Figure 3. Transmittance spectra of MCC 102G tablets with 
increasing tensile strength and relative density. (See colour 
version of this figure online at www.informahealthcare.com/phd)
Figure 4. Calibration and internal validation reference vs. 
predicted property scatter plot of MCC 102G tablet RD prediction 
model; In the upper left corner are the figures of merit of 
the model. (See colour version of this figure online at www.
informahealthcare.com/phd)
Figure 5. Spectra of MCC 102G tablets pretreated with 
normalization by closure; The enlarged regions were used for 
calibration and show the grouping of the spectra according to RD. 
(See colour version of this figure online at www.informahealthcare.
com/phd)
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tablets compacted with these formulations showed 
significantly lower values than the tablets of the other 
formulations.
The occurence of this plotting limitation is a clear 
hint for an essentialy low compressibility. A formulation 
which need to be compressed into tablets with very low 
porosity for reaching a sufficient hardness is the best 
example for a formulation with low compressibility.
By comparing Figure 2 with the bar charts of Figure 1, 
no parallel value distribution for the parameter γ in rela-
tion to the factors k and C could be noticed.
A possible explanation for this outcome is the different 
structure of the Leuenberger equation in comparison to 
the Heckel and the modified Heckel equation. Whereas 
the Heckel and modified Heckel equation have a two 
dimensional structure, the Leuenberger equation is 
based on a 3-axis format.
The additional axis arised from the tensile strength 
values, which are a main part of the Leuenberger equa-
tion, while the Heckel Plot and the modified Heckel 
equation are only considering the compression pressure 
and the relative density of the produced compact.
The fitting of the data set to the Leuenberger equation 
uncovered a main element of this plot. As mentioned 
earlier, two compaction speeds were used in this project. 
For every formulation, one tablet batch was produced at 
Figure 6. The first loading vector of MCC 102G tablet RD prediction 
model; The encircled regions carry the most spectral information 
and correspond to wave number regions used for calibration. (See 
colour version of this figure online at www.informahealthcare.
com/phd)
Figure 7. Spectra of MCC 102G tablets pretreated with Standard 
Normal Variate and Savitsky-Golay first derivative; The enlarged 
regions were used for calibration and show the grouping of the 
spectra according to TS. (See colour version of this figure online at 
www.informahealthcare.com/phd)
Table 6. Summary of the figures of merit obtained for the relative density and tensile strength calibration models.
Formulation
Relative density models Tensile strength models
Data pretreatment LV R2 RMSEP Data pretreatment LV R2 RMSEP
F1 LS ncl 2 0.997 0.0072 SNV 3 0.997 0.0908
HS ncl 2 0.997 0.0090 ncl 2 0.998 0.1275
F2 LS ncl 3 0.999 0.0057 SNV, 1 D 2 0.999 0.1242
HS ncl 3 0.993 0.0106 1 D 3 0.992 0.3099
F3 LS SNV 5 0.982 0.0058 SNV 2 0.923 0.0415
HS SNV 5 0.992 0.0141 SNV 3 0.963 0.1211
F4 LS ncl 2 0.984 0.0101 ncl 3 0.983 0.0229
HS ncl 5 0.973 0.0170 ncl 3 0.945 0.0336
F5 LS ncl 2 0.998 0.0066 SNV 2 0.999 0.0970
HS ncl 4 0.995 0.0103 SNV 5 0.999 0.1062
F6 LS ncl 3 0.996 0.0105 ncl 2 0.999 0.0695
HS ncl 4 0.997 0.0108 1 D 4 0.998 0.0917
F7 LS SNV 3 0.989 0.0092 ncl 2 0.992 0.0650
HS SNV 3 0.981 0.0110 1 D 3 0.974 0.1461
F8 LS ncl 2 0.997 0.0062 SNV, 1 D 2 0.983 0.1530
HS ncl 2 0.992 0.0104 SNV 4 0.988 0.2522
F9 LS SNV 2 0.999 0.0030 ncl 2 0.997 0.0350
HS ncl 5 0.997 0.0090 ncl 5 0.988 0.0600
F10 LS ncl 2 0.998 0.0068 SNV 2 0.996 0.0582
HS ncl 3 0.994 0.0080 SNV 4 0.985 0.0840
F11 LS ncl 3 0.992 0.0111 SNV 5 0.983 0.1313
HS — — — — — — — —
F12 LS ncl 4 0.996 0.0077 SNV 4 0.996 0.1034
HS — — — — — — — —
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lower speed and one batch at higher speed. Each batch 
contained around 40–80 tablets.
With a data set in this size, the value of every single 
tablet had an essential influence on the curve fitting. A 
small change in a data set for a single tablet can lead to a 
big change of the susceptibility value after fitting.
This could be a possible explanation for the deviation 
of the susceptibility values to the calculated numbers for 
the factors k and C.
The necessity of three variables per compacted tablet 
instead of two in combination with the high sensitivity of 
the curve fitting on single variable value deviations made 
the application of the Leuenberger equation to the com-
pressibility measurement being a challenging approach 
for this project.
NIRS measurement and model development
The construction of the calibration models in this 
article is given on an example of the tablets composed 
of microcrystalline cellulose 102 G, manufactured using 
low tableting speed. After the spectra were recorded, as 
shown in Figure 3, different spectral preprocessing meth-
ods were applied in order to enhance the spectral data 
relevant to the analysis and to exclude the excessive scat-
tering effect.
Modeling the tablet relative density and tensile 
strength is based on a different degree of scattering 
between the samples but too high ordinate offsets and 
baseline shifts would impair the models. The criteria 
for the selection of the preprocessing method were the 
degree to which the preprocessed spectra are grouped 
according to the similar reference values and finally, 
the model performance (RMSEP). NIR transmittance 
values increased regularly with an increase in the 
compression force applied to the powder bed as for an 
increase in the tensile strength and relative density of 
the tablets. Transmittance spectra were transformed 
to absorbance by Log 1/T function and it was noticed 
that the baselines are linearly shifted and no evidences 
of multiplicative effect were seen. The effect of the 
increasing compression force was seen as an overall 
spectral effect not related to the specific wavelength 
since the tablet hardness does not have an analytical 
wavelength. Certain wavelength domains had higher 
correlation with the analyzed physical properties (r > 
0.90) and were selected for the construction of the cali-
bration model.
The baseline shifts as well as the offsets on a y-axis 
originate not only from different relative densities 
and tensile strengths but also from the different par-
ticle size of the samples which is not relevant infor-
mation in this study. The spectral offset on a y-axis 
does not carry information on the relative density/
tensile strength only. It is multi-factorial effect and 
was reduced by applying the derivative or normalisa-
tion pre-treatment. The external testing has shown 
that the calibration model predictability was higher 
when the spectra were grouped by applying spectral 
pre-treatment.
Tablet relative density models (Figure 4) gave the best 
performance when the Normalization by Closure (ncl) 
was applied, as seen in Figure 5.
The pretreated spectra were clearly grouped accord-
ing to different relative density values. The calibra-
tion  wave-number range was selected based on the 
Figure 8. The first loading vector of MCC 102G tablet TS prediction 
model; The encircled regions carry the most spectral information 
and correspond to wave number regions used for calibration. (See 
colour version of this figure online at www.informahealthcare.
com/phd)
Figure 9. Comparison of the RMSEP values of the external 
validation set relative density (a) and tensile strength (b) 
predictions for all the studied formulations; L: low tableting 
speed, H: high tableting speed. (See colour version of this figure 
online at www.informahealthcare.com/phd)
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observation of the first loading plot (see Figure 6) and 
PLS regression coefficients.
The wave-number range from 10600 cm−1 to 
11520 cm−1 was excluded due to high ordinate off-
set which ncl could not account for. The best tensile 
strength model was obtained when the Standard 
Normal Variate (SNV) pretreatment was applied 
to correct for the linear baseline shifts and subse-
quently Savitsky-Golay first derivative to correct for 
the ordinate offset which enabled the wave numbers 
from 10600 cm−1 to 11520 cm−1 to be included in the 
calibration (see Figure 7). The first loading vector was 
observed to check the wave number regions, that is, 
variables that were modeled (see Figure 8).
After the preprocessing of the data, the spectra and the 
measured relative density and tensile strength reference 
values were subjected to PLS regression. The overview of 
the figures of merit of the created calibration models for 
all the formulations is given in Table 6.
Created calibration models were compared in terms 
of performance (RMSEP) and it was noticed that all the 
models for the prediction of relative density and tensile 
strength of the tablets made by high tableting speed 
show worse performance (higher RMSEP) comparing 
Table 7. Outcomes of factor values by using the traditional (tra) approach or the developed method (pre).
 
 
 
Heckel equation Modified Heckel equation Leuenberger equation
K A C Critical Gamma S
tmax
tra SD pre SD tra SD pre SD tra SD pre SD tra SD pre SD tra SD pre SD tra SD pre SD
Low speed
MCC 101 (100%) 0.0129 0.00016 0.0131 0.00018 0.6196 0.00569 0.6141 0.00583 0.00886 0.000910 0.009703 0.0005259 0.1406 0.0344 0.1446 0.01911 0.0125674 0.000685747 0.0149438 0.00100839 7.31092 0.26855 6.77104 0.305785
Paracetamol/MCC 
101 L (20%)
0.0097 0.00023 0.0095 0.00027 0.9515 0.02797 0.9674 0.03324 0.00287 0.000102 0.004728 0.0002159 0.3494 0.01054 0.3668 0.01615 0.0027709 0.000285917 0.002664 0.000224636 19.3791 1.46086 19.9551 1.33466
Paracetamol/MCC 
101 L (40%)
0.0101 0.00020 0.0098 0.00033 0.9142 0.01833 0.935 0.03108 0.00434 0.000096 0.004292 0.0003808 0.401 0.00704 0.405 0.02799 0.0018087 0.000264631 0.00172073 0.000304936 15.1827 1.91932 15.8972 1.5243
Mefenamic acid/
MCC 101 L (20%)
0.0135 0.00036 0.0141 0.00090   0.7686 0.01219 0.739 0.02551   0.00666 0.000203 0.006576 0.0005465 0.2869 0.00961 0.2864 0.02591 0.0033108 0.000440024 0.00457211 0.000718201 12.9792 1.35817 10.0376 1.14665
MCC 102 G (100%) 0.0162 0.00025 0.0172 0.00027   0.7778 0.01942 0.724 0.02128   0.01273 0.000492 0.01288 0.0004217 0.1145 0.02022 0.109 0.017 0.0055040 0.000360343 0.00576584 0.000360343 17.0828 0.842176 16.438 0.842176
Mefenamic acid/
MCC 102 G (20%)
0.0144 0.00031 0.0146 0.00031   0.8257 0.02401 0.8103 0.02381   0.00627 0.000537 0.006565 0.0005159 0.34 0.03353 0.3277 0.03165 0.00556456 0.000627079 0.00523316 0.000537957 5.79902 0.425104 6.03112 0.411804
Mefenamic acid/
MCC 102 G (40%)
0.0105 0.00038 0.0114 0.00032   1.205 0.04146 1.147 0.00349   0.00507 0.000235 0.005188 0.000234 0.4277 0.01526 0.4254 0.01502 0.00552612 0.000859025 0.00670111 0.00602235 3.10846 0.308401 6.64314 5.29407
Paracetamol/MCC 
102 G (30%)
0.0128 0.00012 0.0126 0.00015   0.8302 0.01063 0.8371 0.014   0.00750 0.000206 0.007255 0.0002624 0.281 0.01209 0.291 0.01578 0.0036032 0.000371788 0.00415382 0.000354897 8.20486 0.623178 7.6377 0.449094
Paracetamol/
Parteck M200 (20%)
0.0054 0.00033 0.0058 0.00026   1.031 0.04882 0.9891 0.03756   0.00205 0.000132 0.002131 0.0001315 0.442 0.01531 0.4349 0.01531 0.00331118 0.000440024 0.00260538 0.000440024 7.58712 1.35817 9.18249 1.35817
Paracetamol/
Parteck M 300 
(20%)
0.0063 0.00012 0.0062 0.00019   0.9484 0.01348 0.9553 0.00219   0.00252 0.000097 0.002413 0.0000908 0.4095 0.009965 0.4178 0.009578 0.00288876 0.00134468 0.00277918 0.000795574 8.84878 3.21327 9.4519 2.10216
Emcompress 
(100%)
0.0016 0.00063 0.0016 0.00088   0.5763 0.00620 0.5814 0.00854   0.00025 0.000010 0.000271 0.0000727 0.3667 0.00358 0.358 0.02421 No fitting   No fitting   No fitting   No fitting  
Starch 1500 (100%) 0.0050 0.00014 0.0055 0.00025   0.8105 0.00685 0.7839 0.01287   0.00102 0.000045 0.000829 0.0000612 0.4608 0.007228 0.4863 0.01083 No fitting   No fitting   No fitting   No fitting  
High speed
MCC 101 (100%) 0.0126 0.00021 0.0133 0.00002 0.6038 0.006316 0.5788 0.00736 0.00640 0.0001462 0.00618 0.0001238 0.1992 0.009304 0.2099 0.007997 0.00147601 0.000143389 0.000927921 0.000230489 48.0388 4.26322 74.6734 17.5723
Paracetamol/MCC 
101 L (20%)
0.0090 0.00025 0.0090 0.00031 0.8435 0.0323 0.8417 0.04055 0.00526 0.0001813 0.004955 0.0002648 0.2899 0.01385 0.3079 0.02068   0.00276639 0.000285917 0.00279528 0.000224636 18.019 1.46086 17.8554 1.33466
Paracetamol/MCC 
101 L (40%)
0.0107 0.00020 0.0106 0.00022   0.8573 0.01609 0.8569 0.01709   0.00488 0.0001953 0.004752 0.0001761 0.3739 0.0137 0.3621 0.01176   0.0006 0.000276681 0.00172073 0.000276681 36.9461 2.22764 15.8972 2.22764
Mefenamic acid/
MCC 101 L (20%)
0.0130 0.00050 0.0134 0.00050   0.687 0.02717 0.6694 0.02527   0.00466 0.000369 0.004514 0.0003011 0.3279 0.02752 0.3384 0.02274   0.00831021 0.00176721 0.0106034 0.00306169 6.33417 0.664641 4.72677 0.694805
MCC 102 G (100%) 0.0160 0.00071 0.0161 0.00094   0.5824 0.07407 0.5832 0.06701   0.01021 0.0009444 0.01007 0.0009158 0.122 0.04701 0.1267 0.03961   0.003504232 0.000719011 0.00221382 0.000601465 20.3556 3.36363 30.7218 7.33262
Mefenamic acid/
MCC 102 G (20%)
0.0103 0.00050 0.0108 0.00005   0.9561 0.04252 0.9305 0.04685   0.00338 0.0003149 0.003211 0.0003774 0.4407 0.03456 0.451 0.03211   0.00608481 0.000899005 0.00596524 0.000877234 4.46376 0.422988 4.54984 0.433131
Mefenamic acid/
MCC 102 G (40%)
0.0071 0.00054 0.0083 0.00042   1.221 0.05801 1.126 0.04216   0.00236 0.0003452 0.002278 0.0003239 0.5126 0.03159 0.5185 0.02997   0.00410826 0.000854952 0.00350502 0.00125187 2.40258 1.04732 2.66629 0.754081
Paracetamol/
MCC 102 G (30%)
0.0156 0.00016 0.0154 0.00030   0.7544 0.01147 0.7752 0.01631   0.00974 0.0004921 0.009589 0.0004011 0.201 0.02412 0.209 0.01699   0.00422058 0.000376117 0.00217636 0.00058681 8.03293 0.516722 14.1599 3.39755
Emcompress 
(100%)
0.0017 0.00006 0.0016 0.00006   0.5658 0.00589 0.5688 0.05731   0.00025 0.0000106 0.000272 0.0000167 0.3667 0.003998 0.3588 0.005941   No fitting   No fitting   No fitting   No fitting  
Starch 1500 (100%) 0.0038 0.00016 0.0035 0.00017   0.8692 0.01423 0.894 0.01696   0.00107 0.000216 0.000917 0.000208 0.4314 0.03572 0.4555 0.03657   No fitting   No fitting   No fitting   o fitting  
NIR Spectroscopy 167
© 2013 Informa Healthcare USA, Inc. 
to low tableting speed models (Figure 9). It was noticed 
that later models needed fewer latent variables to obtain 
the optimal model performance. This fact can be attrib-
uted to the poorer compaction reproducibility when the 
high tableting speed is applied to the powder bed since 
shorter dwell time gives less chances for particle bond-
ing and the variations in compact density distribution are 
more pronounced.[41] The numerous powder formula-
tions showed really individual compaction properties in 
terms of compressibility which enhanced the differences 
in the models obtained for the low and high tableting 
speed tablets. The difference in prediction accuracy was 
observed between the MCC 101L and MCC 102G. The 
smaller mean particle size of MCC 101L comparing to 
MCC 102G contributed to the smaller difference between 
the relative density (RD) and tensile strength (TS) predic-
tion accuracy of the tablets compacted under low and 
high tableting speed. Small particles have higher specific 
surface area and higher probability of particle bonding 
and thus, are less sensitive to dwell time, that is, tableting 
speed. A difference in predictions for high and low tablet-
ing speed was observed for dicalcium phosphate tablets, 
Table 7. Outcomes of factor values by using the traditional (tra) approach or the developed method (pre).
 
 
 
Heckel equation Modified Heckel equation Leuenberger equation
K A C Critical Gamma S
tmax
tra SD pre SD tra SD pre SD tra SD pre SD tra SD pre SD tra SD pre SD tra SD pre SD
Low speed
MCC 101 (100%) 0.0129 0.00016 0.0131 0.00018 0.6196 0.00569 0.6141 0.00583 0.00886 0.000910 0.009703 0.0005259 0.1406 0.0344 0.1446 0.01911 0.0125674 0.000685747 0.0149438 0.00100839 7.31092 0.26855 6.77104 0.305785
Paracetamol/MCC 
101 L (20%)
0.0097 0.00023 0.0095 0.00027 0.9515 0.02797 0.9674 0.03324 0.00287 0.000102 0.004728 0.0002159 0.3494 0.01054 0.3668 0.01615 0.0027709 0.000285917 0.002664 0.000224636 19.3791 1.46086 19.9551 1.33466
Paracetamol/MCC 
101 L (40%)
0.0101 0.00020 0.0098 0.00033 0.9142 0.01833 0.935 0.03108 0.00434 0.000096 0.004292 0.0003808 0.401 0.00704 0.405 0.02799 0.0018087 0.000264631 0.00172073 0.000304936 15.1827 1.91932 15.8972 1.5243
Mefenamic acid/
MCC 101 L (20%)
0.0135 0.00036 0.0141 0.00090   0.7686 0.01219 0.739 0.02551   0.00666 0.000203 0.006576 0.0005465 0.2869 0.00961 0.2864 0.02591 0.0033108 0.000440024 0.00457211 0.000718201 12.9792 1.35817 10.0376 1.14665
MCC 102 G (100%) 0.0162 0.00025 0.0172 0.00027   0.7778 0.01942 0.724 0.02128   0.01273 0.000492 0.01288 0.0004217 0.1145 0.02022 0.109 0.017 0.0055040 0.000360343 0.00576584 0.000360343 17.0828 0.842176 16.438 0.842176
Mefenamic acid/
MCC 102 G (20%)
0.0144 0.00031 0.0146 0.00031   0.8257 0.02401 0.8103 0.02381   0.00627 0.000537 0.006565 0.0005159 0.34 0.03353 0.3277 0.03165 0.00556456 0.000627079 0.00523316 0.000537957 5.79902 0.425104 6.03112 0.411804
Mefenamic acid/
MCC 102 G (40%)
0.0105 0.00038 0.0114 0.00032   1.205 0.04146 1.147 0.00349   0.00507 0.000235 0.005188 0.000234 0.4277 0.01526 0.4254 0.01502 0.00552612 0.000859025 0.00670111 0.00602235 3.10846 0.308401 6.64314 5.29407
Paracetamol/MCC 
102 G (30%)
0.0128 0.00012 0.0126 0.00015   0.8302 0.01063 0.8371 0.014   0.00750 0.000206 0.007255 0.0002624 0.281 0.01209 0.291 0.01578 0.0036032 0.000371788 0.00415382 0.000354897 8.20486 0.623178 7.6377 0.449094
Paracetamol/
Parteck M200 (20%)
0.0054 0.00033 0.0058 0.00026   1.031 0.04882 0.9891 0.03756   0.00205 0.000132 0.002131 0.0001315 0.442 0.01531 0.4349 0.01531 0.00331118 0.000440024 0.00260538 0.000440024 7.58712 1.35817 9.18249 1.35817
Paracetamol/
Parteck M 300 
(20%)
0.0063 0.00012 0.0062 0.00019   0.9484 0.01348 0.9553 0.00219   0.00252 0.000097 0.002413 0.0000908 0.4095 0.009965 0.4178 0.009578 0.00288876 0.00134468 0.00277918 0.000795574 8.84878 3.21327 9.4519 2.10216
Emcompress 
(100%)
0.0016 0.00063 0.0016 0.00088   0.5763 0.00620 0.5814 0.00854   0.00025 0.000010 0.000271 0.0000727 0.3667 0.00358 0.358 0.02421 No fitting   No fitting   No fitting   No fitting  
Starch 1500 (100%) 0.0050 0.00014 0.0055 0.00025   0.8105 0.00685 0.7839 0.01287   0.00102 0.000045 0.000829 0.0000612 0.4608 0.007228 0.4863 0.01083 No fitting   No fitting   No fitting   No fitting  
High speed
MCC 101 (100%) 0.0126 0.00021 0.0133 0.00002 0.6038 0.006316 0.5788 0.00736 0.00640 0.0001462 0.00618 0.0001238 0.1992 0.009304 0.2099 0.007997 0.00147601 0.000143389 0.000927921 0.000230489 48.0388 4.26322 74.6734 17.5723
Paracetamol/MCC 
101 L (20%)
0.0090 0.00025 0.0090 0.00031 0.8435 0.0323 0.8417 0.04055 0.00526 0.0001813 0.004955 0.0002648 0.2899 0.01385 0.3079 0.02068   0.00276639 0.000285917 0.00279528 0.000224636 18.019 1.46086 17.8554 1.33466
Paracetamol/MCC 
101 L (40%)
0.0107 0.00020 0.0106 0.00022   0.8573 0.01609 0.8569 0.01709   0.00488 0.0001953 0.004752 0.0001761 0.3739 0.0137 0.3621 0.01176   0.0006 0.000276681 0.00172073 0.000276681 36.9461 2.22764 15.8972 2.22764
Mefenamic acid/
MCC 101 L (20%)
0.0130 0.00050 0.0134 0.00050   0.687 0.02717 0.6694 0.02527   0.00466 0.000369 0.004514 0.0003011 0.3279 0.02752 0.3384 0.02274   0.00831021 0.00176721 0.0106034 0.00306169 6.33417 0.664641 4.72677 0.694805
MCC 102 G (100%) 0.0160 0.00071 0.0161 0.00094   0.5824 0.07407 0.5832 0.06701   0.01021 0.0009444 0.01007 0.0009158 0.122 0.04701 0.1267 0.03961   0.003504232 0.000719011 0.00221382 0.000601465 20.3556 3.36363 30.7218 7.33262
Mefenamic acid/
MCC 102 G (20%)
0.0103 0.00050 0.0108 0.00005   0.9561 0.04252 0.9305 0.04685   0.00338 0.0003149 0.003211 0.0003774 0.4407 0.03456 0.451 0.03211   0.00608481 0.000899005 0.00596524 0.000877234 4.46376 0.422988 4.54984 0.433131
Mefenamic acid/
MCC 102 G (40%)
0.0071 0.00054 0.0083 0.00042   1.221 0.05801 1.126 0.04216   0.00236 0.0003452 0.002278 0.0003239 0.5126 0.03159 0.5185 0.02997   0.00410826 0.000854952 0.00350502 0.00125187 2.40258 1.04732 2.66629 0.754081
Paracetamol/
MCC 102 G (30%)
0.0156 0.00016 0.0154 0.00030   0.7544 0.01147 0.7752 0.01631   0.00974 0.0004921 0.009589 0.0004011 0.201 0.02412 0.209 0.01699   0.00422058 0.000376117 0.00217636 0.00058681 8.03293 0.516722 14.1599 3.39755
Emcompress 
(100%)
0.0017 0.00006 0.0016 0.00006   0.5658 0.00589 0.5688 0.05731   0.00025 0.0000106 0.000272 0.0000167 0.3667 0.003998 0.3588 0.005941   No fitting   No fitting   No fitting   No fitting  
Starch 1500 (100%) 0.0038 0.00016 0.0035 0.00017   0.8692 0.01423 0.894 0.01696   0.00107 0.000216 0.000917 0.000208 0.4314 0.03572 0.4555 0.03657   No fitting   No fitting   No fitting   o fitting  
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which is attributed to the tablet density inhomogenity, 
that is, picking and cracking.
Comparison of numerical factors values, measured 
with traditional and predicted approach
Every single tablet of the produced batches was inves-
tigated with NIRS. The measured data signal was then 
applied to the prediction model and the predicted values 
for relative density and tensile strength were determined 
and recorded.
In a second step, the diameter, height and hardness of 
the tablet were measured manually, which allowed us to 
calculate in the traditional way the relative density and 
the hardness of the tablets.
The two data sets (traditional method and predic-
tion model) were applied on the Heckel-Plot, the 
modified Heckel-Plot and the Leuenberger equation. 
With this fitting step, a calculation of the technical 
factor values of the three applied equations could be 
performed.
A reliable evaluation of the designed prediction 
method for hardness and relative density with following 
determination of mathematical equation factor values 
(Heckel-Plot, modified Heckel-Plot and Leuenberger 
equation) prerequisited a scientific comparison of the 
final outcome values for the technical factors k, A, C, ρ
c
, 
γ and σ
tmax
.
Table 7 gives an overview on the technical factor val-
ues for all investigated formulations. The outcomes are 
divided into one column for the traditional approach and 
one column for the NIR-approach.
A significant finding was the really small difference 
between the fitted values of the traditional method and 
the values, determined with the designed predictive 
method for the factors k of the Heckel-Plot and C of the 
modified Heckel-Plot.
The range of difference between the outcome values 
of the two methods was found to be within the standard 
deviation of both methods.
This outcome similarity between the two methods is 
illustrated graphically in Figures 10 and 11.
A similar outcome could be found for the factor criti-
cal density ρ
c
 of the modified Heckel-Plot. As shown in 
Figure 12 the value difference between the ρ
c
 of the 
traditional method and the predictive method was also 
very small and was found to be in the standard deviation 
range of the data sets.
This outcome underlined the usability of the 
designed NIR – method for the reliable fitting of the 
used formulations to the Heckel-Plot and the modi-
fied Heckel-Plot. The particle size of the investigated 
powder did not show to influence the measurement in 
a negative way.
The comparison outcomes of the factors γ and σ
tmax
 
in Figures 13 and 14 show some bigger value differences 
between the fitting results of the traditional and the pre-
dicted approach. Even though, for some formulations 
the value differences between the methods are very 
low, other formulations showed an essential difference 
between the methods.
The reason for this difference can be explained with 
the three dimensional structure of the Leuenberger plot 
and also with the strong sensitivity of the fitting process 
to single data points.
For a further scientific substantiation of the found 
similarity of the equation factor outcomes between the 
traditional approach and the designed method with sup-
port of NIR, all the factor values were applied to a two-
dimensional diagram. The data points were then fitted 
to the trendline according to Equation 6. An example for 
this fitting step is shown in Figure 15.
In the following Table 8 the values of λ and ϕ can 
be seen for all investigated technical factors. A simi-
larity between two data sets can be shown when λ is 
close to 1, ϕ is close to 0 and especially the r2 is higher 
than 0.95.
These conditions are fulfilled for the technical factors 
of the Heckel and the modified Heckel equation. The dif-
ferent particle size of the several chosen formulations did 
not show any influence on the reliability of the technical 
factor analysis with NIR.
The factors γ and σ
tmax
 of the Leuenberger equation 
showed a significant deviation from the conditions for 
similarity. Especially the r2 − values have shown much 
lower values for these technical factors. This outcome 
underlines the non-similarity of the factor values for the 
Leuenberger equation between the traditional method 
and the approach with NIRS.
conclusion
For the investigated formulations, the designed NIR 
method for determining the factors of the Heckel-Plot 
and the modified Heckel-Plot showed reliable results 
and outcomes.
Essentially different outcome values were reached 
with the NIRS method for the factors of the Leuenberger 
equation (γ, σ
tmax
).
In this range of tablet numbers, the mathematical 
fitting to the Leuenberger equation showed a high sen-
sitivity to deviations of the relative density and tensile 
strength of some single tablets.
This sensitivity could be determined as essential 
reason of high outcome deviation between the tra-
ditional approach and the predicted method. The 
relatively high standard deviations of the calculated 
values for γ and σ
tmax
 are an additional hint for this 
sensitivity.
The choice of the formulations to be investigated in 
this study was made with the focus set on the different 
materials showing a widest possible range of particle size 
and a wide range of compression mechanisms. These 
factors showed not to influence the data outcomes of the 
designed method with NIRS.
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Figure 11. High speed batches: values k (a) and C (b) of 
investigated formulations.
Figure 12. ρ
critical
 data comparison: (a) low speed batches; (b) high 
speed batches.
Figure 13. γ data comparison: (a) low speed batches; (b) high 
speed batches.
Figure 10. Low speed batches: values k (a) and C (b) of investigated 
formulations.
170 N. D. Gentis et al.
 Pharmaceutical Development and Technology
The newly designed method is suggested as a prom-
ising approach for a non-destructive compressibility 
measurement of powder formulations. A potential usage 
of NIRS inline during tablet production could be under-
lined with this study in a remarkable way.
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3. Conclusion 
 
ICH defines robustness of an NIRS analytical method as a measure of its capacity to remain 
unaffected by small, deliberate changes in method parameters. It provides an indication of the 
method’s reliability during routine usage. Robustness tests examine the effects of operational 
parameters on the performances of NIRS method. For the determination of robustness of NIRS 
method for prediction of drug content in tablets, a number of method parameters, such as compression 
pressure, pre-compression pressure, tableting speed, formulation parameters, environmental 
temperature, are varied within a realistic range, and the quantitative influence of the variables is 
determined. Design of Experiments methodology is a systematic tool to study the factor effects with 
all the interactions and squared effects unlike conventional method which involves the study of one 
variable at a time.  
If the influence of the studied parameter is within a previously specified limit, the parameter is said to 
be within the method’s robustness range. Obtaining conclusions from DoE study helps to assess 
whether a method needs to be revalidated when one or more process or other parameters are changed, 
for example, tableting speed or compression pressure. In the ICH Q2B document, it is recommended 
to consider the evaluation of a method’s robustness during the phase of method development, and any 
factors that are critical for the method, i.e. significantly affect method performance should be 
documented.  
In the process of NIRS method development and its progression from feasibility study to method 
validation, several groups are usually responsible to run the method and insure its suitability for the 
early clinical phases to the commercial manufacturing. For that reason the method robustness is 
particularly important. The NIRS method should provide reliable data, both on a wide range of 
equipment and in the hands of several operators. It is not uncommon in development and validation of 
NIRS procedures that the robustness is not sufficient. If robustness is not built into methods in early 
stages of development, the result will likely be loss of efficiency during routine quality control testing 
or a lengthy and complicated validation process. The alternative to conventional robustness testing 
where the tests are performed after the NIRS method has been already developed, innovative 
approach suggests building in the robustness during the method development. The approach is in line 
with the Quality by Design initiative which suggests that the quality of the product should be built in 
by design of the process and not tested into a product. 
In this study, tableting process parameters were chosen to be studied in detail. Pre-compression 
pressure, compression pressure and tableting speed are often varied during the scale-up of tableting 
process. Robust method needs to insure the long-term stability of the NIRS model predictions and for 
that reason, it is crucial to define the tableting process factors that significantly influence the NIRS 
model performance. The list of the factors that potentially influence the performance of the NIRS 
 Vranic Z. Branko PhD Thesis Page 117 
 
methods developed in this work is not exhaustive. The aim of the author was to point out the need for 
systematic approach to studying these effects with DoE methodology as a suggested tool. The setup of 
the DoE study, i.e. the selection of factors and responses, is another critical point that needs to be 
taken into account. The right design of the DoE study enables the saving of time and resources and 
even more importantly, ensures the relevancy of the conclusions from the study. This is particularly 
important in case of NIRS method development for the analysis of tablets since the list of potential 
factors that may influence the method performance is very long.  
Systematic and science-based approach in studying critical factors of tableting process affecting NIR 
spectra and calibration model performance was proposed in this work. DoE study was carefully 
designed with particular attention to the responses studied. The author suggests the use of Average 
Euclidean Distance (AED) as a response reflecting the influence of tableting process parameters on 
NIR spectral features. The effects of the studied factors on the AED are independent of the spectral 
pretreatments or any other parameter used during the calibration step. The disadvantage of evaluating 
the factor effects based on AED is the fact that AED does not reflect directly the performances of the 
developed NIRS model. The second studied response was Root Mean Squared Error of Prediction 
(RMSEP). RMSEP value reflects the performances of the NIRS method but is dependent on spectral 
pretreatments and parameters chosen during modeling phase (PCs, wavenumber range). The author 
suggests the use of both responses during the interpretation of the tableting process factor effects on 
the NIR spectral information of tablets. 
Response Surface Modeling study revealed that compression pressure and tableting speed have shown 
significant effect on the responses Root Mean Squared Error of Prediction and Average Euclidean 
Distance in DT measurement mode. DR spectral information of the intact tablets was significantly 
affected by the compression pressure, pre-compression pressure and tableting speed.  
Conclusions of the Design of Experiments study were confirmed on five independent test sets of 
caffeine tablets. Test sets were predicted by the developed global and local calibration models in both 
studied measurement modes and RMSEP was calculated. The effect of the studied factors on the 
RMSEP of the five test sets confirmed the conclusions of the DOE study. 
Developed global calibration models for tablet caffeine content prediction in diffuse reflectance and 
transmittance measurement mode were compared in terms of performances and it was found that the 
DT global model shown better performances exhibiting RMSEP of 1.21 % compared to 1.54 % for 
the global DR model. Both global calibration models have shown comparable performances to the 
UV-spectrophotometric reference method which performed with the standard error of 1 %. Global 
models were suitable for implementation in Content Uniformity Test of the tablets since the total error 
limit of 5% of nominal drug content was not exceeded. 
The conclusions from the performed study certainly need more supporting cases. The sample sets 
used for the DoE study were based on twenty samples which is considered to be the minimum 
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statistically relevant number of observations. For higher reliability of the results the larger data set is 
needed.  
The conclusions of the DoE study are formulation dependent. Different deformation behavior of the 
formulation components would lead to different conclusions. For that reason, the author suggests the 
study to be replicated with the formulations that would show different deformation behavior. 
The list of the process, formulation, environmental and acquisition factors influencing NIR spectral 
information of tablets is very long. Process factors studied in this work represent some of them. For 
complete picture of the relevant variables, further studies are necessary. 
The D-optimal design was chosen in this work as the optimum for the tailor made and problem 
specific solutions. It allows great flexibility in the specifications of the problem. The author suggests 
the study to be replicated with classical designs.  
 
Simultaneous NIRS quantification of two APIs in powders and tablets requires several challenges to 
be overcome. Overlapping absorption peaks of formulation components result in method specificity 
problem. Strategy for the design of the sample sets for NIRS method development is of crucial 
importance. Robustness towards the formulation factors is critical to insure since the problem of co-
linearity in case of complex formulations is quite frequent. The experimental setup for the 
development of NIRS method for quantitation of Hydrochlorothiazide (HTZ) and Metoprolol Tartrate 
(MTP) in powders and tablets proposed in this work is suggested for the feasibility study stage of the 
method development. EMA, ICH and PASG guidelines on NIRS method development and validation 
suggest that feasibility study should be done at the onset of method development. Simulation of 
industrial scale tablet machines using tablet press replicator - Presster® and Balance Reference 
Method (BRM) as an alternative to HPLC and UV-spectroscopy which are traditionally used as 
reference methods in NIRS method development, could be a good solution for the feasibility study 
stage. With a proposed experimental setup, the resource savings are evident bearing in mind that the 
further stages of NIRS method development would require industrial scale tablet press instead of 
tablet press replicator and validated official reference method instead of Balance Reference Method in 
order to be able to validate the procedure with the relevant regulatory authorities. 
Metoprolol Tartrate and Hydrochlorothiazide were simultaneously determined in powder and tablet 
samples using NIR spectroscopy with satisfying accuracy. Balance reference method was shown to be 
accurate enough, fast and convenient for feasibility studies at the onset of method development. The 
proposed approach involving compaction simulator for sample set design and manufacture, quick and 
simple gravimetrical reference method for developing the NIR calibration model, presents a fast and 
cost-effective alternative that could be applied for the initial stages of NIR method development. The 
proposed approach could be applied in feasibility study step, optimization of sample presentation and 
scanning, study of the variables affecting spectral response, evaluation of the quality of the scans, i.e. 
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repeatability, effect of inhomogeneities. For the further steps in method development an official 
reference method, validated according to ICH Q2 guidelines should be used. 
 
The developed NIR method for determining the factors of the Heckel-plot and the modified Heckel-
plot have shown promising results for the studied powder formulations. 
Essentially different outcome values were reached with the Near-Infrared spectroscopy method for 
the Prediction of the factors of Leuenberger equation (tmax) using developed NIR method have 
shown descrepancies when compared to the traditional approach which could be attributed to the 
relatively small data set used for modeling and the high influence of the outliers in the data set. 
The choice of the studied formulations was made with the focus set on the different materials 
showing a widest possible range of particle size and a wide range of compression mechanisms. 
These factors have shown no influence on the NIR predictions of the studied technical factors. The 
proposed method is suggested as a promising approach for a non-destructive compressibility 
measurement of powder formulations. However, it should be noted that the study has been performed 
off-line with a time delay between the production and the actual measurements. The promising results 
suggest that an on-line and in-line sampling approach should be attempted which would bring higher 
benefits to process control and optimization.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Vranic Z. Branko PhD Thesis Page 120 
 
4. References 
 
1. Saeed M., 2011 “Pharmaceutical Tablets and Near-infrared Spectral Information – 
Investigation of Sampled Tablet Sections and Press Effect on Predictions”, PhD dissertation, 
University of Basel, Switzerland. 
 
2. Davies, T. "The history of near infrared spectroscopic analysis: Past, present and future-
From sleeping technique to the morning star of spectroscopy." Analusis 26.4 (1998): M17. 
 
3. Maxwell, J. C. The Scientific Papers of James Clerk Maxwell. Vol. 1. Cambridge University 
Press, 2011. 
 
4. Planck, M. "On the law of distribution of energy in the normal spectrum." Annalen der 
Physik 4.553 (1901): 1. 
 
5. Pasquini, C. "Near infrared spectroscopy: fundamentals, practical aspects and analytical 
applications." Journal of the Brazilian Chemical Society 14.2 (2003): 198-219. 
 
6. Wahr, J. A., et al. "Near-infrared spectroscopy: theory and applications." Journal of 
cardiothoracic and vascular anesthesia 10.3 (1996): 406-418. 
 
7. Ben‐Gera, I. T. A. M. A. R., and Norris. H. K. "Direct spectrophotometric determination of 
fat and moisture in meat products." Journal of Food Science 33.1 (1968): 64-67. 
 
8. Wilson, Edgar Bright. Molecular vibrations: the theory of infrared and Raman vibrational 
spectra. DoverPublications. com, 1955. 
 
9. Quack, Martin. "Spectra and dynamics of coupled vibrations in polyatomic molecules." 
Annual Review of Physical Chemistry 41.1 (1990): 839-874. 
 
10. Sokolnikoff, I. S., and Dickerson S. R. Mathematical theory of elasticity. Vol. 83. New 
York: McGraw-Hill, 1956. 
 
11. Rychlewski, J. "On Hooke's law." Journal of Applied Mathematics and Mechanics 48.3 
(1984): 303-314. 
 
 Vranic Z. Branko PhD Thesis Page 121 
 
12. Workman, J. J. "NIR spectroscopy calibration basics." Practical Spectroscopy Series 13 
(1992): 247-247. 
 
13. Cozzolino, D., and I. Murray. "Effect of sample presentation and animal muscle species on 
the analysis of meat by near infrared reflectance spectroscopy." Journal of Near Infrared 
Spectroscopy 10.1 (2002): 37-44. 
 
14. Siesler, Heinz W., et al., eds. Near-infrared spectroscopy: principles, instruments, 
applications. Wiley. com, 2008. 
 
15. Wendlandt, W. W., and Harry G. H. Reflectance spectroscopy. Vol. 110. New York: 
Interscience, 1966. 
 
16. Fuller, M. P., and Griffiths P. R. "Diffuse reflectance measurements by infrared Fourier 
transform spectrometry." Analytical Chemistry 50.13 (1978): 1906-1910. 
 
17. Simmons, E. L. "Diffuse reflectance spectroscopy: a comparison of the theories." Applied 
optics 14.6 (1975): 1380-1386. 
 
18. Steinke, J. M., and Shepherd A. P. "Comparison of Mie theory and the light scattering of red 
blood cells." Applied Optics 27.19 (1988): 4027-4033. 
 
19. Kubelka, P. "New contributions to the optics of intensely light-scattering materials. Part I." 
JOSA 38.5 (1948): 448-448. 
 
20. Nobbs, James H. "Kubelka—Munk theory and the prediction of reflectance." Review of 
Progress in Coloration and Related Topics 15.1 (1985): 66-75. 
 
21. Zaccanti, G., and P. Bruscaglioni. "Deviation from the Lambert-Beer law in the 
transmittance of a light beam through diffusing media: experimental results." Journal of 
Modern Optics 35.2 (1988): 229-242. 
 
22. Langhals, H., G. Abbt‐Braun, and F. H. Frimmel. "Association of Humic Substances: 
Verification of Lambert‐Beer Law." Acta hydrochimica et hydrobiologica 28.6 (2000): 329-
332. 
 
 Vranic Z. Branko PhD Thesis Page 122 
 
23. Workman, J. J., and Donald A. Burns. "Commercial NIR instrumentation." PRACTICAL 
SPECTROSCOPY SERIES 27 (2001): 53-70. 
 
24. Osborne, B. G. et al. Practical NIR spectroscopy with applications in food and beverage 
analysis. Longman scientific and technical, 1993. 
 
25. Shenk, J. S., and Westerhaus M. O. "Accuracy of NIRS instruments to analyze forage and 
grain." Crop science 25.6 (1985): 1120-1122. 
 
26. Malinen, J. et al. "LED-based NIR spectrometer module for hand-held and process analyser 
applications." Sensors and Actuators B: Chemical 51.1 (1998): 220-226. 
 
27. Pasquini, C. "Near infrared spectroscopy: fundamentals, practical aspects and analytical 
applications." Journal of the Brazilian Chemical Society 14.2 (2003): 198-219. 
 
28. Armstrong, P. R., et al. "Comparison of dispersive and Fourier-transform NIR instruments 
for measuring grain and flour attributes." Applied engineering in agriculture 22.3 (2006): 
453. 
 
29. Cozzolino, D., et al. "Prediction of colour and pH in grapes using a diode array 
spectrophotometer (400-1100 nm)." Journal of near infrared spectroscopy 12.2 (2004): 105-
111. 
 
30. Vandeginste, B. G. M., et al. "Chemometrics: a textbook." (1988): 20-21. 
 
31. Aiken, L. S. et al. "Multiple linear regression." Handbook of psychology (2003). 
 
32. Jolliffe, I. Principal component analysis. John Wiley & Sons, Ltd, 2005 
 
33. Kohavi, R. "A study of cross-validation and bootstrap for accuracy estimation and model 
selection." IJCAI. Vol. 14. No. 2. 1995. 
 
34. Geladi, Paul, and Bruce R. Kowalski. "Partial least-squares regression: a tutorial." Analytica 
chimica acta 185 (1986): 1-17. 
 
35. Seasholtz, Mary Beth, and Bruce R. Kowalski. "The effect of mean centering on prediction 
in multivariate calibration." Journal of chemometrics 6.2 (1992): 103-111. 
 Vranic Z. Branko PhD Thesis Page 123 
 
 
36. Savitzky, A., and Golay J. E. M. "Smoothing and differentiation of data by simplified least 
squares procedures." Analytical chemistry 36.8 (1964): 1627-1639. 
 
37. Faber, N. M. "Multivariate sensitivity for the interpretation of the effect of spectral 
pretreatment methods on near-infrared calibration model predictions." Analytical chemistry 
71.3 (1999): 557-565. 
 
38. Isaksson, T., and Naes T. "The effect of multiplicative scatter correction (MSC) and 
linearity improvement in NIR spectroscopy." Applied Spectroscopy 42.7 (1988): 1273-
1284. 
 
39. Barnes, R. J. et al. "Standard normal variate transformation and de-trending of near-infrared 
diffuse reflectance spectra." Applied spectroscopy 43.5 (1989): 772-777. 
 
40. Shenk, J. S., and M. O. Westerhaus. "Population definition, sample selection, and calibration 
procedures for near infrared reflectance spectroscopy." Crop science 31.2 (1991): 469-474. 
 
41. FDA 2005: “ICH Harmonized Tripartide guideline, Q2 (R1), Validation of Analytical 
Procedures: Text and Methodology”. 
 
42. European Medicines Agency “Guideline on the use of Near Infrared Spectroscopy (NIRS) 
by the pharmaceutical industry and the data requirements for new submissions and 
variations.” (2012): 1-28. 
 
43. PASG NIR subgroup “PASG guidelines for the development and validation of near-infrared 
(NIR) spectroscopy methods” (2001): 1-41. 
 
44. Shenk, J. S. et al. "Application of NIR spectroscopy to agricultural products." PRACTICAL 
SPECTROSCOPY SERIES 27 (2001): 419-474. 
 
45. Eriksson, L. “Design of experiments: principles and applications”. MKS Umetrics AB, 
2008. 
 
46. Levin, M., ed. Pharmaceutical process scale-up. CRC Press, 2001. 
 
 Vranic Z. Branko PhD Thesis Page 124 
 
47. Sinka, I. C., et al. "The effect of processing parameters on pharmaceutical tablet properties." 
Powder Technology 189.2 (2009): 276-284. 
 
48. Marshall, K. "A new technique for investigating the process of tablet compression: A 
preliminary report." Journal of Pharmacy and Pharmacology 15.1 (1963): 413-421. 
 
49. Sheikh-Salem, M., and J. T. Fell. "Compaction characteristics of mixtures of materials with 
dissimilar compaction mechanisms." Int. J. Pharm. Tech. Prod. Mfr 2.1 (1981): 19-22. 
 
50. Kesavan, Jothi G., and Garnet E. Peck. "Pharmaceutical granulation and tablet formulation 
using neural networks." Pharmaceutical development and technology 1.4 (1996): 391-404. 
 
51. Sun, C. and Grant D. J. W. "Influence of crystal structure on the tableting properties of 
sulfamerazine polymorphs." Pharmaceutical research 18.3 (2001): 274-280. 
 
52. Sun, C. and Grant D. J. W. "Effects of initial particle size on the tableting properties of L-
lysine monohydrochloride dihydrate powder." International Journal of pharmaceutics 215.1 
(2001): 221-228. 
 
53. Berggren, J. and Alderborn G. "Effect of drying rate on porosity and tabletting behaviour of 
cellulose pellets." International Journal of Pharmaceutics 227.1 (2001): 81-96. 
 
54. Stiel, D. M. "Method invoking tabletting compression force control for optimizing tabletted 
formulation parameters." U.S. Patent No. 4,121,289. 17 Oct. 1978. 
 
55. Vezin, W. R. et al. "Adjustment of precompression force to reduce mixing‐time dependence 
of tablet tensile strength." Journal of pharmacy and pharmacology 35.9 (1983): 555-558. 
 
56. Tye, C. K. et al. "Evaluation of the effects of tableting speed on the relationships between 
compaction pressure, tablet tensile strength, and tablet solid fraction." Journal of 
pharmaceutical sciences 94.3 (2005): 465-472. 
 
57. Lin, S. Y. "Effect of excipients on tablet properties and dissolution behavior of theophylline‐
tableted microcapsules under different compression forces." Journal of pharmaceutical 
sciences 77.3 (1988): 229-232. 
 
 Vranic Z. Branko PhD Thesis Page 125 
 
58. Sebhatu, T. et al. "Effect of moisture sorption on tabletting characteristics of spray dried 
(15% amorphous) lactose." Pharmaceutical research 11.9 (1994): 1233-1238. 
 
59. Kanig, J. L. "DIRECT COMPRESSION TABLETTING." U.S. Patent No. 3,873,694. 1975. 
 
60. Çelik, M. and Marshall K. "Use of a compaction simulator system in tabletting research." 
Drug Development and Industrial Pharmacy 15.5 (1989): 759-800. 
 
61. Neuhaus, T. “Investigation and optimisation of the presster: a linear compaction simulator 
for rotary tablet presses” Verlag Dr. Hut, 2007. 
 
62. M. Saeed, L. Probst, G. Betz. Assessment of diffuse transmission mode in near-infrared 
quantification – part II: comparison of information depth with diffuse reflection. Journal of 
Pharmaceutical Sciences. Volume 100, Issue 3, pages 1130–1141, March 2011. 
 
63. Ben-Gera, I., and K. H. Norris. "Determination of moisture content in soybeans by direct 
spectrophotometry." Isr. J. Agric. Res 18.3 (1968): 125-132. 
 
64. Ben-Gera, I. T. A. M. A. R., and KARL H. NORRIS. "Direct spectrophotometric 
determination of fat and moisture in meat products." Journal of Food Science 33.1 (1968): 
64-67. 
 
65. Saeed et al. Assessment of diffuse transmission mode in near-infrared quantification - part I: 
The press effect on low-dose pharmaceutical tablets. Journal of Pharmaceutical Sciences. 
2009, 98 (12), 4877-4886. 
 
66. Cruz J, Blanco M. Content uniformity studies in tablets by NIR-CI, J Pharm Biomed Anal 
2011;in press 
 
67. Dou Y, Sun Y, Ren Y, Ju P, Ren Y. Simultaneous non-destructive determination of two 
components of combined paracetamol and amantadine hydrochloride in tablets and powder 
by NIR spectroscopy and artificial neural networks, J Pharm Biomed Anal 2005;37: 543-
549 
 
68. Ito M, Suzuki T, Yada S, Nakagami H, Teramoto H, Yonemuchi E, Terada K. Development 
of a method for nondestructive NIR transmittance spectroscopic analysis of acetaminophen 
and caffeine anhydrate in intact bilayer tablets, J Pharm Biomed Anal 2010; 53: 396-402 
 Vranic Z. Branko PhD Thesis Page 126 
 
 
69. Blanco M, Eustaquio J, Gonzalez, Serrano D. Identification and quantitation assays for 
intact tablets of two related pharmaceutical preparations by reflectance near-infrared 
spectroscopy: validation of the procedure, J Pharm Biomed Anal, 2000;22: 139-148 
 
70. Alvarenga L, Ferreira D, Altekruse D, Menezes JC, Lochmann D. Tablet identification 
using near-infrared spectroscopy (NIRS) for pharmaceutical quality control, J Pharm 
Biomed Anal, 2008;48: 62-69 
 
71. Karande A, Heng P, Liew C. In-line quantification of micronized drug and excipients in 
tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process, Int J 
Pharm,2010;396: 63-74 
 
72. Sekulic, S. Sonja, et al. "On-line monitoring of powder blend homogeneity by near-infrared 
spectroscopy." Analytical Chemistry 68.3 (1996): 509-513. 
 
73. Hailey, P. A., et al. "Automated system for the on-line monitoring of powder blending 
processes using near-infrared spectroscopy part I. System development and control." Journal 
of pharmaceutical and biomedical analysis 14.5 (1996): 551-559. 
 
74. Rosa, Sílvia S., et al. "Development and validation of a method for active drug identification 
and content determination of ranitidine in pharmaceutical products using near-infrared 
reflectance spectroscopy: A parametric release approach." Talanta 75.3 (2008): 725-733. 
 
75. Luypaert, J., D. L. Massart, and Y. Vander Heyden. "Near-infrared spectroscopy 
applications in pharmaceutical analysis." Talanta 72.3 (2007): 865-883. 
 
76. Gemperline, Paul J., Laurie D. Webber, and Frank O. Cox. "Raw materials testing using soft 
independent modeling of class analogy analysis of near-infrared reflectance spectra." 
Analytical Chemistry 61.2 (1989): 138-144. 
 
77. Candolfi, A., et al. "Identification of pharmaceutical excipients using NIR spectroscopy and 
SIMCA." Journal of pharmaceutical and biomedical analysis 19.6 (1999): 923-935. 
 
78. Blanco, M., and M. A. Romero. "Near-infrared libraries in the pharmaceutical industry: a 
solution for identity confirmation." Analyst 126.12 (2001): 2212-2217. 
 
 Vranic Z. Branko PhD Thesis Page 127 
 
79. Blanco, Marcelo, and Manel Alcalá. "Content uniformity and tablet hardness testing of 
intact pharmaceutical tablets by near infrared spectroscopy: a contribution to process 
analytical technologies." Analytica chimica acta 557.1 (2006): 353-359. 
 
80. Blanco, Marcelo, et al. "A process analytical technology approach based on near infrared 
spectroscopy: tablet hardness, content uniformity, and dissolution test measurements of 
intact tablets." Journal of pharmaceutical sciences 95.10 (2006): 2137-2144. 
 
81. Blanco, M., et al. "Quantitation of the active compound and major excipients in a 
pharmaceutical formulation by near infrared diffuse reflectance spectroscopy with fibre 
optical probe." Analytica chimica acta 333.1 (1996): 147-156. 
 
82. Chalus, Pascal, Serge Walter, and Michel Ulmschneider. "Combined wavelet transform–
artificial neural network use in tablet active content determination by near-infrared 
spectroscopy." Analytica chimica acta 591.2 (2007): 219-224. 
 
83. Mantanus, Jérôme, et al. "Active content determination of non-coated pharmaceutical pellets 
by near infrared spectroscopy: Method development, validation and reliability evaluation." 
Talanta 80.5 (2010): 1750-1757. 
 
84. Moes, Johannes J., et al. "Application of process analytical technology in tablet process 
development using NIR spectroscopy: Blend uniformity, content uniformity and coating 
thickness measurements." International journal of pharmaceutics 357.1 (2008): 108-118. 
 
85. Sulub, Yusuf, et al. "Real-time on-line blend uniformity monitoring using near-infrared 
reflectance spectrometry: A noninvasive off-line calibration approach." Journal of 
pharmaceutical and biomedical analysis 49.1 (2009): 48-54. 
 
86. Lyon, Robbe C., et al. "Near-infrared spectral imaging for quality assurance of 
pharmaceutical products: analysis of tablets to assess powder blend homogeneity." AAPS 
PharmSciTech 3.3 (2002): 1-15. 
 
87. Ely, David, Sai Chamarthy, and M. Teresa Carvajal. "An investigation into low dose blend 
uniformity and segregation determination using NIR spectroscopy." Colloids and Surfaces 
A: Physicochemical and Engineering Aspects 288.1 (2006): 71-76. 
 
 Vranic Z. Branko PhD Thesis Page 128 
 
88. Morisseau, Karen M., and Christopher T. Rhodes. "Near-infrared spectroscopy as a 
nondestructive alternative to conventional tablet hardness testing." Pharmaceutical research 
14.1 (1997): 108-111 
 
89. Donoso, M., D. O. Kildsig, and Evone S. Ghaly. "Prediction of tablet hardness and porosity 
using near-infrared diffuse reflectance spectroscopy as a nondestructive method." 
Pharmaceutical development and technology 8.4 (2003): 357-366. 
 
90. Santos, A. F., E. L. Lima, and J. C. Pinto. "In‐line evaluation of average particle size in 
styrene suspension polymerizations using near‐infrared spectroscopy." Journal of Applied 
Polymer Science 70.9 (1998): 1737-1745. 
 
91. Rantanen, Jukka, et al. "On-line monitoring of moisture content in an instrumented fluidized 
bed granulator with a multi-channel NIR moisture sensor." Powder Technology 99.2 (1998): 
163-170. 
 
92. Zheng, Yiwu, et al. "Determination of moisture content of lyophilized allergen vaccines by 
NIR spectroscopy." Journal of pharmaceutical and biomedical analysis 46.3 (2008): 592-
596. 
 
93. Andersson, Martin, et al. "Quantitative analysis of film coating in a fluidized bed process by 
in-line NIR spectrometry and multivariate batch calibration." Analytical chemistry 72.9 
(2000): 2099-2108. 
 
94. Pérez-Ramos, José D., et al. "Quantitative analysis of film coating in a pan coater based on 
in-line sensor measurements." Aaps Pharmscitech 6.1 (2005): E127-E136. 
 
95. Römer, Meike, et al. "Prediction of tablet film-coating thickness using a rotating plate 
coating system and NIR spectroscopy." Aaps Pharmscitech 9.4 (2008): 1047-1053. 
 
96. Lee, Min-Jeong, et al. "In line NIR quantification of film thickness on pharmaceutical 
pellets during a fluid bed coating process." International journal of pharmaceutics 403.1 
(2011): 66-72. 
 
97. Aldridge, Paulá K, and S. á Sonja Sekulic. "Determination of end-points for polymorph 
conversions of crystalline organic compounds using on-line near-infrared spectroscopy." 
Analyst 122.6 (1997): 549-552. 
 Vranic Z. Branko PhD Thesis Page 129 
 
 
98. Blanco, Marcelo, et al. "Application of NIR spectroscopy in polymorphic analysis: Study of 
pseudo‐polymorphs stability." Journal of pharmaceutical sciences 94.6 (2005): 1336-1342.  
 
99. Otsuka, Makoto, Fumie Kato, and Yoshihisa Matsuda. "Determination of indomethacin 
polymorphic contents by chemometric near-infrared spectroscopy and conventional powder 
X-ray diffractometry." Analyst 126.9 (2001): 1578-1582.  
 
100. Schneider, Ralph Carsten, and Karl-Artur Kovar. "Analysis of ecstasy tablets: comparison 
of reflectance and transmittance near infrared spectroscopy." Forensic science international 
134.2 (2003): 187-195. 
 
101. Trafford, AndrewáD, RogeráD Jee, and AnthonyáC Moffat. "A rapid quantitative assay of 
intact paracetamol tablets by reflectance near-infrared spectroscopy." Analyst 124.2 (1999): 
163-167. 
 
102. Chalus, Pascal, et al. "Near-infrared determination of active substance content in intact low-
dosage tablets." Talanta 66.5 (2005): 1294-1302. 
 
103. Feng, Yan-Chun, and Chang-Qin Hu. "Construction of universal quantitative models for 
determination of roxithromycin and erythromycin ethylsuccinate in tablets from different 
manufacturers using near infrared reflectance spectroscopy." Journal of pharmaceutical and 
biomedical analysis 41.2 (2006): 373-384. 
 
104. Laasonen, Magali, et al. "Development and validation of a near-infrared method for the 
quantitation of caffeine in intact single tablets." Analytical chemistry 75.4 (2003): 754-760. 
 
105. Dyrby, M., et al. "Chemometric quantitation of the active substance (containing C≡ N) in a 
pharmaceutical tablet using near-infrared (NIR) transmittance and NIR FT-Raman spectra." 
Applied spectroscopy 56.5 (2002): 579-585. 
 
106. Gottfries, J., et al. "Vibrational spectrometry for the assessment of active substance in 
metoprolol tablets: a comparison between transmission and diffuse reflectance near-infrared 
spectrometry." Journal of pharmaceutical and biomedical analysis 14.11 (1996): 1495-1503. 
 
107. Abrahamsson, Christoffer, et al. "Time-resolved NIR spectroscopy for quantitative analysis 
of intact pharmaceutical tablets." Analytical chemistry 77.4 (2005): 1055-1059. 
 Vranic Z. Branko PhD Thesis Page 130 
 
 
108. Saeed, M., et al. "Assessment of diffuse transmission mode in near‐infrared quantification—
part I: The press effect on low‐dose pharmaceutical tablets." Journal of pharmaceutical 
sciences 98.12 (2009): 4877-4886. 
 
109. Ito, Masatomo, et al. "Development of a method for nondestructive NIR transmittance 
spectroscopic analysis of acetaminophen and caffeine anhydrate in intact bilayer tablets." 
Journal of pharmaceutical and biomedical analysis 53.3 (2010): 396-402. 
 
110. Meza, Carlos Peroza, María A. Santos, and Rodolfo J. Romañach. "Quantitation of drug 
content in a low dosage formulation by transmission near infrared spectroscopy." Aaps 
Pharmscitech 7.1 (2006): E206-E214. 
 
111. Xiang, Dong, et al. "Development of robust quantitative methods by near-infrared 
spectroscopy for rapid pharmaceutical determination of content uniformity in complex tablet 
matrix." Analyst 134.7 (2009): 1405-1415. 
 
112. Ito, Masatomo, et al. "Development of a method for the determination of caffeine anhydrate 
in various designed intact tables by near-infrared spectroscopy: A comparison between 
reflectance and transmittance technique." Journal of pharmaceutical and biomedical analysis 
47.4 (2008): 819-827. 
 
113. Xiang, Dong, et al. "Evaluation of transmission and reflection modalities for measuring 
content uniformity of pharmaceutical tablets with near-infrared spectroscopy." Applied 
spectroscopy 63.1 (2009): 33-47. 
 
114. Mark, Howard, et al. "Validation of a near-infrared transmission spectroscopic procedure, 
part A: validation protocols." Journal of pharmaceutical and biomedical analysis 28.2 
(2002): 251-260. 
 
115. Wu, W., et al. "Artificial neural networks in classification of NIR spectral data: design of the 
training set." Chemometrics and intelligent laboratory systems 33.1 (1996): 35-46. 
 
116. Borer, Matthew W., et al. "Evaluation of key sources of variability in the measurement of 
pharmaceutical drug products by near infrared reflectance spectroscopy." Journal of 
pharmaceutical and biomedical analysis 17.4 (1998): 641-650. 
 
 Vranic Z. Branko PhD Thesis Page 131 
 
117. Rutan, Sarah C., Onno E. de Noord, and Ronald R. Andréa. "Characterization of the sources 
of variation affecting near-infrared spectroscopy using chemometric methods." Analytical 
chemistry 70.15 (1998): 3198-3201. 
 
118. Blanco, Marcelo, and Anna Peguero. "Influence of physical factors on the accuracy of 
calibration models for NIR spectroscopy." Journal of pharmaceutical and biomedical 
analysis 52.1 (2010): 59-65. 
 
119. Data Reduction and Error Analysis for the Physical Sciences, Second Edition, by Philip R. 
Bevington and D.Keith Robinson, McGraw-Hill Inc., 1992. 
 
120. European Medicines Agency “Guideline on the use of Near Infrared Spectroscopy (NIRS) 
by the pharmaceutical industry and the data requirements for new submissions and 
variations.” (2012): 1-28. 
 
121. PASG NIR subgroup “PASG guidelines for the development and validation of near-infrared 
(NIR) spectroscopy methods” (2001): 1-41. 
 
122. Hailey, P. A., et al. "Automated system for the on-line monitoring of powder blending 
processes using near-infrared spectroscopy part I. System development and control." Journal 
of pharmaceutical and biomedical analysis 14.5 (1996): 551-559. 
 
123. Momose, Wataru, et al. "Process analytical technology applied for end-point detection of 
pharmaceutical blending by combining two calibration-free methods: Simultaneously 
monitoring specific near-infrared peak intensity and moving block standard deviation." 
Powder Technology 210.2 (2011): 122-131. 
 
124. ISO 12099:2010 – Animal feeding stuffs, cereals and milled cereal products Guidelines for 
the application of near infrared spectrometry, http://www.iso.org ; 2010. 
 
125. Williams, P. C. 2001. Implementation of near-infrared technology. Pages 145–169 in Near-
Infrared Technology in the Agriculture and Food Sciences. 2nd ed. P. Williams and K. 
Norris, ed. Am. Assoc. Cereal Chem., St. Paul, MN. 
 
126. Carol J. Bruegge ; Arthur W. Springsteen ; Albert E. Stiegman and Richard A. Rainen 
"Use of Spectralon as a diffuse reflectance standard for in-flight calibration of earth-orbiting 
sensors", Opt. Eng. 32(4), 805-814 (Apr 01, 1993). ; http://dx.doi.org/10.1117/12.132373  
 Vranic Z. Branko PhD Thesis Page 132 
 
 
127. Garg, Gopal, Shailendra Saraf, and Swarnlata Saraf. "Spectrophotometric and column high-
performance liquid chromatographic methods for simultaneous estimation of metoprolol 
tartrate and hydrochlorothiazide in tablets." Journal of AOAC International 91.5 (2008): 
1045-1550. 
 
128. Rawool, N. D., and A. Venkatchalam. "Analytical Method for the Simultaneous Estimation 
of Hydrochlorothiazide and Metoprolol Tartrate using RP HPLC." Indian journal of 
pharmaceutical sciences 73.2 (2011): 219-223. 
 
129. Gupta, K. R., M. R. Tajne, and S. G. Wadodkar. "New spectrophotometric method for 
simultaneous determination of metoprolol tartarate and hydrochlorthiazide in tablets." 
Indian journal of pharmaceutical sciences 70.4 (2008): 511. 
 
130. Gao, Feng, et al. "Simultaneous quantitation of hydrochlorothiazide and metoprolol in 
human plasma by liquid chromatography–tandem mass spectrometry." Journal of 
pharmaceutical and biomedical analysis 52.1 (2010): 149-154. 
 
131. Stolarczyk, M. A. R. I. U. S. Z., et al. "Determination of metoprolol and hydrochlorothiazide 
by derivative spectrophotometric method in pharmaceutical preparations." Acta Poloniae 
Pharmaceutica 63 (2006): 169-173. 
 
132. Ramadan, Nesrin K., Heba M. Mohamed, and Azza A. Mostafa. "Miniaturized membrane 
sensors for potentiometric determination of metoprolol tartrate and hydrochlorothiazide." 
Acta chimica Slovenica 59.2 (2012): 344-352. 
 
133. Alnajjar, Ahmed O., et al. "Capillary Electrophoresis Assay Method for Metoprolol and 
Hydrochlorothiazide in their Combined Dosage Form with Multivariate Optimization." 
Journal of chromatographic science 51.1 (2013): 92-97. 
 
134. Dou, Ying, et al. "Artificial neural network for simultaneous determination of two 
components of compound paracetamol and diphenhydramine hydrochloride powder on NIR 
spectroscopy." Analytica chimica acta 528.1 (2005): 55-61. 
 
135. Dou, Ying, et al. "Determination of compound aminopyrine phenacetin tablets by using 
artificial neural networks combined with principal components analysis." Analytical 
biochemistry 351.2 (2006): 174-180. 
 Vranic Z. Branko PhD Thesis Page 133 
 
 
136. Blanco, M., and M. Alcala. "Simultaneous quantitation of five active principles in a 
pharmaceutical preparation: Development and validation of a near infrared spectroscopic 
method." European journal of pharmaceutical sciences 27.2 (2006): 280-286. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Branko Z. Vranic 
 
Address: Schaffhauserstrasse 5, 8006 Zürich, Switzerland 
Phone:    + 41 76 273 97 27  
E-mail:  vranic.b@buchi.com 
Age: 31 
 
 
 
 
Summary: PhD candidate in pharmaceutical technology with 5+ years of experience in research and development  
 
 
Professional Experience 
 
  05.2014 – present BUCHI Labortechnik AG, Meierseggstrasse 40, CH-9230 Flawil                        
   Global Application Specialist NIR-Online / Product Specialist NIR-Online Switzerland & Austria 
 
• Global NIR-Online application support for customers, distributor partners and affiliates 
• Consulting and implementation plans 
• Feasibility studies 
• Sales support for Switzerland and Austria 
 
 
09.2011 – 05.2014 BUCHI Labortechnik AG, Meierseggstrasse 40, CH-9230 Flawil                        
   Global Application and Training Specialist NIR 
 
• Development of near-infrared spectroscopic applications for the clients in pharmaceutical industry  
• Consulting and implementation plans 
• Installations (IQ, OQ, PQ)  
• Method validation 
• Feasibility studies 
• Collaborative development projects with Academia  
• Global application and software support  
• Trainings and seminars 
• Development of innovative training methodologies 
• QA - development of instrument testing procedures and SOPs  
• Software and hardware development and testing 
• Technology scouting; strategic projects; sales project management 
• Interaction with pharmaceutical regulatory bodies (EMA) 
 
 
09.2008 – 09.2011 University of Basel, Industrial Pharmacy Research Group Klingelbergstrasse 50, CH-4056 Basel                  
   Researcher and Teaching Assistant 
 
• Research in the field of NIR implementation in pharmaceutical production process monitoring and QC of 
solid dosage forms 
• Organization, preparation and execution of practical exercises in pharmaceutical technology, industrial 
pharmacy and physical chemistry 
• Supervision of student research projects in pharmaceutical technology and near-infrared spectroscopy 
 
 
Education 
 
 
09.2008 – present             PhD Student - Pharmaceutical Technology, University of Basel, Switzerland 
                       
Title of the thesis: ` Design of Experiments Methodology in Studying Near-Infrared Spectral Information of 
Model Intact Tablets - Simultaneous Determination of Metoprolol Tartrate and Hydrochlorothiazide in Solid 
Dosage Forms and Powder Compressibility Assessment Using Near-Infrared Spectroscopy`, Department of 
Pharmaceutical Sciences, University of Basel. 
 
10.2002 – 06.2008             MSc in Pharmaceutical Sciences, University of Belgrade, Serbia 
 
Title of the thesis: `Formulation, Preparation and Evaluation of Modified - Release Verapamil 
Hydrochloride Matrix Tablets`, Department of Pharmaceutical Technology, Pharmaceutical Faculty, 
University of Belgrade.   
 
Skills 
 
 
Pharmaceutical process technologies: 
Fluid bed granulation, drying and coating; drum coating; high-share mixer granulation; roller-compaction; rotary and eccentric 
tablet presses (Korsch); compaction-simulator (Presster®). 
 
 Characterization (QC) methods:  
Near-infrared spectroscopy (mixing end-point determination, content determination of API(s) and excipients, CUT, tablet hardness 
and relative density, LOD,  prediction of disintegration time and dissolution profiles, prediction of compression and compaction 
properties of powders and granules, prediction of particle size); dissolution and disintegration tests; tablet hardness and friability 
testing; flowability of powders and granules; particle size determination methods (sieve analysis and laser diffraction); specific surface 
area determination; true, bulk and tapped density determination; powder compressibility and compactibility assessment; SEM; 
differential scanning calorimetry. 
 
 Analytical methods:  
NIR, UV, Chromatography. 
 
 Process Analytical Technologies:  
NIR (at-line, on-line, in-line – fiber optic probes and non-contact NIR), Focused Beam Reflectance Measurement (FBRM), Power 
Consumption (high-share mixer). 
 
 Software skills:  
Chemometric software packages: NIRCal, OPUS, XLSTAT, Matlab (basic), Unscrambler 
Artificial Neuronal Networks: Synapse 
Design of Experiments: Stavex, MODDE, Minitab 
Various: CRM (Customer Relationship Management), ERP (Enterprise Resource Planning) 
 
 Regulations and Standards:  
cGMP; ICH Q2, Q8, Q9 and Q10; USP; EP; ISO 9001:2008; EMA guidelines 
 
 Other skills:  
Chemometrics, Design of Experiments, Multivariate Data Analysis Methods, QbD, PAT, modified drug-release technologies, 
compression and compaction physics, descriptive statistics and hypothesis testing, Kaizen, Miller-Heiman strategic selling, Lean 
Manufacturing. 
 
Languages 
 
 
English – Full Professional Proficiency 
German – Moderate 
Russian – Basic 
 
References 
 
Prof. Dr. Thierry F. Vandamme, Pharmaceutical Faculty, University of Strasbourg; E-mail: vandamme@unistra.fr 
 
Christian Lehmann, Product Group Manager NIR, BÜCHI Labortechnik AG; E-mail: lehmann.c@buchi.com 
 
Dr. Volker Frost, Chief Profit Center Spectroscopy, Metrohm AG; E-mail: info@metrohm.com 
 
PD Dr. Gabriele Betz, Department of Pharmaceutical Sciences, University of Basel; E-mail: gabriele.betz@unibas.ch  
 
Prof. Dr. Georg Gescheidt, Graz University of Technology; E-mail: g.gescheidt-demner@tugraz.at 
 
Prof. Dr. Svetlana Ibric; Pharmaceutical Faculty, University of Belgrade; E-mail: svetlana.ibric@pharmacy.bg.ac.rs 
 
LIST OF PUBLICATIONS 
 
1. Alfuzosin milk protein nanoparticles: NIR spectral  characterization and floating tablets 
preparation 
 
Journal of Pharmaceutical Development and Technology – Under Review 
Elgindy N. a, Vranic B. b and Elzoghby A.a 
a  Dept. of  Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Egypt 
b  BÜCHI Labortechnik AG, Switzerland  
2. Assessing compressibility and compactibility of powder formulations with Near-Infrared 
Spectroscopy 
 
Journal of Pharmaceutical Development and Technology; Febuary 2013, Vol. 18, No. 1, 
Pages 156-171 (doi:10.3109/10837450.2012.663388) 
 
Nicolaos D. Gentis, Branko Z. Vranic, Gabriele Betz 
Department of Pharmaceutical Sciences, Industrial Pharmacy Research Group, University 
of Basel, Basel, Switzerland 
 
3. Effect of simulated precompression, compression pressure and tableting speed on an 
offline diffuse transmittance and reflectance near-infrared spectral information of 
model intact caffeine tablets  
Journal of Pharmaceutical Development and Technology; Early Online: 1–9; 2014 
Informa Healthcare USA, Inc. DOI: 10.3109/10837450.2014.949267 
Branko Z. Vranic 
1, 2, Thierry F. Vandamme 3 
1 Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 
50, CH-4056 Basel, Switzerland. 
2 Büchi Labortechnik AG, Meierseggstrasse 40, Postfach CH-9230 Flawil 1, 
Switzerland. 
3 Université de Strasbourg, Faculté de Pharmacie, CNRS 7199 Laboratoire de 
Conception et Application de Molécules Bioactives, équipe de Pharmacie 
Biogalénique, 74 route du Rhin BP 60024 F-67401 Illkirch Cedex, France. 
 
4. Preliminary study of an offline simultaneous determination of metoprolol tartrate and 
hydrochlorothiazide in powders and tablets by reflectance near-infrared spectroscopy 
Journal of Pharmaceutical Development and Technology; Early Online: 1–6; 2014 
Informa Healthcare USA, Inc. DOI: 10.3109/10837450.2014.949268 
Branko Z. Vranic 
1, 2, Thierry F. Vandamme 3 
1 University of Basel, Department of Pharmaceutical Sciences, Klingelbergstrasse 
50, CH-4056 Basel, Switzerland. 
2 Büchi Labortechnik AG, Meierseggstrasse 40, Postfach CH-9230 Flawil 1, 
Switzerland. 
3 Université de Strasbourg, Faculté de Pharmacie, CNRS 7199 Laboratoire de 
Conception et Application de Molécules Bioactives, équipe de Pharmacie 
Biogalénique, 74 route du Rhin BP 60024 F-67401 Illkirch Cedex, France. 
 
5. Preliminary assessment of vegetable oil adulteration of pistachio paste by near infrared 
spectroscopy 
 
NIR News; Vol. 25 No. 4 June/July 2014; DOI: 10.1255/nirn.1447 
 
N. Bernardi,a G. Benetti,a G. Campolongo,b G. Ferrari,b R. Palermob and B. Vranicb 
 
aReal Aromi Spa, Italy 
 
bBüchi Labortechnik AG, Switzerland 
 
6. At-Line Determination of Different Quality Parameters of Fresh Meat Using NIR 
Spectroscopy 
 
16th International Conference on Near Infrared Spectroscopy – Proceedings (Peer 
Reviewed) – Published ; P-1342 
 
Charles D. Dago1, B. Vranic 2, G. Campolongo2, G. Ferrari2   
 
1 16 Associazione Italiana Allevatori (A.I.A. - Italian Breeders Association), Rome, 
00161, Italy 
 
2 27 BUCHI Labortechnik AG – NIR Division, Flawil, 9230, Switzerland 
 
 
7. Design of Experiments Methodology in Studying Critical Factors Influencing Near-
Infrared Diffuse Transmission Spectra of Tablets 
 
16th International Conference on Near Infrared Spectroscopy – Proceedings (Peer 
Reviewed) – Published; P-1410 
 
 
Branko Vranic
1 
 
1 BUCHI Labortechnik AG – NIR Division, Flawil, 9230, Switzerland 
 
 
8. Feasibility of FT-NIR Spectroscopy as a Useful Tool for Rapid Process Control 1 in Palm 
Oil Mill 
 
16th International Conference on Near Infrared Spectroscopy – Proceedings (Peer 
Reviewed) – Published; P-1413 
 
 
Xue Ni, Ng1, Siat Pei, Chin1, Tee Ching Yee1, Yee Chee Hong2, Apichai 
Kittipanprayoon3, B. Vranic4 
 
1 14 Chemopharm Sdn Bhd, 20, Jalan SS2/66, 47300 Petaling Jaya. Selangor. Malaysia. 
2 25 Milivest Sdn Bhd, Block A, Lot 4, Ground Floor, Taman Grandview, PPM 111 
6 Elopura, 90000 Sandakan, Sabah. 
3 37 Buchi (Thailand) Ltd., ASEAN Competence Center, 77/121 Sin Sathorn Tower, 
Krungtonburi Rd. 
8 Klongtonsai, Klongsan, Bangkok 10600, Thailand. 
4 BUCHI Labortechnik AG – NIR Division, Flawil, 9230, Switzerland 
 
 
9. Evaluation of the Performance of NIRMaster™ Near-Infrared Spectrometer on Cheese 
Samples 
 
16th International Conference on Near Infrared Spectroscopy – Proceedings (Peer 
Reviewed) – Published; P-1415 
 
G. Campolongo, B. Vranic, V. Iplikci  
 
BUCHI Labortechnik AG – NIR Division, Flawil, 9230, Switzerland 
 
 
 
10. Critical Factors Influencing NIR Diffuse Transmission Spectra of Intact Tablets 
 
Russian Journal "Drug Development and Registration", ISSN: 2305-2066. (Peer    
Review) – Under Review 
 
Branko Vranic
1 
 
1 BUCHI Labortechnik AG – NIR Division, Flawil, 9230, Switzerland 
 
 
 
11.  Optimization of Drug Release from Compressed Multiparticulate Units Using 
Generalized Regression Neural Network 
 
7th Central European Symposium on Pharmaceutical Technology and Biotechnology - 
Proceedings (Peer Reviewed) – Published; OP021 
 
 
Ivić B.1, Ibrić S.2, Betz G.3, Vranic B.2, Đuric Z.2 
 
1 R&D Institute, Galenika a.d., Belgrade, Serbia 
2 Institute for Pharmaceutical Technology, Faculty of Pharmacy, University of Belgrade, 
Belgrade, Serbia 
3 Industrial Pharmacy Research Group, Department of Pharmaceutical Sciences, 
University of Basel, Switzerland 
 
 
 
 
 
 
LIST OF PRESENTATIONS 
 
1. Evaluation of the Performance of NIRMaster™ Near-Infrared Spectrometer on Cheese 
Samples: G. Campolongo, B. Vranic, V. Iplikci, 16th International Conference on NIR 
Spectroscopy, 2. – 7/06/2013, La Grande-Motte, France – poster presentation. 
 
 
2. Feasibility of FT-NIR Spectroscopy as a Useful Tool for Rapid Process Control in Palm 
Oil Mill: Xue Ni, Ng, Siat Pei, Chin, Tee Ching Yee, Yee Chee Hong, Apichai 
Kittipanprayoon, Vranic B., 16th International Conference on NIR Spectroscopy, 2. – 
7/06/2013, La Grande-Motte, France – poster presentation. 
 
 
3. Design of Experiments Methodology in Studying Critical Factors Influencing Near - 
Infrared Diffuse Transmission Spectra of Tablets: Vranic B., 16th International 
Conference on NIR Spectroscopy, 2. – 7/06/2013, La Grande-Motte, France – poster 
presentation. 
 
4. At-Line Determination of Different Quality Parameters of Fresh Meat Using NIR 
Spectroscopy: Charles D. Dago, B. Vranic, G. Campolongo, G. Ferrari, 16th International 
Conference on NIR Spectroscopy, 2. – 7/06/2013, La Grande-Motte, France – poster 
presentation. 
 
5. Examples of Rapid NIR Implementation Solutions in the Food Industry: Vranic B., 
Seminar “Automation in Food Industry”, Campden BRI, 19/06/2013, Gloucestershire, 
UK – oral presentation. 
 
6. Improving Near-Infrared Calibration Model Robustness Against Parameters of Tableting 
Process: Vranic B., QbD / PAT Conference 2011, 5. – 7/10/2011, Heidelberg, Germany 
– oral presentation. 
 7. Simultaneous Quantification of Metoprolol – Tartrate and Hydrochlorthiazide in 
Powders and Tablets Using NIR Spectroscopy: Vranic B., Frost V., Betz G., 15th 
International Conference on NIR Spectroscopy, 13. – 20/05/2011, Cape Town, South 
Africa. – poster presentation.  
 
8. Compressibility and Compactibility of Powder Formulations - Investigation from a 
Physico - Mathematical Perspective with Introduction of Near-Infrared Spectroscopy: 
Gentis N., Vranic B., Betz G., FIP Pharmaceutical Sciences World Congress, New 
Orleans, Louisiana, USA, 14. – 18/11/2010. – poster presentation. 
 
9. Prediction of Active Pharmaceutical Ingredient in Intact Tablets Using NIR Spectroscopy 
and Multivariate Data Analysis Methods: Vranic B., Frost V., Betz G., 5th Congress of 
Pharmacists of Serbia, Belgrade, Serbia, 13. – 17/10/2010. – oral presentation.  
 
10. Prediction of Drug Content in Intact Tablets Using Near - Infrared Spectroscopy and 
Artificial Neural Networks: Vranic B., Frost V., Betz G., Joint Meeting of Universities of 
Geneve, Zurich and Basel, 18/06/2010. – oral presentation. 
 
11. At-line Monitoring of Drug Content in Intact Tablets Using NIR Spectroscopy: PAT 
Initiative: Vranic B., Frost V., Betz G., University of Belgrade, Serbia, 20/04/2010 – 
Invited lecture. 
 
12. Compaction Behavior of Powder Mixtures with the Focus on Variation of Tablet Relative 
Density: Gentis N., Vranic B., Betz G., 7th World Meeting on Pharmaceutics, 
Biopharmaceutics and Pharmaceutical Technology, Valletta, Malta, 8. – 11/03/2010. – 
poster presentation. 
 
13. Simultaneous Quantification of Two Actives in Powders and Tablets Using NIR 
Spectroscopy: Vranic B., Frost V., Betz G., Annual Research Meeting, University of 
Basel, Switzerland, 02/2010. – poster presentation. 
 
14. Near-Infrared Spectroscopy as a Novel Tool for Studying Compressibility and 
Compactibility of Pharmaceutical Powders: Gentis N., Vranic B., Betz G., Annual 
Research Meeting, University of Basel, Switzerland, 02/2010. – poster presentation. 
 
15. Case Study: Robust Method for the Quantification of Active Pharmaceutical Ingredient in 
Intact Tablets Using NIR Spectroscopy: Vranic B., Frost V., Betz G., 7th PAT and 
Quality by Design Conference, London, UK, 19/01/2010. – oral presentation. 
 
16. Application of Near - Infrared Spectroscopy in the Prediction of Drug Content in Intact 
Tablets: Vranic B., Frost V., Betz G., Symposium BIOFARM 2009, Belgrade, Serbia, 
22/10/2009. - poster presentation. 
 
17. Robust Method for Determination of Caffeine in Intact Tablets by NIR Spectroscopy – 
Comparison Between Reflection and Transmission mode: Vranic B., Frost V., Betz G., 
IPL Symposium, Industrial Pharmacy Lab, University of Basel, Switzerland, 21/08/2009. 
– oral presentation. 
 
18. Prediction of Drug Content in Intact Tablets by Near-Infrared Spectroscopy: Vranic B., 
Frost V., Betz G., Annual Research Meeting, University of Basel, Switzerland, 02/2009. 
– poster presentation. 
 
19. Optimization of Drug Release from Compressed Multiparticulate Units Using 
Generalized Regression Neural Network: Ivić B., Ibrić S., Betz G., Vranic B., Đuric Z., 
7th Central European Symposium on Pharmaceutical Technology and Biotechnology, 
Ljubljana, Slovenia,18.–20/09/2008. – oral presentation. 
 
20. Preparation and Evaluation of pH – Independent Sustained – Release Matrix Tablets of 
Verapamil Hydrochloride Using Kollidon
® 
 SR: Ibrić S., Vranic B., Parojčić J., Đurić Z. 
The 1st Conference on Innovation in Drug Delivery, Naples, Italy, 30/09/2007 – 
03/10/2007. – poster presentation. 
